https://www.lmi.no/2023/03/24/dupixent-med-gode-kols-data/ 2023-03-24T09:17:34+00:00 https://www.lmi.no/2023/03/24/na-er-sanofis-blockbuster-eu-godkjent-mot-alvorlig-eksem-hos-barn-fra-seks-maneders-alder/ 2023-03-24T09:18:55+00:00 https://www.lmi.no/2023/03/24/ous-forsker-vil-etablere-nytt-selskap-onsker-a-forbedre-presisjons-behandling-mot-kreft/ 2023-03-24T09:19:58+00:00 https://www.lmi.no/2023/03/24/nytt-senter-for-nukleaer-forskning-er-godt-nytt-for-farmasistudenter/ 2023-03-24T09:22:00+00:00 https://www.lmi.no/2023/03/24/pharm-assist-er-na-del-av-link-medical/ 2023-03-24T09:52:51+00:00 https://www.lmi.no/2023/03/24/se-nortrials-velkommen-til-norge-video/ 2023-03-27T07:47:45+00:00 https://www.lmi.no/wp-content/uploads/2023/03/kjerkol-i-nortrialsvideo.png https://www.lmi.no/2023/03/27/eksplosiv-okning-av-kvinner-som-bruker-testosteron/ 2023-03-27T08:08:27+00:00 https://www.lmi.no/2023/03/27/ingen-i-verden-har-kommet-like-langt-som-marit-har-brukt-18-ar-og-200-millioner-kroner/ 2023-03-27T08:10:26+00:00 https://www.lmi.no/2023/03/27/2-av-3-bruker-denne-medisinen-feil/ 2023-03-27T08:11:46+00:00 https://www.lmi.no/2023/03/27/ber-regjeringa-sikre-curida/ 2023-03-27T08:18:56+00:00 https://www.lmi.no/2023/03/27/bor-jeg-ta-flattvaksine/ 2023-03-27T08:39:49+00:00 https://www.lmi.no/2023/03/27/na-far-de-fleste-pasienter-med-alvorlig-nyrekreft-immunterapi/ 2023-03-27T09:10:26+00:00 https://www.lmi.no/2023/03/27/inspire-rapport-markant-endring-i-behandling-av-nyrekreft/ 2023-03-27T09:54:57+00:00 https://www.lmi.no/wp-content/uploads/2023/03/Inspire-nyrekreft-forside.png https://www.lmi.no/wp-content/uploads/2023/03/nyrekreft-figur.png https://www.lmi.no/wp-content/uploads/2023/03/Giske-Ursin-bredde550.jpg https://www.lmi.no/wp-content/uploads/2022/11/Leif-Rune-Skymoen_portrett-2-halvnaert-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Lena-Holmstrom2.png https://www.lmi.no/2023/03/28/vil-ikke-a-satse-penger-pa-at-helseministeren-til-fredag-sier-ja-til-et-vaksinasjonsprogram-for-voksne/ 2023-03-28T07:44:15+00:00 https://www.lmi.no/2023/03/28/dette-sier-helseokonomene-om-prioritering-i-helsevesenet/ 2023-03-28T07:44:55+00:00 https://www.lmi.no/2023/03/28/novo-nordisk-nadde-malet-i-fase-3-studie-pa-oral-semaglutid/ 2023-03-28T07:45:33+00:00 https://www.lmi.no/2023/03/28/studie-manga-vill-helst-ha-miljovanligare-lakemedel/ 2023-03-28T07:46:05+00:00 https://www.lmi.no/2023/03/28/vil-stille-hoyere-krav-til-studier-for-a-gi-kreftlegemidler-akselerert-godkjenning/ 2023-03-28T07:46:42+00:00 https://www.lmi.no/2023/03/28/regjeringen-investerer-200-millioner-i-nukleaer-forskning/ 2023-03-28T07:48:56+00:00 https://www.lmi.no/2023/03/28/nytt-styre-i-lmi-4/ 2023-03-28T12:49:07+00:00 https://www.lmi.no/wp-content/uploads/2023/03/LMIs-styre-2023-25-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/LMIs-styre-2023-25_crop1-scaled.jpg https://www.lmi.no/2023/03/09/nordisk-veikart-for-sjeldne-sykdommer-2-0/ 2023-03-28T13:18:19+00:00 https://www.lmi.no/wp-content/uploads/2023/03/633d602b07a27435f333d722_nordic-rare-disease-2023.png https://www.lmi.no/wp-content/uploads/2023/03/633d602b07a27435f333d722_nordic-rare-disease-2023.png https://www.lmi.no/2023/03/29/eu-pharma-legislation-utsatt/ 2023-03-29T07:32:16+00:00 https://www.lmi.no/wp-content/uploads/2022/02/bente-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/05/Bente-Cecilie-By-Jansen.png https://www.lmi.no/2023/03/29/bayer-leder-om-eus-utsatte-legemiddellov-haper-de-bruker-tiden-pa-a-lage-et-bedre-utkast/ 2023-03-29T08:49:10+00:00 https://www.lmi.no/2023/03/29/fda-forslag-kan-gjore-det-vanskeligere-for-nykode-a-fa-akselerert-godkjenning/ 2023-03-29T08:49:44+00:00 https://www.lmi.no/2023/03/29/curida-styrelederen-det-var-akutt/ 2023-03-29T08:50:14+00:00 https://www.lmi.no/2023/03/29/immunterapi-mot-livmorkreft-imponerer-forskere-dette-er-den-nye-behandlingsstandarden/ 2023-03-29T08:50:41+00:00 https://www.lmi.no/2023/03/29/debatt-skal-vi-prioritere-for-helsetjenesten-eller-for-samfunnet-som-helhet/ 2023-03-29T08:51:12+00:00 https://www.lmi.no/2023/03/29/statssekretaer-ga-sniktitt-inn-i-arbeidet-med-ny-prioriteringsmelding/ 2023-03-29T08:51:47+00:00 https://www.lmi.no/2023/03/29/mote-hos-helse-og-omsorgsdepartementet-for-a-lykkes-ma-det-ligge-en-felles-nasjonal-strategi-til-grunn/ 2023-03-29T08:52:18+00:00 https://www.lmi.no/2023/03/29/reviderte-vedtekter-for-lmi/ 2023-03-29T12:25:15+00:00 https://www.lmi.no/wp-content/uploads/2023/03/LR-GF-23-beh-scaled.jpg https://www.lmi.no/2023/03/28/lmi-ntnu-og-st-olavs-hospital-arrangerer-mote-om-partnerskap-for-okt-helsedataforskning-i-trondheim-13-april/ 2023-03-29T13:49:54+00:00 https://www.lmi.no/wp-content/uploads/2016/12/helsedata.jpg https://www.lmi.no/2023/03/30/astrazeneca-pensjonerer-diabetesmiddel-i-norden/ 2023-03-30T08:34:36+00:00 https://www.lmi.no/2023/03/30/navamedic-vil-kjope-svensk-selskap-for-75-millioner-et-viktig-skritt-fremover/ 2023-03-30T08:35:12+00:00 https://www.lmi.no/2023/03/30/norske-sykehus-ga-40-000-flere-kreftkurer-pa-poliklinikk-i-fjor-enn-for-fem-ar-siden-det-blir-travlere-og-travlere/ 2023-03-30T08:36:36+00:00 https://www.lmi.no/2023/03/30/undersokelse-nordmenn-tror-ikke-helsevesenet-klarer-seg-uten-private-aktorer/ 2023-03-30T08:37:23+00:00 https://www.lmi.no/2023/03/30/undersokelse-nesten-7-av-10-mangler-kunnskap-om-kliniske-studier/ 2023-03-30T08:40:54+00:00 https://www.lmi.no/2023/03/30/eu-styrker-forsyningssikkerheten-for-legemidler-hva-betyr-det-for-norge/ 2023-03-30T09:07:45+00:00 https://www.lmi.no/wp-content/uploads/2023/03/20230329_110952-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/20230329_110952-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/20230329_110124-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/20230329_104617-scaled.jpg https://www.lmi.no/2023/03/30/arbeidet-med-ny-prioriteringsmelding-hod-setter-ned-tre-ekspertgrupper-for-a-utdype-ulike-omrader-innen-prioritering/ 2023-03-30T10:38:27+00:00 https://www.lmi.no/wp-content/uploads/2023/03/image00015-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/image00015-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/IMG_3096-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/IMG_3088-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/IMG_3086-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/image00104-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/image00116-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/IMG_3084-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/image00022-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/03/IMG_3080-scaled.jpg https://www.lmi.no/2023/03/30/politiker-besok-hos-ge-healthcare/ 2023-03-30T17:48:56+00:00 https://www.lmi.no/wp-content/uploads/2023/03/I-fabrikken-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Gruppebilde-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Moterommet-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/I-fabrikken-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Omvisning-scaled.jpg https://www.lmi.no/2023/03/30/skymoen-etterlyser-tydelige-tilgangs-ambisjoner/ 2023-03-30T17:49:22+00:00 https://www.lmi.no/wp-content/uploads/2023/03/IMG_0107-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/IMG_0105-scaled.jpg https://www.lmi.no/2023/03/31/jj-avbryter-fase-3-studie-og-skroter-rsv-vaksine/ 2023-03-31T08:30:17+00:00 https://www.lmi.no/2023/03/31/elverum-kommune-blir-eier-i-curida/ 2023-03-31T08:30:48+00:00 https://www.lmi.no/2023/03/31/gledelig-at-kommunen-stiller-opp-for-curida-lmi-kommenterer/ 2023-03-31T08:31:17+00:00 https://www.lmi.no/2023/03/31/ny-slankemedisin-godkjennes-for-diabetes-2-pasienter-ikke-nok-mener-professor/ 2023-03-31T08:31:46+00:00 https://www.lmi.no/2023/03/31/helseministeren-det-nytter-ikke-a-starte-fra-bunnen-av-nar-krisen-er-et-faktum/ 2023-03-31T08:32:20+00:00 https://www.lmi.no/2023/03/31/horing-sykehusutvalgets-rapport/ 2023-03-31T08:47:02+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/03/31/regjeringen-sier-nei-til-omfattende-vaksinasjonsprogram-for-voksne/ 2023-03-31T12:08:40+00:00 https://www.lmi.no/2023/03/31/lmi-har-levert-innspill-til-digitalisering-i-helse-og-samhandlingsplan/ 2023-03-31T12:27:28+00:00 https://www.lmi.no/wp-content/uploads/2023/03/Monica-HOD.jpg https://www.lmi.no/wp-content/uploads/2023/03/Monica-HOD.jpg https://www.lmi.no/2023/03/31/bransjen-skuffet-over-regjeringens-vaksineambisjoner-vi-venter-utalmodig-som-alle-andre/ 2023-03-31T12:31:05+00:00 https://www.lmi.no/2023/03/31/ny-folkehelsemelding-lagt-frem-i-dag/ 2023-03-31T13:26:15+00:00 https://www.lmi.no/wp-content/uploads/2023/03/LR-med-Folkehelsemeldingen-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/LR-med-Folkehelsemeldingen-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Kjerkol-legger-frem-Folkehelsemeldingen-1-scaled.jpg https://www.lmi.no/2023/04/11/alt-star-pa-spill-for-mari-37-det-er-skummelt-a-hape/ 2023-04-11T10:14:05+00:00 https://www.lmi.no/2023/04/11/onkologer-frykter-at-implementeringen-av-helseplattformen-har-satt-pasientsikkerheten-i-fare/ 2023-04-11T10:18:09+00:00 https://www.lmi.no/2023/04/11/dommer-vil-forby-abortpille-i-usa/ 2023-04-11T10:19:04+00:00 https://www.lmi.no/2023/04/11/sjefen-i-biogen-norge-om-spinraza-avtalen-fantastisk/ 2023-04-11T10:23:43+00:00 https://www.lmi.no/2023/04/11/disse-legemiddelselskapene-brukte-mest-pa-forskning-og-utvikling/ 2023-04-11T10:30:19+00:00 https://www.lmi.no/2023/04/11/sier-ja-til-sma-medisin/ 2023-04-11T10:31:59+00:00 https://www.lmi.no/2023/04/11/ny-vikardirektor-for-myndighetskontakt-i-novartis/ 2023-04-11T10:32:39+00:00 https://www.lmi.no/2023/04/11/studie-indikerer-at-enkelte-leddgiktpasienter-kan-klare-seg-uten-medisin/ 2023-04-11T10:33:50+00:00 https://www.lmi.no/2023/04/11/koronapandemien-har-gitt-hap-om-kreftvaksine/ 2023-04-11T10:35:21+00:00 https://www.lmi.no/2023/04/11/salgstall-fra-farmastat-for-mars-2023/ 2023-04-11T11:34:20+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/03/23/nye-metoder-og-lmi-arrangerer-informasjonsmote-for-leverandorer-overgang-til-anmodning-om-metodevurdering-av-legemidler-i-nye-metoder/ 2023-04-11T12:43:59+00:00 https://www.lmi.no/wp-content/uploads/2016/11/meeting-business-936059_1920.jpg https://www.lmi.no/2023/04/11/den-regulatoriske-fremtiden-i-norden/ 2023-04-11T13:03:29+00:00 https://www.lmi.no/wp-content/uploads/2023/04/Nordic-meeting-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Nordic-meeting-scaled.jpg https://www.lmi.no/2023/04/11/oppsummering-1-kvartal-2023-faggruppen-for-regulatory-og-pharmacovigilance/ 2023-04-11T13:33:12+00:00 https://www.lmi.no/wp-content/uploads/2023/04/Pharmacovigilance_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/04/Pharmacovigilance_AdobeStock-scaled.jpeg https://www.lmi.no/2023/03/09/meld-deg-pa-frokostmotet-folkehelse-pa-anbud-18-april/ 2023-04-12T07:47:56+00:00 https://www.lmi.no/wp-content/uploads/2023/03/nan-wisanmongkol-AUwXJkPUgzs-unsplash-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Deichman-logoer-4-scaled.jpg https://www.lmi.no/2023/04/12/ny-kunnskap-aktualiserer-ideen-om-ms-vaksiner/ 2023-04-12T09:52:16+00:00 https://www.lmi.no/2023/04/12/spinraza-saken-hadde-et-krevende-utgangspunkt/ 2023-04-12T09:52:59+00:00 https://www.lmi.no/2023/04/12/ny-kunnskap-aktualiserer-ideen-om-ms-vaksiner-2/ 2023-04-12T09:54:42+00:00 https://www.lmi.no/2023/04/13/legemiddelselskap-%e2%88%92-nye-vaksiner-vil-kunne-redde-millioner-av-liv/ 2023-04-13T09:35:56+00:00 https://www.lmi.no/2023/04/13/villere-enn-da-viagra-kom/ 2023-04-13T09:37:16+00:00 https://www.lmi.no/2023/04/12/fa-med-deg-nye-metoder-og-lmis-informasjonsmote-her/ 2023-04-13T10:21:32+00:00 https://www.lmi.no/wp-content/uploads/2023/04/paul-einerhand-Dy6a8sLrVl4-unsplash-scaled.jpg https://www.lmi.no/2023/04/14/nordisk-informasjonsmote-om-implementering-av-eus-hta-forordning/ 2023-04-14T06:53:41+00:00 https://www.lmi.no/wp-content/uploads/2021/11/EU-scaled.jpg https://www.lmi.no/2023/04/14/ultimovacs-har-fatt-europeisk-patentvarsel/ 2023-04-14T07:53:20+00:00 https://www.lmi.no/2023/04/14/na-ma-legemiddelselskapene-selv-be-om-metodevurdering-malet-er-raskere-saksbehandling-lmi-mote/ 2023-04-14T07:54:21+00:00 https://www.lmi.no/2023/04/14/novo-nordisk-slar-rekord-de-har-bare-funnet-en-gullare/ 2023-04-14T07:55:00+00:00 https://www.lmi.no/2023/04/14/rungende-slanke-beskjed-i-debatten-pa-grensen-til-en-skandale/ 2023-04-14T07:56:25+00:00 https://www.lmi.no/2023/04/14/se-informasjonsmotet-om-overgang-til-ny-anmodningsprosess-i-opptak-her/ 2023-04-14T11:29:33+00:00 https://www.lmi.no/wp-content/uploads/2023/04/anmodningsmote-LMI-4196-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/anmodningsmote-LMI-4196-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/anmodningsmote-LMI-4196-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/anmodningsmote-LMI-4166-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/anmodningsmote-LMI-4141-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/anmodningsmote-LMI-4154-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/anmodningsmote-LMI-4089-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/anmodningsmote-LMI-4099-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/anmodningsmote-LMI-4095-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/anmodningsmote-LMI-4118-scaled.jpg https://www.lmi.no/2023/04/14/kickstart-pa-nytt-helsedatasamarbeid/ 2023-04-14T12:25:53+00:00 https://www.lmi.no/wp-content/uploads/2023/04/Sigrid-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Kristian-Hveem.jpg https://www.lmi.no/wp-content/uploads/2023/04/Pal-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Haakon-NTNU-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Salen-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Sigrid-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Helseplattform-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Steinar-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Siri-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/HUNT-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Christian-scaled.jpg https://www.lmi.no/2023/04/17/seks-legemiddelselskaper-pilotevalueringen-som-ikke-vil-fortelle-noe/ 2023-04-17T07:27:46+00:00 https://www.lmi.no/2023/04/17/mowi-brukte-56-prosent-mer-lakselusmedisin-i-fjor/ 2023-04-17T07:30:30+00:00 https://www.lmi.no/2023/04/17/jeg-fikk-panikkanfall-pustevansker-og-sterke-smerter-i-kroppen/ 2023-04-17T07:49:18+00:00 https://www.lmi.no/2023/04/17/legemiddelfirma-ber-hoyesterett-i-usa-sikre-distribusjon-av-abortpille/ 2023-04-17T07:52:06+00:00 https://www.lmi.no/2023/04/17/msd-kjoper-prometheus-biosciences-for-108-milliarder-dollar/ 2023-04-17T07:55:04+00:00 https://www.lmi.no/2023/04/14/gikk-ned-20-kg-mener-flere-bor-fa-fedmemedisin/ 2023-04-17T13:47:57+00:00 https://www.lmi.no/2023/04/18/hurtigvirkende-nesespray-mot-migrene-pa-vei/ 2023-04-18T08:57:05+00:00 https://www.lmi.no/2023/04/18/digitalt-medlemsmote-om-bransjereglene-er-utsatt/ 2023-04-18T08:57:08+00:00 https://www.lmi.no/wp-content/uploads/2020/02/Lovkurs-2020-DIGFORSIDE-uten-tekst.jpg https://www.lmi.no/2023/04/18/spennende-data-fra-studie-pa-msd-og-modernas-kreftvaksine-mot-foflekkreft/ 2023-04-18T08:57:56+00:00 https://www.lmi.no/2023/04/18/norske-helsebedrifter-far-stotte-til-a-bli-store-i-usa/ 2023-04-18T08:59:41+00:00 https://www.lmi.no/2023/04/18/schizofreni-forbindes-med-betennelser/ 2023-04-18T09:02:53+00:00 https://www.lmi.no/2023/04/18/utprovende-antibiotika-fra-gsk-mot-urinveisinfeksjon-kan-bli-forste-nye-pa-over-20-ar/ 2023-04-18T09:04:07+00:00 https://www.lmi.no/2023/04/18/stor-okning-i-omsetningen-av-midler-som-brukes-mot-overvekt/ 2023-04-18T09:06:43+00:00 https://www.lmi.no/2023/04/18/resultatbasert-prising-mener-registrene-ikke-er-klare-slik-de-er-i-dag/ 2023-04-18T09:07:59+00:00 https://www.lmi.no/2023/04/18/abbvie-far-eu-godkjennelse-for-rinvoq-til-crohns-sykdom/ 2023-04-18T09:08:53+00:00 https://www.lmi.no/2023/04/18/msd-og-moderna-skal-teste-kreftvaksine-pa-lungekreft/ 2023-04-18T09:10:10+00:00 https://www.lmi.no/2023/04/18/skaper-nye-arbeidsplasser-med-antistoffer/ 2023-04-18T09:11:11+00:00 https://www.lmi.no/2023/04/18/slv-klar-med-evalueringen-av-anbudspiloten-for-legemidler-pa-bla-resept/ 2023-04-18T09:15:51+00:00 https://www.lmi.no/2023/04/18/na-skal-undergrupper-kunne-fa-en-medisin-selv-om-pasientgruppen-har-fatt-nei/ 2023-04-18T09:18:09+00:00 https://www.lmi.no/2023/04/18/hva-vil-eu-pharma-legislation-bety-for-norden/ 2023-04-18T10:55:23+00:00 https://www.lmi.no/wp-content/uploads/2023/04/rare-disease-panel-2.png https://www.lmi.no/wp-content/uploads/2023/04/Rare-Disease_panel-1.png https://www.lmi.no/wp-content/uploads/2023/04/rare-disease-vasvik-total.png https://www.lmi.no/wp-content/uploads/2023/04/rare-disease-panel-3.png https://www.lmi.no/2023/04/19/hadde-alle-land-vaert-som-norge-sa-hadde-vi-ikke-fatt-noen-nye-legemidler/ 2023-04-19T08:44:20+00:00 https://www.lmi.no/2023/04/19/apotekene-i-beredskap-pga-streiken-bekymringsfullt/ 2023-04-19T08:47:28+00:00 https://www.lmi.no/2023/04/19/prurigo-nodularis-gir-ekstrem-kloe-ny-medisin-gir-nytt-hap/ 2023-04-19T08:50:40+00:00 https://www.lmi.no/2023/04/19/interesseforeningen-for-kortvokste-mener-barn-skades-av-treg-medisingodkjenning/ 2023-04-19T08:51:51+00:00 https://www.lmi.no/2023/04/19/christina-kile-skal-lede-nho-geneo-avdeling/ 2023-04-19T08:53:56+00:00 https://www.lmi.no/2023/04/19/nykode-med-endelige-resultater-fra-kreftvaksine-studie-gir-en-enorm-folelse-av-mening-etter-alle-arene-med-hardt-arbeid/ 2023-04-19T09:00:01+00:00 https://www.lmi.no/2023/04/19/uio-forskere-fikk-forskningspriser-fra-nasjonalforeningen-for-folkehelsen/ 2023-04-19T10:24:25+00:00 https://www.lmi.no/2023/04/19/eli-lilly-investerer-ytterligere-16-milliarder-dollar-i-amerikanske-produksjonsanlegg/ 2023-04-19T10:25:41+00:00 https://www.lmi.no/2023/04/19/debatt-pilotevalueringen-som-ikke-vil-fortelle-noe/ 2023-04-19T10:28:51+00:00 https://www.lmi.no/2023/04/19/oppdatering-av-den-nordiske-compliance-oversikten/ 2023-04-19T10:30:31+00:00 https://www.lmi.no/wp-content/uploads/2023/04/norden-scaled.jpg https://www.lmi.no/2023/04/19/om-blareseptanbudet-tror-aldri-jeg-har-sett-industrien-legene-og-pasientforeningene-sa-enige/ 2023-04-19T10:33:29+00:00 https://www.lmi.no/2023/04/19/nordic-nanovector-publiserer-data-fra-omstridt-studie/ 2023-04-19T10:34:41+00:00 https://www.lmi.no/2023/04/19/hoyre-om-blareseptanbudet-vi-kan-ikke-kun-male-pa-pris/ 2023-04-19T10:46:06+00:00 https://www.lmi.no/2023/04/19/enighet-om-at-anbudsordning-for-blaresept-kan-fore-til-darligere-behandling-og-tilgangsutfordringer/ 2023-04-19T11:10:26+00:00 https://www.lmi.no/wp-content/uploads/2023/04/bla%CC%8Aresept-deichman-lmi-19-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/bla%CC%8Aresept-deichman-lmi-13-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/IMG_1509.jpg https://www.lmi.no/wp-content/uploads/2023/04/bla%CC%8Aresept-deichman-lmi-18-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/bla%CC%8Aresept-deichman-lmi-24-scaled.jpg https://www.lmi.no/2023/04/19/full-kapitaltorke-men-dette-mener-de-er-oppskriften-pa-a-skape-en-sterk-norsk-helsenaering/ 2023-04-19T11:15:55+00:00 https://www.lmi.no/2023/04/19/nls-days-i-kobenhavn-2023/ 2023-04-19T11:47:49+00:00 https://www.lmi.no/wp-content/uploads/2023/04/Front-NLS-Days-23-kopi-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/NLSDays2023-social-media-square-2000x2000-px.png https://www.lmi.no/2023/04/19/ahus-store-ambisjoner-om-a-fa-flere-hjertestudier-til-norge/ 2023-04-19T13:08:01+00:00 https://www.lmi.no/wp-content/uploads/2023/04/ahus-peder-intervju.png https://www.lmi.no/wp-content/uploads/2023/04/NorTrials-team-Ahus_foto-Ahus-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Ahus-fasade_foto-Ahus-scaled.jpg https://www.lmi.no/2023/04/19/kjerkol-svarte-wold-om-blareseptanbud/ 2023-04-19T13:59:26+00:00 https://www.lmi.no/wp-content/uploads/2023/03/kjerkol-i-nortrialsvideo.png https://www.lmi.no/wp-content/uploads/2023/04/wold.jpg https://www.lmi.no/wp-content/uploads/2022/06/INK_full-scaled.jpg https://www.lmi.no/2023/04/20/okt-skepsis-til-a-vaksinere-barn-etter-pandemien/ 2023-04-20T10:00:54+00:00 https://www.lmi.no/2023/04/20/gsk-kjoper-bellus-health-for-2-milliarder-dollar-far-legemiddel-mot-kronisk-hoste/ 2023-04-20T10:06:02+00:00 https://www.lmi.no/2023/04/20/vil-hindre-spredning-av-kreft-ved-hjelp-av-pasientens-immunceller/ 2023-04-20T10:07:40+00:00 https://www.lmi.no/2023/04/20/ny-rapport-helsepersonell-varslet-bare-om-fire-av-ti-feilbehandlinger-pa-sykehus/ 2023-04-20T10:09:26+00:00 https://www.lmi.no/2023/04/20/helsetilsynet-helseplattformen-kan-true-pasientsikkerheten-ved-st-olavs-hospital/ 2023-04-20T10:12:44+00:00 https://www.lmi.no/2023/04/20/targovax-blir-circio-styrker-satsingen-pa-sirkulaert-rna/ 2023-04-20T10:14:38+00:00 https://www.lmi.no/2023/04/20/nykode-gjor-borsbyks-etter-nye-data-fra-kreftvaksinestudie/ 2023-04-20T10:18:09+00:00 https://www.lmi.no/2023/04/20/vi-ma-torre-a-vaere-legemiddeleksperter/ 2023-04-20T10:35:10+00:00 https://www.lmi.no/wp-content/uploads/2023/04/Anne-Margrethe-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Anne-Margrethe-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/hausken-webinar.jpg https://www.lmi.no/2023/03/31/lmi-novo-og-novartis-arrangerer-mote-om-folkehelse-og-legemidler-betydning-for-forebygging/ 2023-04-20T13:24:48+00:00 https://www.lmi.no/wp-content/uploads/2023/03/folkehelse1.jpg https://www.lmi.no/2023/04/21/lmi-deltok-i-viktige-diskusjoner-i-efpias-regulatoriske-nettverk/ 2023-04-21T08:07:39+00:00 https://www.lmi.no/wp-content/uploads/2023/04/NTA-reg.-network-meeting-Madrid-1.jpg https://www.lmi.no/wp-content/uploads/2023/04/NTA-reg.-network-meeting-Madrid-1.jpg https://www.lmi.no/wp-content/uploads/2023/04/NTA-reg.-network-meeting-Madrid-2.jpg https://www.lmi.no/2023/04/21/nytt-mote-i-beslutningsform-skal-vurdere-enda-et-legemiddel-for-spinal-muskelatrofi/ 2023-04-21T09:16:43+00:00 https://www.lmi.no/2023/04/21/polivy-far-usa-godkjenning-for-forstelinjebehandling-av-lymfom/ 2023-04-21T09:21:57+00:00 https://www.lmi.no/2023/04/21/forskningsprosjekt-vil-utvikle-screeningverktoy-for-demens/ 2023-04-21T09:25:37+00:00 https://www.lmi.no/2023/04/21/skal-forsoke-immunterapi-mot-schizofreni/ 2023-04-21T09:27:29+00:00 https://www.lmi.no/2023/04/21/okt-selvforsyning-med-nytt-senter-for-mrna-vaksiner-i-sor-afrika/ 2023-04-21T09:34:16+00:00 https://www.lmi.no/2023/04/21/teknologi-for-en-mer-baerekraftig-helse-og-omsorgstjeneste/ 2023-04-21T09:37:41+00:00 https://www.lmi.no/2023/04/21/styrker-nordisk-samarbeid-om-forhandlinger-om-nye-legemidler-pris-alene-ikke-viktigst/ 2023-04-21T10:13:59+00:00 https://www.lmi.no/2023/04/21/biogen-norge-mulig-a-ta-registrene-i-bruk-for-utfallsbaserte-avtaler-allerede-i-dag/ 2023-04-21T10:39:32+00:00 https://www.lmi.no/2023/04/24/sa-nei-til-to-brystkreftmedisiner-vil-ha-nye-prisforhandlinger-med-produsentene/ 2023-04-24T12:35:05+00:00 https://www.lmi.no/2023/04/24/camilla-stoltenberg-slutter-i-fhi-blir-konsernsjef-i-forskningskonsernet-norce/ 2023-04-24T12:35:42+00:00 https://www.lmi.no/2023/04/24/ous-nevrolog-er-medforfatter-i-lancet-studie-pa-sjelden-nevrologisk-sykdom-haper-medisinen-blir-tilgjengelig/ 2023-04-24T12:36:21+00:00 https://www.lmi.no/2023/04/24/beslutningsforum-sier-nei-til-roches-sma-behandling-til-voksne/ 2023-04-24T12:37:16+00:00 https://www.lmi.no/2023/04/24/sykehusledere-klor-seg-i-hodet-over-pasienter-som-betaler-medisiner-av-egen-lomme-helseministeren-varsler-avklaringer/ 2023-04-24T12:38:13+00:00 https://www.lmi.no/2023/04/24/ny-studie-viser-stor-effekt-av-celleterapi-hap-om-at-noen-kreftpasienter-kan-bli-kurert/ 2023-04-24T12:38:59+00:00 https://www.lmi.no/2023/04/24/webinar-efpia-og-iqvia-presenterer-arets-wait-tall-om-legemiddeltilgang/ 2023-04-24T12:50:35+00:00 https://www.lmi.no/wp-content/uploads/2020/02/webinar_adobestock.jpeg https://www.lmi.no/2023/04/24/felleskatalogen-blir-oppdatert-med-beslutningsforum/ 2023-04-24T13:00:13+00:00 https://www.lmi.no/2023/04/25/studenter-i-lmi-med-kronikk-om-antimikrobiell-resistens-amr/ 2023-04-25T07:46:47+00:00 https://www.lmi.no/wp-content/uploads/2023/04/trainee-og-intern-antibiotikaresistens-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/trainee-og-intern-antibiotikaresistens-scaled.jpg https://www.lmi.no/2023/04/25/mener-vaksiner-og-legemidler-ma-bli-mer-sentrale-i-forebyggingen-av-ikke-smittsomme-sykdommer/ 2023-04-25T07:58:42+00:00 https://www.lmi.no/2023/04/25/innforer-ny-medisin-til-400-pasienter-med-alvorlig-lungesykdom/ 2023-04-25T08:04:48+00:00 https://www.lmi.no/2023/04/25/eli-lilly-starter-sammenlikningsstudie-med-wegovy-til-novo-nordisk/ 2023-04-25T08:09:55+00:00 https://www.lmi.no/2023/04/25/fhi-norge-i-verdenstoppen-for-hpv-vaksinasjon/ 2023-04-25T08:10:57+00:00 https://www.lmi.no/2023/04/25/horingssvar-fra-lmi-om-folkehelsemeldingen/ 2023-04-25T10:41:28+00:00 https://www.lmi.no/wp-content/uploads/2023/04/Horing_crop.png https://www.lmi.no/2023/04/26/hvordan-kan-eus-missions-vaere-losningen-pa-fremtidens-kreftbehandling/ 2023-04-26T10:19:37+00:00 https://www.lmi.no/wp-content/uploads/2023/04/kreftforskning-mote-litteraturhuset-4547-9-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/kreftforskning-mote-litteraturhuset-4547-9-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/kreftforskning-mote-litteraturhuset-4547-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/kreftforskning-mote-litteraturhuset-4547-11-scaled.jpg https://www.lmi.no/2023/04/26/abbvie-thermo-fisher-og-amgen-er-blant-norges-beste-arbeidsplasser/ 2023-04-26T11:04:35+00:00 https://www.lmi.no/wp-content/uploads/2023/04/amgen-abbvie-thermo-logoer.jpg https://www.lmi.no/wp-content/uploads/2023/04/amgen-abbvie-thermo-logoer.jpg https://www.lmi.no/2023/04/26/stoltenberg-om-samfunnsoppdrag-pa-kreft-for-snevert-med-fokus-kun-pa-behandling/ 2023-04-26T11:09:33+00:00 https://www.lmi.no/2023/04/26/stortingshoring-gi-apotekfarmasoytene-rekvireringsrett-til-pneumokokkvaksiner-og-utvid-medisinstart/ 2023-04-26T11:14:52+00:00 https://www.lmi.no/2023/04/26/forsker-pa-vaksine-mot-livmorhalskreft-%e2%88%92-sterk-effekt-pa-overlevelse/ 2023-04-26T11:18:26+00:00 https://www.lmi.no/2023/04/26/navamedic-overbys-i-kamp-om-sensidose/ 2023-04-26T11:24:07+00:00 https://www.lmi.no/2023/04/26/beskyldes-for-a-ta-lett-pa-apotekavvik-vi-er-pa-ingen-mate-ferdige/ 2023-04-26T11:26:05+00:00 https://www.lmi.no/2023/04/26/millionstotte-til-ous-ledet-eu-prosjekt-innen-persontilpasset-kreftbehandling/ 2023-04-26T11:28:09+00:00 https://www.lmi.no/2023/04/26/ultimovacs-varsler-forsinkede-resultater-fra-foflekkreft-studie/ 2023-04-26T11:31:07+00:00 https://www.lmi.no/2023/04/26/novartis-venter-okt-vekst/ 2023-04-26T11:37:56+00:00 https://www.lmi.no/2023/04/26/lyser-opp-og-angriper-kreften-innenifra/ 2023-04-26T11:40:58+00:00 https://www.lmi.no/2023/04/26/til-frontalangrep-pa-ordningen-med-anbud-pa-blaresept-medisin/ 2023-04-26T11:43:01+00:00 https://www.lmi.no/2023/04/26/efpias-respons-pa-ny-lovgivning/ 2023-04-27T07:16:28+00:00 https://www.lmi.no/wp-content/uploads/2021/11/EU2-scaled.jpg https://www.lmi.no/2023/04/27/eu-reform-hisser-pa-seg-legemiddelindustrien-er-gift-for-innovasjon-og-konkurranseevne-i-europa/ 2023-04-27T09:34:03+00:00 https://www.lmi.no/2023/04/27/novo-nordisk-utlyser-stipender-til-forskning-pa-diabetes-og-metabolisme/ 2023-04-27T09:42:14+00:00 https://www.lmi.no/2023/04/27/janssen-fikk-eu-godkjent-kombinasjonstablett-mot-prostatakreft/ 2023-04-27T09:51:36+00:00 https://www.lmi.no/2023/04/27/slik-gikk-vaksineringen-i-mars/ 2023-04-27T09:57:08+00:00 https://www.lmi.no/2023/04/27/finnes-losningen-pa-kreftgaten/ 2023-04-27T10:05:47+00:00 https://www.lmi.no/2023/04/27/feira-opprettinga-av-eigen-seksjon-for-kliniske-studiar/ 2023-04-27T10:07:27+00:00 https://www.lmi.no/2023/04/27/mangler-antibiotika-til-barn/ 2023-04-27T12:27:16+00:00 https://www.lmi.no/2023/04/28/industriinitiativ-gir-nytt-kunnskapsgrunnlag-om-arsaker-til-forsinkelser/ 2023-04-28T07:01:26+00:00 https://www.lmi.no/wp-content/uploads/2023/04/Hurdles-forside.jpg https://www.lmi.no/wp-content/uploads/2023/04/hurdles-konklusjon-1.jpg https://www.lmi.no/2023/04/28/arets-wait-tall-om-legemiddeltilgang-viser-fortsatt-nedgang-i-norge-2/ 2023-04-28T08:20:11+00:00 https://www.lmi.no/wp-content/uploads/2023/04/WAIT-forside.jpg https://www.lmi.no/wp-content/uploads/2023/04/total.jpg https://www.lmi.no/wp-content/uploads/2023/04/tid.jpg https://www.lmi.no/wp-content/uploads/2023/04/privat.jpg https://www.lmi.no/wp-content/uploads/2023/04/kreft.jpg https://www.lmi.no/wp-content/uploads/2023/04/orphan.jpg https://www.lmi.no/2023/04/28/arets-wait-tall-om-legemiddeltilgang-viser-fortsatt-nedgang-i-norge/ 2023-04-28T08:20:24+00:00 https://www.lmi.no/wp-content/uploads/2023/04/WAIT-forside.jpg https://www.lmi.no/wp-content/uploads/2023/04/total.jpg https://www.lmi.no/wp-content/uploads/2023/04/tid.jpg https://www.lmi.no/wp-content/uploads/2023/04/privat.jpg https://www.lmi.no/wp-content/uploads/2023/04/kreft.jpg https://www.lmi.no/wp-content/uploads/2023/04/orphan.jpg https://www.lmi.no/2023/04/28/innen-2030-vil-100-legemidler-ga-av-patent-farma-norge-fronter-de-som-lager-de-generiske-konkurrentene/ 2023-04-28T08:41:05+00:00 https://www.lmi.no/2023/04/28/astrazeneca-okte-inntektene-tross-nedgang-i-salg-av-covid-legemidler/ 2023-04-28T08:55:15+00:00 https://www.lmi.no/2023/04/28/bertil-storvik-til-msd-animal-health/ 2023-04-28T08:57:14+00:00 https://www.lmi.no/2023/04/28/brystkreftforeningen-skuffet-og-oppgitt-over-nei-i-beslutningsforum/ 2023-04-28T09:02:42+00:00 https://www.lmi.no/2023/04/28/forste-rsv-vaksine-og-totalt-syv-nye-legemidler-anbefales-av-ema/ 2023-04-28T09:05:07+00:00 https://www.lmi.no/2023/04/28/eli-lilly-presenterer-nye-fedmeresultater-og-venter-fda-svar-mot-slutten-av-aret/ 2023-04-28T09:09:20+00:00 https://www.lmi.no/2023/05/02/salgstall-fra-farmastat-for-april-2023/ 2023-05-02T10:36:22+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/05/02/norsk-forsker-far-pris-overlevelsen-av-lungekreft-naer-doblet-pa-20-ar/ 2023-05-02T12:08:50+00:00 https://www.lmi.no/2023/05/02/slv-direktoren-fornoyd-med-gjennomslag-i-eus-forslag-til-legemiddellov/ 2023-05-02T12:09:14+00:00 https://www.lmi.no/2023/05/02/bms-naermer-seg-eu-godkjenning-av-medisin-mot-arvelig-hjertesykdom/ 2023-05-02T12:11:08+00:00 https://www.lmi.no/2023/05/02/sylvi-listhaug-raser-nordmenn-lider-og-dor-unodvendig/ 2023-05-02T12:14:15+00:00 https://www.lmi.no/2023/05/02/eli-lillys-mounjaro-gir-16-prosent-vektnedgang-hos-personer-med-diabetes-type-2/ 2023-05-02T12:16:58+00:00 https://www.lmi.no/2023/05/02/norges-forste-fotoutstilling-om-overvekt-og-fedme-skal-bidra-til-a-fjerne-stigma/ 2023-05-02T12:19:38+00:00 https://www.lmi.no/2023/05/02/uforstaelig-at-loddtrekning-skal-avgjore-kreftbehandling/ 2023-05-02T12:20:55+00:00 https://www.lmi.no/2023/05/02/pfizers-rsv-vaksine-kan-bli-forsinket-med-flere-ar-i-lavinntektsland/ 2023-05-02T12:22:14+00:00 https://www.lmi.no/2023/05/03/leger-frykter-nytt-eu-regelverk-kan-fore-til-mangel-pa-medisinsk-utstyr/ 2023-05-03T08:32:39+00:00 https://www.lmi.no/2023/05/03/fresenius-kabi-tilbakekaller-infusjonspumper-i-usa/ 2023-05-03T08:34:02+00:00 https://www.lmi.no/2023/05/03/bms-lyktes-i-to-studier-med-car-t-mot-ulike-lymfekreft-typer/ 2023-05-03T08:37:21+00:00 https://www.lmi.no/2023/05/03/duarte-marchand-har-forlatt-takeda-har-blitt-norden-og-sverige-sjef-i-janssen/ 2023-05-03T08:42:52+00:00 https://www.lmi.no/2023/05/03/innforing-av-presisjonsmedisin-innen-kreft-i-norge/ 2023-05-03T08:47:20+00:00 https://www.lmi.no/2023/05/03/dette-betyr-det-a-bli-et-satsingsomrade/ 2023-05-03T13:37:52+00:00 https://www.lmi.no/wp-content/uploads/2023/04/Oversikt-scaled.jpg https://www.lmi.no/2023/05/04/eksportradet-anbefaler-helseindustrien-som-eksportsatsing-lmi-kommenterer/ 2023-05-04T06:54:44+00:00 https://www.lmi.no/2023/05/04/regjeringen-bevilger-62-milliarder-kroner-til-sykehusene-vil-gjore-hverdagen-til-helsepersonell-enklere/ 2023-05-04T06:58:12+00:00 https://www.lmi.no/2023/05/04/alzheimer-medisin-bremser-kognitiv-nedgang-med-35-prosent-i-stor-studie/ 2023-05-04T07:04:36+00:00 https://www.lmi.no/2023/05/04/sverige-tar-ikke-tak-i-uforsvarlig-forskrivning/ 2023-05-04T07:04:54+00:00 https://www.lmi.no/2023/05/04/marianne-arnemo-blir-forste-ansatte-i-moderna-norge/ 2023-05-04T07:25:46+00:00 https://www.lmi.no/2023/05/04/send-inn-lenker-med-verdioverforingstallene-og-nokkeltall-fra-ditt-selskap/ 2023-05-04T07:34:57+00:00 https://www.lmi.no/wp-content/uploads/2016/06/Offentliggj%C3%B8ring-av-verdioverf%C3%B8ringer.gif https://www.lmi.no/2023/05/04/gsk-ansatte-streiker-for-bedre-lonn/ 2023-05-04T07:36:07+00:00 https://www.lmi.no/2023/05/04/helsedirektoratet-og-fhi-anbefaler-revidert-nasjonal-strategi-for-hepatitt-b-og-c/ 2023-05-04T07:37:21+00:00 https://www.lmi.no/2023/05/04/forste-vaksine-mot-rs-virus-godkjent-i-usa/ 2023-05-04T07:41:28+00:00 https://www.lmi.no/2023/05/04/novo-nordisk-lyser-ut-to-forskningsstipend-i-norge/ 2023-05-04T09:06:01+00:00 https://www.lmi.no/wp-content/uploads/2023/05/Novo-sproyte-og-Novo-penn.jpg https://www.lmi.no/2023/05/04/margit-selsjord-ny-ressurs-i-lmi/ 2023-05-04T13:46:22+00:00 https://www.lmi.no/wp-content/uploads/2023/04/Margit-Selsjord-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Margit-Selsjord-scaled.jpg https://www.lmi.no/2022/04/01/nye-bransjeregler-trer-i-kraft-1-april/ 2023-05-05T08:27:07+00:00 https://www.lmi.no/wp-content/uploads/2022/04/Bransjeregler_forside-2022.jpg https://www.lmi.no/wp-content/uploads/2020/05/Ramona2-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/04/Bransjeregler-2022-Forside.png https://www.lmi.no/2023/05/05/novo-nordisk-ma-kutte-i-produksjonen-av-slankemedisin-til-usa/ 2023-05-05T09:07:49+00:00 https://www.lmi.no/2023/05/05/ber-stortinget-utsette-beslutning-om-helseforvaltningen/ 2023-05-05T10:06:00+00:00 https://www.lmi.no/2023/05/05/svensk-studie-koronavaksinen-har-ikke-fort-til-at-flere-kvinner-oppsoker-lege-for-mensforstyrrelser/ 2023-05-05T10:07:29+00:00 https://www.lmi.no/2023/05/05/her-er-pandemien-langt-fra-over/ 2023-05-05T10:08:50+00:00 https://www.lmi.no/2023/05/05/oppdagelsen-av-dette-genet-kan-bidra-til-utvikling-av-p-pille-for-menn/ 2023-05-05T10:10:42+00:00 https://www.lmi.no/2023/05/05/livsvitenskapsbygget-vil-gi-norsk-farmasi-et-loft/ 2023-05-05T10:12:19+00:00 https://www.lmi.no/2023/05/05/novo-nordisk-forventer-mangel-pa-fedmemiddel-i-noen-maneder/ 2023-05-05T10:17:42+00:00 https://www.lmi.no/2023/05/05/vil-gi-bimzelx-to-nye-indikasjoner/ 2023-05-05T10:18:54+00:00 https://www.lmi.no/2023/05/05/tilbud-om-a-bli-med-pa-menon-rapport-om-ny-terskelverdi/ 2023-05-05T10:29:46+00:00 https://www.lmi.no/wp-content/uploads/2023/05/forside-rapportsak.png https://www.lmi.no/wp-content/uploads/2023/05/Menon-forslag-til-forside.png https://www.lmi.no/wp-content/uploads/2023/05/rapport_adobe-stock-scaled.jpeg https://www.lmi.no/2023/05/08/utviklingen-gar-feil-vei-vi-ma-jobbe-sammen-for-a-bedre-tilgangen-til-nye-legemidler-i-norge/ 2023-05-08T07:44:11+00:00 https://www.lmi.no/wp-content/uploads/2023/04/Image-from-iOS-22-1280x771-1.jpg https://www.lmi.no/2023/05/08/lmi-har-sendt-innspill-til-arbeidet-med-prioriteringsmeldingen/ 2023-05-08T11:21:18+00:00 https://www.lmi.no/wp-content/uploads/2019/04/Prioritering-e1554375409707.jpg https://www.lmi.no/2023/05/09/debatt-flere-av-tiltakene-i-eus-legemiddelreform-bygger-darlig-opp-under-hovedformalet-med-reformen/ 2023-05-09T10:47:48+00:00 https://www.lmi.no/2023/05/09/fagforeninger-advarer-mot-forhastede-endringer-av-helseforvaltningen/ 2023-05-09T10:49:15+00:00 https://www.lmi.no/2023/05/09/eu-trapper-opp-kampen-mot-antibiotikaresistens/ 2023-05-09T10:51:31+00:00 https://www.lmi.no/2023/05/09/forskerteam-fra-ntnu-har-utviklet-ny-lovende-kreftmedisin/ 2023-05-09T10:55:04+00:00 https://www.lmi.no/2023/05/09/amerikanske-legemiddelmyndigheter-krever-flere-data-for-novo-nordisk-nye-potensielle-blockbuster/ 2023-05-09T10:56:22+00:00 https://www.lmi.no/2023/05/09/fem-nordiske-land-med-felles-strategi-for-legemiddelkjop/ 2023-05-09T10:59:33+00:00 https://www.lmi.no/2023/05/09/fagdirektor-om-kritikk-mot-beslutningsforum-nei-forstaelse-for-at-dette-er-vanskelig/ 2023-05-09T11:01:11+00:00 https://www.lmi.no/2023/05/09/nalen-som-slanker/ 2023-05-09T11:04:07+00:00 https://www.lmi.no/2023/05/09/norsk-kreft-funn-hylles-internasjonalt/ 2023-05-09T11:05:27+00:00 https://www.lmi.no/2023/05/09/oslo-cancer-cluster-med-i-stort-eu-prosjekt/ 2023-05-09T11:06:34+00:00 https://www.lmi.no/2023/05/09/arctic-bioscience-forventer-hurtig-rekruttering-til-studie/ 2023-05-09T11:07:50+00:00 https://www.lmi.no/2023/05/09/pfizers-vaksine-mot-borreliose-forsinket-med-ett-ar/ 2023-05-09T11:09:08+00:00 https://www.lmi.no/2023/05/09/mote-om-digitale-terapier/ 2023-05-09T11:42:08+00:00 https://www.lmi.no/wp-content/uploads/2023/05/Digitale-terapier.jpg https://www.lmi.no/wp-content/uploads/2023/05/Digitale-terapier.jpg https://www.lmi.no/2023/05/10/healthtalk-lmi-sjef-om-wait-rapport-norge-bruker-lenger-tid-enn-andre-land/ 2023-05-10T08:13:20+00:00 https://www.lmi.no/wp-content/uploads/2023/05/Skymoen-HT.png https://www.lmi.no/2023/05/10/slv-adrenalinpennen-emerade-trekkes-tilbake-fra-markedet/ 2023-05-10T08:21:21+00:00 https://www.lmi.no/2023/05/10/potensmiddel-viste-god-effekt-pa-diabetes-2/ 2023-05-10T08:24:20+00:00 https://www.lmi.no/2023/05/10/bergenbios-finansdirektor-om-kommende-emisjon-pengene-skal-brukes-pa-lungekreft/ 2023-05-10T08:25:34+00:00 https://www.lmi.no/2023/05/10/nykode-direktoren-vi-har-alle-mann-pa-dekk/ 2023-05-10T08:26:27+00:00 https://www.lmi.no/2023/05/09/leif-rune-skymoen-pa-blodkreftforeningens-landkonferanse/ 2023-05-10T08:36:11+00:00 https://www.lmi.no/wp-content/uploads/2023/05/LRS-BLODKREFT-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/05/LRS-BLODKREFT-scaled.jpg https://www.lmi.no/2023/05/10/beslutningstakere-er-kritiske-til-wait-rapporten-sammenligner-epler-og-paerer/ 2023-05-10T08:38:16+00:00 https://www.lmi.no/2023/05/10/rapport-norge-godkjenner-faerre-nye-legemidler-og-bruker-lenger-tid-enn-nabolandene/ 2023-05-10T08:39:10+00:00 https://www.lmi.no/2023/05/10/joint-statement-from-the-nordic-pharmaceutical-industry-on-the-implementation-of-eu-hta-regulation/ 2023-05-10T12:17:59+00:00 https://www.lmi.no/wp-content/uploads/2023/05/Logoer-norden.jpg https://www.lmi.no/wp-content/uploads/2023/05/Logoer-norden.jpg https://www.lmi.no/2023/05/10/legemiddelverket-stanser-prisrevidering-av-maksimalpriser-i-host/ 2023-05-10T13:48:56+00:00 https://www.lmi.no/wp-content/uploads/2018/02/pris.jpg https://www.lmi.no/wp-content/uploads/2018/02/pris.jpg https://www.lmi.no/2023/05/11/takeda-reagerer-pa-uttalelse-fra-fagdirektor-i-helse-vest-overrasket-og-skuffet/ 2023-05-11T10:48:57+00:00 https://www.lmi.no/2023/05/11/nord-europa-sjefen-i-roche-dypt-bekymret-over-eus-reformforslag/ 2023-05-11T10:50:42+00:00 https://www.lmi.no/2023/05/11/nordisk-legemiddelindustri-mener-det-haster-a-fullfore-forberedelsene-til-ny-eu-forordning/ 2023-05-11T10:51:55+00:00 https://www.lmi.no/2023/05/11/etaten-direktoratet-for-medisinske-produkter-far-helhetlig-ansvar-for-metodevurderinger/ 2023-05-11T11:14:36+00:00 https://www.lmi.no/wp-content/uploads/2023/05/RNB-2023.jpg https://www.lmi.no/wp-content/uploads/2021/01/karoline-knutsen.jpg https://www.lmi.no/2023/05/11/legemiddelverket-skifter-navn-til-direktoratet-for-medisinske-produkter/ 2023-05-11T11:14:44+00:00 https://www.lmi.no/wp-content/uploads/2019/12/SLV-skilt.png https://www.lmi.no/wp-content/uploads/2019/12/SLV-skilt.png https://www.lmi.no/2023/05/11/de-viktigste-sakene-fra-revidert-nasjonalbudsjett-2023/ 2023-05-11T13:27:17+00:00 https://www.lmi.no/wp-content/uploads/2023/05/RNB-2023.jpg https://www.lmi.no/wp-content/uploads/2023/05/RNB-2023.jpg https://www.lmi.no/2023/05/03/eksportradet-anbefaler-satsing-pa-helseindustri/ 2023-05-12T08:52:13+00:00 https://www.lmi.no/wp-content/uploads/2023/04/Fylling-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/04/Oversikt-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/05/Leif-Rune-Skymoen_portrett-halvnaert-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/09/Monica-Larsen-edited.jpg https://www.lmi.no/2023/05/15/meld-deg-pa-varens-lov-og-bransjekurs-2/ 2023-05-15T06:48:37+00:00 https://www.lmi.no/wp-content/uploads/2020/02/Lovkurs-2020-DIGFORSIDE-uten-tekst.jpg https://www.lmi.no/2023/05/15/pfizer-toppsjef-anklager-usa-for-a-ville-forhandle-legemiddelpriser-med-en-pistol-mot-hodene-vare/ 2023-05-15T08:25:17+00:00 https://www.lmi.no/2023/05/15/kunstig-intelligens-i-helsevesenet-hype-eller-hap/ 2023-05-15T08:26:42+00:00 https://www.lmi.no/2023/05/15/arctic-bioscience-er-i-gang-med-pasientrekrutteringen/ 2023-05-15T08:27:43+00:00 https://www.lmi.no/2023/05/15/noen-av-de-sykeste-fedmepasientene-kan-fa-wegovy-pa-bla-resept-fagmiljoet-forstar-ikke-hvilke/ 2023-05-15T08:29:01+00:00 https://www.lmi.no/2023/05/15/ny-indikasjon-for-astrazeneca-legemiddel-mot-autoimmun-sykdom-innfort-i-eu/ 2023-05-15T08:34:04+00:00 https://www.lmi.no/2023/05/15/lovende-mrna-vaksine-mot-bukspyttkjertelkreft/ 2023-05-15T08:36:50+00:00 https://www.lmi.no/2023/05/15/okning-i-industristudier-innen-hjernehelse/ 2023-05-15T10:45:55+00:00 https://www.lmi.no/wp-content/uploads/2023/05/Kjell-Morten-skjermdump.png https://www.lmi.no/2023/05/16/regulatorisk-hostmote-blir-26-oktober/ 2023-05-16T07:29:59+00:00 https://www.lmi.no/wp-content/uploads/2022/06/regulatorisk-hostmote-2021_linn-camilla-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/regulatorisk-hostmote-2021_linn-camilla-scaled.jpg https://www.lmi.no/2023/05/16/usa-godkjenner-pille-for-behandling-av-hetetokter-i-overgangsalderen/ 2023-05-16T08:48:50+00:00 https://www.lmi.no/2023/05/16/ja-til-nytt-kreftsenter-i-oslo/ 2023-05-16T08:50:07+00:00 https://www.lmi.no/2023/05/16/kreftlege-roper-varsko-frykter-at-beslutningsforum-vil-si-nei-til-leukemimedisin-fordi-legemiddelverket-overdriver-kostnadene/ 2023-05-16T08:52:08+00:00 https://www.lmi.no/2023/05/16/sykehusene-klarer-ikke-a-spare-inn-penger-som-kan-brukes-til-nye-kreftlegemidler/ 2023-05-16T08:53:39+00:00 https://www.lmi.no/2023/05/16/lmis-horingssvar-til-nouen-om-fremtidens-apotek/ 2023-05-16T09:00:35+00:00 https://www.lmi.no/wp-content/uploads/2018/11/scanning-apotek2.jpg https://www.lmi.no/wp-content/uploads/2018/11/scanning-apotek2.jpg https://www.lmi.no/2023/05/16/faggruppen-for-pasientkontakt-i-lmi-arrangerer-pasientseminar-meld-deg-pa-her/ 2023-05-16T09:18:33+00:00 https://www.lmi.no/wp-content/uploads/2019/12/pasientforeninger-og-legemiddelindustrien-Arr_bilde.jpg https://www.lmi.no/2023/05/19/danmark-blir-med-i-nordisk-samarbeid-om-legemiddel-vurderinger/ 2023-05-19T07:48:43+00:00 https://www.lmi.no/2023/05/19/hoyre-vil-ha-vaksinetvang-for-helsepersonell/ 2023-05-19T07:50:14+00:00 https://www.lmi.no/2023/05/19/else-kass-furuseth-begynte-pa-fedmemedisiner-for-forste-gang-i-mitt-liv-har-jeg-folt-meg-mett/ 2023-05-19T07:52:48+00:00 https://www.lmi.no/2023/05/19/unikt-smertemestringskurs-laget-for-a-unnga-opioidkrise-i-norge/ 2023-05-19T07:56:51+00:00 https://www.lmi.no/2023/05/19/lungekreftpasienter-fikk-vonde-symptomer-senere-med-immunterapi/ 2023-05-19T07:58:53+00:00 https://www.lmi.no/2023/05/16/meld-deg-pa-motet-om-digitale-terapier/ 2023-05-22T09:24:14+00:00 https://www.lmi.no/wp-content/uploads/2023/05/Digitale-terapier.jpg https://www.lmi.no/wp-content/uploads/2023/05/Digitale-terapier.jpg https://www.lmi.no/2023/05/22/novo-nordisk-pauser-annonseringen-av-slankemedisinen-wegovy/ 2023-05-22T10:50:35+00:00 https://www.lmi.no/2023/05/22/konkurransetilsynet-vil-ha-markedsforing-av-priser-pa-reseptfrie-legemidler/ 2023-05-22T10:52:27+00:00 https://www.lmi.no/2023/05/22/56684/ 2023-05-22T10:55:37+00:00 https://www.lmi.no/2023/05/22/visste-du-at-kliniske-studier-kan-bli-en-del-av-din-behandling/ 2023-05-22T11:51:48+00:00 https://www.lmi.no/wp-content/uploads/2023/05/Kliniske-studier-brosjyre-forside.png https://www.lmi.no/wp-content/uploads/2023/05/nettside-bilde-1-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/05/Kliniske-studier-brosjyre-forside.png https://www.lmi.no/2023/05/23/beslutningsforum-sa-nei-til-lymfekreftbehandling/ 2023-05-23T10:36:04+00:00 https://www.lmi.no/2023/05/23/beslutningsforum-sa-ja-til-15-legemidler-to-saker-med-venclyxto-utsettes/ 2023-05-23T10:37:07+00:00 https://www.lmi.no/2023/05/23/legemiddelverket-ma-redusere-med-opptil-30-ansatte-uten-oppsigelser/ 2023-05-23T10:39:11+00:00 https://www.lmi.no/2023/05/29/se-lmis-seminar-for-pasientforeninger-i-opptak-her/ 2023-05-29T17:17:57+00:00 https://www.lmi.no/wp-content/uploads/2023/05/MicrosoftTeams-image-1.jpg https://www.lmi.no/wp-content/uploads/2023/05/MicrosoftTeams-image-1.jpg https://www.lmi.no/2023/05/30/lmis-innspill-til-ekspertgruppenes-arbeid-i-forkant-av-ny-prioriteringsmelding/ 2023-05-30T08:45:22+00:00 https://www.lmi.no/wp-content/uploads/2017/11/HOD.jpg https://www.lmi.no/2023/05/30/fa-med-deg-lmi-og-biogens-frokostseminar-om-digitale-terapier-mandag-5-juni/ 2023-05-30T12:13:40+00:00 https://www.lmi.no/wp-content/uploads/2023/05/2-bilder.jpg https://www.lmi.no/wp-content/uploads/2023/05/2-bilder.jpg https://www.lmi.no/2023/05/30/leo-er-kortvokst-medisinen-som-kan-hjelpe-ham-far-han-ikke-i-norge/ 2023-05-30T12:18:05+00:00 https://www.lmi.no/2023/05/30/vistin-pharma-vil-bygge-nytt/ 2023-05-30T12:23:32+00:00 https://www.lmi.no/2023/05/30/2022-ble-rekordar-for-kliniske-industristudier-gledelig/ 2023-05-30T12:25:27+00:00 https://www.lmi.no/2023/05/30/nho-geneo-arskonferanse-kliniske-studier-gir-hap-til-pasientene/ 2023-05-31T08:01:19+00:00 https://www.lmi.no/wp-content/uploads/2023/05/66A8702.jpg https://www.lmi.no/wp-content/uploads/2023/05/NHO-Geneo-arskonferanse-8701-scaled.jpg https://www.lmi.no/2023/05/31/beslutningsforum-ga-motbud-i-prisforhandlingen-med-legemiddelselskapet-det-gikk-ikke-sa-bra/ 2023-05-31T09:03:43+00:00 https://www.lmi.no/2023/05/31/kun-to-nye-anbefalinger-om-eu-godkjente-legemidler/ 2023-05-31T09:07:46+00:00 https://www.lmi.no/2023/05/31/ema-mener-novartis-middel-ma-av-markedet-fordelene-veier-ikke-opp-for-ulempene/ 2023-05-31T09:09:49+00:00 https://www.lmi.no/2023/05/31/pfizer-lykkes-med-nytt-hemofili-middel/ 2023-05-31T09:10:47+00:00 https://www.lmi.no/2023/05/31/asco-forventninger-til-studier-i-behandling-av-bryst-og-lungekreft-i-tidlig-fase/ 2023-05-31T10:07:25+00:00 https://www.lmi.no/2023/05/31/reuters-eu-endrer-vaksinekontrakt-med-pfizer-og-biontech/ 2023-05-31T10:09:28+00:00 https://www.lmi.no/2023/05/31/legemiddelverket-vil-ha-tettere-nordisk-samarbeid-for-flere-legemidler-til-barn/ 2023-05-31T10:10:30+00:00 https://www.lmi.no/2023/05/31/lmi-i-panelsamtale-om-persontilpasset-medisin/ 2023-05-31T11:57:58+00:00 https://www.lmi.no/wp-content/uploads/2023/05/image00027-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/05/image00027-scaled.jpeg https://www.lmi.no/2023/05/30/nho-geneo-arskonferanse-helsenaeringen-er-en-del-av-losningen-for-a-klare-a-opprettholde-velferdsstaten/ 2023-05-31T13:00:11+00:00 https://www.lmi.no/wp-content/uploads/2023/05/66A8515.jpg https://www.lmi.no/wp-content/uploads/2023/05/NHO-Geneo-arskonferanse-8516-scaled.jpg https://www.lmi.no/2023/06/01/curida-styrelederen-motte-formannskapet-haper-pa-nye-investorer-i-lopet-av-de-naermeste/ 2023-06-01T08:27:06+00:00 https://www.lmi.no/2023/06/01/slv-okning-av-ulovlig-markedsforing-av-fedmemidler/ 2023-06-01T08:29:56+00:00 https://www.lmi.no/2023/06/01/asco-setter-fokus-pa-fremskrittene-med-malrettet-cellegift/ 2023-06-01T08:30:56+00:00 https://www.lmi.no/2023/06/01/medisin-mot-blodkreft-fikk-fem-nei-i-beslutningsforum-men-ous-lege-tar-avslag-med-fatning/ 2023-06-01T08:31:53+00:00 https://www.lmi.no/2023/06/01/als-legemiddel-godkjent-i-usa-blir-trolig-ikke-anbefalt-innfort-i-europa/ 2023-06-01T08:32:57+00:00 https://www.lmi.no/2023/06/01/nykode-utvider-samarbeidet-med-roche-om-kreftvaksine/ 2023-06-01T08:34:18+00:00 https://www.lmi.no/2023/06/01/fresenius-sjefen-har-dialog-med-flere-kjopere/ 2023-06-01T10:07:57+00:00 https://www.lmi.no/2023/06/01/far-ikke-behandling-for-alvorlig-blodsykdom-dypt-problematisk/ 2023-06-01T10:52:42+00:00 https://www.lmi.no/2023/06/01/lmis-innspill-til-helse-nords-revisjon-av-handtering-av-konfidensielle-enhetspriser/ 2023-06-01T12:51:16+00:00 https://www.lmi.no/wp-content/uploads/2015/11/helse-nord-logo-1.png https://www.lmi.no/2023/06/01/salgstall-fra-farmastat-for-mai-2023/ 2023-06-01T13:02:07+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/06/01/fa-med-deg-frokostmotet-hvorfor-er-det-sa-vanskelig-a-prioritere-forebygging-i-helse/ 2023-06-02T07:51:17+00:00 https://www.lmi.no/wp-content/uploads/2023/05/GSK-folkehelse-scaled.jpg https://www.lmi.no/2023/06/02/esc-kongressen-presenterer-norge-som-studieland/ 2023-06-02T08:03:39+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Amsterdam_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/06/Amsterdam_AdobeStock-scaled.jpeg https://www.lmi.no/2023/06/02/farma-norge-er-bekymret-for-tilgangen-til-lavprislegemidler-i-norge-vil-oke-prisen/ 2023-06-02T10:44:41+00:00 https://www.lmi.no/2023/06/02/pfizers-rsv-vaksine-far-usa-godkjennelse/ 2023-06-02T10:45:38+00:00 https://www.lmi.no/2023/06/02/fresenius-kabi-onsker-a-selge-halden-fabrikken/ 2023-06-02T10:47:16+00:00 https://www.lmi.no/2023/06/02/fresenius-sjefen-jeg-forstar-at-mange-kjenner-pa-usikkerhet-krever-abonnement/ 2023-06-02T10:47:56+00:00 https://www.lmi.no/2023/06/02/sonnen-var-nektes-behandlingen-som-lar-ham-leve/ 2023-06-02T11:45:47+00:00 https://www.lmi.no/2023/06/02/helsenaering-valgt-som-neste-nasjonale-eksportfremmesatsing/ 2023-06-02T13:06:30+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Ministrene-helse-naering-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/Ministrene-helse-naering-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/Leif-Rune-Skymoen_portrett-nytt-scaled.jpg https://www.lmi.no/2023/06/05/keytruda-for-og-etter-kirurgi-av-lungekreft-reduserer-risiko-for-tilbakefall-med-42-prosent/ 2023-06-05T09:56:07+00:00 https://www.lmi.no/2023/06/05/ble-syk-for-sent-og-far-ikke-medisin-na-har-helseministeren-svart/ 2023-06-05T09:57:06+00:00 https://www.lmi.no/2023/06/05/okt-pris-viktig-for-a-sikre-tilgang-pa-legemidler/ 2023-06-05T09:58:08+00:00 https://www.lmi.no/2023/06/05/fremskritt-for-pasienter-med-hjernesvulst-sannsynligvis-det-storste-noensinne/ 2023-06-05T09:59:02+00:00 https://www.lmi.no/2023/06/05/helsenaeringen-blir-norges-neste-eksportsatsing-lmi-kommenterer/ 2023-06-05T09:59:59+00:00 https://www.lmi.no/2023/06/05/lmi-viktig-at-kompetansen-og-erfaringene-ikke-forsvinner-ut-av-norge-krever-abonnement/ 2023-06-05T10:00:55+00:00 https://www.lmi.no/2023/06/05/ny-leder-i-lmi-er-glad-for-a-ha-farmasien-som-fundament/ 2023-06-05T10:51:36+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Farmatid.png https://www.lmi.no/wp-content/uploads/2023/06/Farmatid.png https://www.lmi.no/2023/06/05/disse-er-nye-styremedlemmer-i-oslo-cancer-cluster/ 2023-06-05T12:49:45+00:00 https://www.lmi.no/2023/06/06/lungekreft-studie-viser-drastisk-forbedring-svaert-gledelig/ 2023-06-06T07:19:55+00:00 https://www.lmi.no/2023/06/06/hva-koster-ulike-sykdommer-i-helsevesenet/ 2023-06-06T07:20:52+00:00 https://www.lmi.no/2023/06/06/skymoen-nytt-styremedlem-i-oslo-cancer-cluster/ 2023-06-06T07:52:59+00:00 https://www.lmi.no/wp-content/uploads/2023/03/leif-rune-skymoen-lmi-portrett-4673-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/leif-rune-skymoen-lmi-portrett-4673-scaled.jpg https://www.lmi.no/2023/06/06/mote-om-digitale-terapier-ma-fa-pa-plass-systemer-ordninger-og-et-sterkt-hjemmemarked-for-a-lykkes/ 2023-06-06T11:08:02+00:00 https://www.lmi.no/wp-content/uploads/2023/06/digitale-terapier-deichman-9144-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/digitale-terapier-deichman-9144-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/digitale-terapier-deichman-9044-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/digitale-terapier-deichman-9016-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/digitale-terapier-deichman-8912-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/digitale-terapier-deichman-9113-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/digitale-terapier-deichman-8917-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/digitale-terapier-deichman-9165-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/digitale-terapier-deichman-8955-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/digitale-terapier-deichman-8986-scaled.jpg https://www.lmi.no/2023/06/07/gmo-regler-ma-ikke-fa-stoppe-utviklingen-av-avanserte-terapier/ 2023-06-07T07:22:46+00:00 https://www.lmi.no/2023/06/07/gar-inn-for-a-kjope-curida-eiendommen-krever-abonnement/ 2023-06-07T07:23:34+00:00 https://www.lmi.no/2023/06/07/forebyggende-folkehelsearbeid-er-litt-wishy-washy/ 2023-06-07T14:52:55+00:00 https://www.lmi.no/wp-content/uploads/2023/06/panel-folkehelse.jpg https://www.lmi.no/wp-content/uploads/2023/06/66A9250-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/katrine-folkehelse-scaled.jpg https://www.lmi.no/2023/06/09/hold-av-mandag-6-november-2023-for-drug-safety-forums-hostmote-2023/ 2023-06-09T08:19:59+00:00 https://www.lmi.no/wp-content/uploads/2020/02/mikrofon.jpeg https://www.lmi.no/2023/06/09/asco-oppsummert-podcast-lytt-til-de-viktigste-studiene-fra-verdens-storste-kreftkongress/ 2023-06-09T08:52:17+00:00 https://www.lmi.no/2023/06/09/gsk-streiken-i-storbritannia-trappes-opp/ 2023-06-09T08:54:27+00:00 https://www.lmi.no/2023/06/09/kreftvaksinen-fra-moderna-og-msd-far-saerstatus-i-bade-usa-og-europa/ 2023-06-09T08:55:19+00:00 https://www.lmi.no/2023/06/12/asco-viste-fram-overlevelses-gevinsten-til-nye-kreftmedisiner/ 2023-06-12T07:34:29+00:00 https://www.lmi.no/2023/06/12/professor-%e2%88%92-losningen-pa-kreftgaten-er-ikke-slik-vi-tror/ 2023-06-12T07:39:45+00:00 https://www.lmi.no/2023/06/12/saksoker-vaksineprodusent-krever-17-millioner/ 2023-06-12T07:43:31+00:00 https://www.lmi.no/2023/06/12/industrien-har-ikke-endret-mening-om-blareseptanbudet-etter-evalueringen/ 2023-06-12T07:54:29+00:00 https://www.lmi.no/2023/06/12/lmi-ut-mot-hemmelighold-om-blareseptanbudet-frykter-snikinnforing/ 2023-06-12T10:33:50+00:00 https://www.lmi.no/wp-content/uploads/2023/06/medwatch-skjermdump.png https://www.lmi.no/wp-content/uploads/2023/06/medwatch-skjermdump.png https://www.lmi.no/2023/06/13/kronikk-blir-gode-levear-mindre-verdt/ 2023-06-13T07:30:02+00:00 https://www.lmi.no/wp-content/uploads/2023/06/matheus-ferrero-yfmjALh1S6s-unsplash-scaled.jpg https://www.lmi.no/2023/06/13/har-forskerne-funnet-en-vaksine-mot-kreft-denne-teknologien-kan-vaere-losningen/ 2023-06-13T10:21:07+00:00 https://www.lmi.no/2023/06/13/ny-studie-halverer-risikoen-for-a-do/ 2023-06-13T10:25:22+00:00 https://www.lmi.no/2023/06/13/novo-nordisk-bygger-ut-vil-investere-247-milliarder-kroner/ 2023-06-13T10:26:43+00:00 https://www.lmi.no/2023/06/13/svensk-medtek-gigant-kjoper-amerikansk-produsent/ 2023-06-13T10:27:56+00:00 https://www.lmi.no/2023/06/14/direktoratet-for-medisinske-produkter-et-skritt-i-feil-retning/ 2023-06-14T09:06:12+00:00 https://www.lmi.no/2023/06/14/roche-blir-ny-partner-i-health2b/ 2023-06-14T09:07:16+00:00 https://www.lmi.no/2023/06/14/rsv-vaksine-i-norge-blir-klar-for-sesongen/ 2023-06-14T09:08:12+00:00 https://www.lmi.no/2023/06/14/starter-studie-pa-langtidsvirkende-sproyter-mot-diabetes-og-fedme/ 2023-06-14T09:10:23+00:00 https://www.lmi.no/2023/06/14/mener-anbudspiloten-og-evalueringen-av-den-er-problematisk/ 2023-06-14T09:11:38+00:00 https://www.lmi.no/2023/06/14/ekspertpanel-i-usa-stotter-alzheimers-medisin/ 2023-06-14T09:12:39+00:00 https://www.lmi.no/2023/06/14/venclyxto-opprettholdt-progresjonsfri-overlevelse-i-pasienter-med-leukemi/ 2023-06-14T09:14:32+00:00 https://www.lmi.no/2023/06/14/hva-kan-vi-sammen-gjore-for-a-fa-mt-er-for-legemidler-norge-onsker/ 2023-06-14T09:34:20+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Medisin-i-apotek_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/06/Medisin-i-apotek_AdobeStock-scaled.jpeg https://www.lmi.no/2023/06/14/ultimovacs-om-nipu-studien-vi-er-mer-optimistiske-na-enn-vi-var-for-avlesning/ 2023-06-14T10:24:51+00:00 https://www.lmi.no/2023/06/15/lmis-horingssvar-om-forslag-til-endring-av-produksjonsomrade-forskriften/ 2023-06-15T07:39:56+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2021/02/19/om-tilgang-til-nye-legemidler/ 2023-06-15T10:52:41+00:00 https://www.lmi.no/wp-content/uploads/2020/08/Penger-legemidler-scaled.jpeg https://www.lmi.no/wp-content/uploads/2021/01/NyeMetoder.png https://www.lmi.no/2023/06/15/referat-fra-kontaktmote-med-slv/ 2023-06-15T12:46:51+00:00 https://www.lmi.no/wp-content/uploads/2019/12/SLV-skilt.png https://www.lmi.no/wp-content/uploads/2019/12/SLV-skilt.png https://www.lmi.no/2023/06/16/mellomoppgjoret-2023-enighet-i-forhandlingene-for-farmasoytisk-industri/ 2023-06-16T07:54:27+00:00 https://www.lmi.no/2023/06/16/sanofi-satser-pa-kunstig-intelligens-og-datateknologi-med-ny-app/ 2023-06-16T07:54:39+00:00 https://www.lmi.no/2023/06/16/vista-rapport-apotekene-bidrar-til-milliardinnsparinger-i-helsetjenesten/ 2023-06-16T07:54:52+00:00 https://www.lmi.no/2023/06/16/fedmeekspert-hyllet-nye-slankemedisiner-men-ingen-fikk-vite-hva-de-heter/ 2023-06-16T07:55:04+00:00 https://www.lmi.no/2023/06/16/fremskritt-koster/ 2023-06-16T07:55:19+00:00 https://www.lmi.no/2023/06/16/nykode-setter-covid-kandidat-pa-hylla-potensialet-for-koronavaksiner-faller-raskt/ 2023-06-16T08:31:27+00:00 https://www.lmi.no/2023/06/16/kjopt-for-fire-millioner-solgt-for-40-millioner/ 2023-06-16T08:32:53+00:00 https://www.lmi.no/2023/06/16/sglt2-hemmere-til-behandling-av-hjertesvikt/ 2023-06-16T08:34:03+00:00 https://www.lmi.no/2023/06/16/kutter-arets-gjennomgang-av-legemidler-som-selges-utenom-apotek/ 2023-06-16T08:35:19+00:00 https://www.lmi.no/2023/06/16/astrazeneca-flytter-til-bryggerikvartal-i-kobenhavn/ 2023-06-16T08:36:42+00:00 https://www.lmi.no/2023/06/16/fedme-og-overvekt-koster-oss-238-milliarder-kroner-i-aret-nesten-like-mye-som-kreft/ 2023-06-16T08:37:51+00:00 https://www.lmi.no/2023/06/16/synspunkt-mari-sundli-tveit-helsenaeringa-er-en-foregangsnaering/ 2023-06-16T08:39:32+00:00 https://www.lmi.no/2023/06/16/kong-harald-apnet-norsk-dansk-naeringslivskonferanse-i-kobenhavn/ 2023-06-16T11:21:35+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Kongen-pa-naeringslivskonf.jpg https://www.lmi.no/wp-content/uploads/2023/06/Kongen-pa-naeringslivskonf.jpg https://www.lmi.no/wp-content/uploads/2023/06/Leif-Rune-i-koben-2.png https://www.lmi.no/wp-content/uploads/2023/06/Thomassen-pa-naeringslivskonf.jpg https://www.lmi.no/wp-content/uploads/2023/06/Michael-workshop-koben-scaled.jpg https://www.lmi.no/2023/06/19/inger-cathrine-bryne-takker-av-som-leder-for-beslutningsforum/ 2023-06-19T09:15:14+00:00 https://www.lmi.no/2023/06/19/wiborg-tar-opp-sporsmal-om-fresenius-kabi-salget-pa-stortinget/ 2023-06-19T09:23:41+00:00 https://www.lmi.no/2023/06/19/ultimovacs-melder-om-positive-data-fra-studie-pa-kreftvaksine/ 2023-06-19T09:27:34+00:00 https://www.lmi.no/2023/06/19/kreftregisteret-kjemper-for-livet-vil-ikke-bli-en-del-av-fhi/ 2023-06-19T09:30:36+00:00 https://www.lmi.no/2023/06/19/pgeu-apotekene-er-sentrale-i-kampen-mot-antibiotikaresistens/ 2023-06-19T09:31:50+00:00 https://www.lmi.no/2023/06/19/banebrytende-migrene-studie-sammenlignet-daglig-tablett-og-manedlig-injeksjon/ 2023-06-19T09:32:14+00:00 https://www.lmi.no/2023/06/19/ny-norden-sjef-i-astrazeneca/ 2023-06-19T09:32:31+00:00 https://www.lmi.no/2023/06/19/belsutningsforum-skal-ta-stilling-til-innforing-av-bryskreftmedisin-for-fjerde-gang/ 2023-06-19T10:31:14+00:00 https://www.lmi.no/2023/06/19/medlemsmote-om-bransjeregler-2023-samt-revisjon-av-avtalen-med-rhf/ 2023-06-19T12:29:03+00:00 https://www.lmi.no/wp-content/uploads/2020/02/Lovkurs-2020-DIGFORSIDE-uten-tekst.jpg https://www.lmi.no/2023/06/20/horing-nou-202317-na-er-det-alvor-totalberedskapskommisjonen/ 2023-06-20T07:16:46+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/06/20/lmi-om-ny-strategi-for-nye-metoder-for-lite-konkret/ 2023-06-20T07:33:15+00:00 https://www.lmi.no/wp-content/uploads/2021/01/karoline-knutsen-svart-hvit.jpg https://www.lmi.no/2023/06/20/skriftlig-sporsmal-fra-listhaug-til-helse-og-omsorgsminister-kjerkol-om-wait-tallene-om-legemiddeltilgang/ 2023-06-20T08:20:36+00:00 https://www.lmi.no/wp-content/uploads/2021/02/sylvi-listhaug_stortinget2.jpg https://www.lmi.no/2023/06/20/du-lovet-a-ta-tak-kjerkol-hva-har-du-gjort-det-siste-aret/ 2023-06-20T10:22:15+00:00 https://www.lmi.no/2023/06/20/dette-skal-nye-metoder-satse-pa-de-neste-fem-arene/ 2023-06-20T10:23:56+00:00 https://www.lmi.no/2023/06/20/ny-crohns-medisin-meget-god-effekt/ 2023-06-20T10:28:14+00:00 https://www.lmi.no/2023/06/20/trodelvy-saken-i-dag-feller-jeg-tarer-i-glede-og-sorg/ 2023-06-20T10:35:28+00:00 https://www.lmi.no/2023/06/20/beslutningsforum-sier-ja-til-trodelvy/ 2023-06-20T10:36:29+00:00 https://www.lmi.no/2023/06/20/god-nyrebeskyttende-behandling-er-god-hjertebeskyttende-behandling/ 2023-06-20T10:39:56+00:00 https://www.lmi.no/2023/06/20/janssen-norge-om-beslutningsforum-nei-ma-tilrettelegge-for-avtaler-som-balanserer-risiko/ 2023-06-20T10:50:37+00:00 https://www.lmi.no/2023/06/20/emily-hauge-er-ny-leder-i-farmasoyter-uten-grenser/ 2023-06-20T10:51:59+00:00 https://www.lmi.no/2023/06/20/financial-times-astrazeneca-vil-skille-ut-aktiviteter-i-kina/ 2023-06-20T10:53:03+00:00 https://www.lmi.no/2023/06/20/novo-nordisk-overtar-fransk-selskap-i-avtale-med-hovedaksjonaer/ 2023-06-20T10:53:59+00:00 https://www.lmi.no/2023/06/20/besvaerlig-soknadsprosess-for-legemiddelstudier/ 2023-06-20T10:57:24+00:00 https://www.lmi.no/2023/06/20/curida-lante-en-million-fra-kommunen-allerede-i-fjor-host/ 2023-06-20T10:58:53+00:00 https://www.lmi.no/2023/06/20/horing-nou-2023-16-evaluering-av-pandemihandteringen-rapport-fra-koronautvalget/ 2023-06-20T11:17:26+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/06/20/helsenaeringa-er-en-foregangsnaering/ 2023-06-20T13:24:18+00:00 https://www.lmi.no/wp-content/uploads/2023/06/mari-sundli-tveit-fgt-00693-foto_thomas_keilman.png https://www.lmi.no/wp-content/uploads/2023/06/mari-sundli-tveit-fgt-00693-foto_thomas_keilman.png https://www.lmi.no/2023/06/21/pfizer-blareseptanbud-noen-ma-trekke-i-nodbremsen/ 2023-06-21T07:54:19+00:00 https://www.lmi.no/2023/06/21/ny-rapport-eli-lilly-overtar-diabetes-og-fedmeposisjonen-til-novo-nordisk-innen-kort-tid/ 2023-06-21T07:57:04+00:00 https://www.lmi.no/2023/06/21/enhertu-er-lovende-i-enda-flere-krefttyper-privat-klinikk-bruker-medisinen-allerede/ 2023-06-21T07:57:54+00:00 https://www.lmi.no/2023/06/21/novo-nordisk-setter-ned-tempoet-pa-lansering-av-fedmemiddel-i-nye-markeder/ 2023-06-21T08:02:06+00:00 https://www.lmi.no/2023/06/21/studie-tidlig-oppstart-av-blodfortynnende-behandling-etter-hjerneinfarkt-er-trygt/ 2023-06-21T08:03:40+00:00 https://www.lmi.no/2023/06/21/hold-av-datoen-lmis-strategisamling-2023/ 2023-06-21T12:09:09+00:00 https://www.lmi.no/wp-content/uploads/2019/10/St%C3%B8tvig.jpeg https://www.lmi.no/wp-content/uploads/2022/11/Strategisamling-LR-scaled.jpg https://www.lmi.no/2023/06/22/lmis-innspill-til-ny-strategi-for-nye-metoder/ 2023-06-22T07:39:58+00:00 https://www.lmi.no/wp-content/uploads/2022/06/KKBeskjaert.jpg https://www.lmi.no/2023/06/22/skal-utrede-flytting-av-forskningsinstitutter-pa-rikshospitalet/ 2023-06-22T07:41:49+00:00 https://www.lmi.no/2023/06/22/overtar-midlertidig-som-fhi-sjef/ 2023-06-22T07:42:45+00:00 https://www.lmi.no/2023/06/22/havbruk-oppdrettsbransjen-loper-fra-ansvaret-flytter-miljoproblemene-ut-pa-havet/ 2023-06-22T07:45:22+00:00 https://www.lmi.no/2023/06/22/ny-studie-overraskende-losning-for-kneartrose/ 2023-06-22T07:47:09+00:00 https://www.lmi.no/2023/06/22/biotek-veteraner-etablerer-ny-kreftmygg/ 2023-06-22T07:52:11+00:00 https://www.lmi.no/2023/06/22/ny-podcast-derfor-sa-beslutningsforum-ja-i-omstridt-brystkreftsak-fedmerapport-gir-skremmende-utsikter/ 2023-06-22T07:56:13+00:00 https://www.lmi.no/2023/06/22/norsk-nevrolog-om-ny-studie-tror-migrene-tablett-vil-brukes-mer-i-fremtiden/ 2023-06-22T07:57:27+00:00 https://www.lmi.no/2023/06/22/laksesjukdom-med-hog-prislapp-for-oppdrettsnaeringa-tap-pa-8-milliarder-kroner/ 2023-06-22T07:59:25+00:00 https://www.lmi.no/2023/06/22/medisiner-stjalet-dyra-som-taper/ 2023-06-22T08:02:41+00:00 https://www.lmi.no/2023/06/22/lmis-horingssvar-om-forlenget-rekvireringsrett-for-farmasoyter-og-sykepleiere/ 2023-06-22T08:32:07+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/06/23/bedre-samarbeid-om-legemidler/ 2023-06-23T11:01:41+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Antibtioka-apotek-legemidler-Adobe-scaled.jpeg https://www.lmi.no/2023/06/23/bedre-samarbeid-om-legemidler-2/ 2023-06-23T11:02:20+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Antibtioka-apotek-legemidler-Adobe-scaled.jpeg https://www.lmi.no/2023/06/23/else-kass-furuseth-startet-pa-omstridt-slankemedisin-dette-sier-hun-na/ 2023-06-23T11:30:06+00:00 https://www.lmi.no/2023/06/23/96-prosent-fikk-hoyeffektiv-ms-behandling-kan-bidra-til-a-gjore-sykdomsforlopet-lettere-krever-abonnement/ 2023-06-23T11:31:43+00:00 https://www.lmi.no/2023/06/23/kari-vil-sette-verdensrekord-i-overlevelse-av-lungekreft/ 2023-06-23T11:32:29+00:00 https://www.lmi.no/2023/06/26/referat-fra-kontaktmotet-med-hod-2/ 2023-06-26T06:24:09+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Kontaktmote-HOD-juni-23-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/Kontaktmote-HOD-juni-23-scaled.jpg https://www.lmi.no/2023/06/26/de-nye-bransjereglene-pa-3-minutter/ 2023-06-26T07:27:19+00:00 https://www.lmi.no/wp-content/uploads/2023/06/ramona-forklarer.png https://www.lmi.no/2023/06/26/ema-anbefaler-nye-legemidler-og-indikasjoner/ 2023-06-26T08:47:51+00:00 https://www.lmi.no/2023/06/26/legemiddel-mot-kronisk-nyresykdom-anbefales-godkjent-i-eu/ 2023-06-26T08:53:25+00:00 https://www.lmi.no/2023/06/26/diabetes-og-fedmemidler-undersokes-for-psykiske-og-kreftfremkallende-bivirkninger/ 2023-06-26T08:55:02+00:00 https://www.lmi.no/2023/06/26/godkjenner-forste-genterapi-i-usa-mot-sjelden-muskelsykdom/ 2023-06-26T08:56:23+00:00 https://www.lmi.no/2023/06/26/nye-prosjektmidler-fra-eu/ 2023-06-26T09:19:41+00:00 https://www.lmi.no/wp-content/uploads/2023/06/EU4HE.jpg https://www.lmi.no/wp-content/uploads/2023/06/EU4HE.jpg https://www.lmi.no/2023/06/26/storbritannia-astrazeneca-domt-i-etisk-rad-etter-engasjement-pa-sosiale-medier/ 2023-06-26T11:08:35+00:00 https://www.lmi.no/2023/06/27/vanskelige-forhold-for-digitale-terapier-i-norge/ 2023-06-27T08:19:02+00:00 https://www.lmi.no/2023/06/27/novo-nordisk-og-eli-lilly-med-nye-fedmepille-resultater/ 2023-06-27T08:26:39+00:00 https://www.lmi.no/2023/06/27/lundbeck-toppsjefen-gar-av/ 2023-06-27T08:27:41+00:00 https://www.lmi.no/2023/06/27/prioritering-og-industribygging-pa-dagsorden-under-arendalsuka/ 2023-06-27T08:31:32+00:00 https://www.lmi.no/2023/06/28/kjerkol-pa-besok-hos-ge/ 2023-06-28T08:46:10+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Kjerkol-trapp.jpg https://www.lmi.no/wp-content/uploads/2023/06/Kjerkol-GE.jpg https://www.lmi.no/wp-content/uploads/2023/06/Kjerkol-moterom.jpg https://www.lmi.no/2023/06/28/store-forventninger-til-eli-lillys-neste-fedmekandidat/ 2023-06-28T08:49:33+00:00 https://www.lmi.no/2023/06/28/blankt-nei-til-blaresept-for-migrenetablett-fra-pfizer/ 2023-06-29T07:59:32+00:00 https://www.lmi.no/2023/06/29/skal-revurdere-legemiddel-mot-sjelden-sykdom/ 2023-06-29T08:03:14+00:00 https://www.lmi.no/2023/06/29/kapplop-om-medisiner-mot-overvekt-kan-bli-en-gullgruve/ 2023-06-29T08:05:31+00:00 https://www.lmi.no/2023/06/29/insulife-har-inngatt-avtaler-om-produksjon-og-analyser-i-norge/ 2023-06-29T08:06:19+00:00 https://www.lmi.no/2023/06/29/horing-forslag-til-endringer-i-helselovgivningen/ 2023-06-29T09:11:09+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/06/29/kjerkol-har-svart-om-legemiddelverket/ 2023-06-29T09:46:28+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Spm-Hox-kjerk-kopi-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/Spm-Hox-kjerk-kopi-scaled.jpg https://www.lmi.no/2023/06/29/kjerkol-har-svart-om-norsk-deltagelse-i-hera/ 2023-06-29T09:59:13+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Spm-Hox-tro-kopi-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/06/Spm-Hox-tro-kopi-scaled.jpg https://www.lmi.no/2023/06/29/horingssvar-nou-2023-8-fellesskapets-sykehus-styring-finansiering-samhandling-og-ledelse/ 2023-06-29T12:39:07+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/06/30/debatt-hva-er-prisen-for-et-liv/ 2023-06-30T09:25:33+00:00 https://www.lmi.no/2023/06/30/abbvie-far-ny-leder-for-skandinavia/ 2023-06-30T09:26:31+00:00 https://www.lmi.no/2023/06/30/lmi-i-healthtalk-om-nordiske-prisforhandlinger/ 2023-06-30T09:33:54+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Healthtalk.png https://www.lmi.no/wp-content/uploads/2023/06/Healthtalk.png https://www.lmi.no/2023/06/30/lmi-i-medwatch-om-priskriterier-og-prio-melding/ 2023-06-30T12:33:17+00:00 https://www.lmi.no/wp-content/uploads/2023/06/MedW-kat.png https://www.lmi.no/wp-content/uploads/2023/06/MedW-kat.png https://www.lmi.no/2023/07/03/skymoen-i-aftenposten-vi-ma-samarbeide/ 2023-07-03T08:58:04+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Leif-Rune-Skymoen-beredskapskonferanse.-Foto-Norsk-Industri-scaled.jpg https://www.lmi.no/2023/07/03/biontech-og-oncoc4-starter-fase-3-studie-pa-lungekreft/ 2023-07-03T09:04:35+00:00 https://www.lmi.no/2023/07/03/sanofi-spar-10-milliarder-euro-i-vaksineinntekter-innen-2030/ 2023-07-03T09:05:29+00:00 https://www.lmi.no/2023/07/03/eu-inngar-vaksineavtale-med-en-rekke-selskap/ 2023-07-03T09:06:12+00:00 https://www.lmi.no/2023/07/03/salgstall-fra-farmastat-for-juni-2023/ 2023-07-03T11:37:58+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/07/04/novo-nordisk-og-slv-er-i-dialog-om-wegovy-refusjon/ 2023-07-04T07:19:16+00:00 https://www.lmi.no/2023/07/04/moderna-fortsetter-sitt-inntog-i-norden-marianne-arnemo-er-medisinsk-direktor-i-norge/ 2023-07-04T07:20:53+00:00 https://www.lmi.no/2023/07/04/skymoen-oppsummerer-sine-100-forste-dager-som-lmi-leder/ 2023-07-04T11:34:29+00:00 https://www.lmi.no/wp-content/uploads/2023/05/Leif-Rune-Skymoen_portrett-halvnaert-scaled.jpg https://www.lmi.no/2023/07/05/kronikk-norge-har-bare-tilgang-til-47-prosent-av-de-nye-medisinene/ 2023-07-05T08:15:09+00:00 https://www.lmi.no/wp-content/uploads/2023/07/Leif-Rune-Skymoen1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/07/Leif-Rune-Skymoen1-scaled.jpg https://www.lmi.no/2023/07/05/pfizer-og-samsung-biologics-inngar-milliardavtale/ 2023-07-05T08:17:58+00:00 https://www.lmi.no/2023/07/05/slik-unngar-legemiddelselskapene-lik-og-del-fella/ 2023-07-05T08:18:43+00:00 https://www.lmi.no/2023/07/05/legemiddelverket-om-reklameregler-og-sosiale-medier-vi-forutsetter-at-bransjen-folger-reglene/ 2023-07-05T08:19:29+00:00 https://www.lmi.no/2023/07/05/helsepolitikere-om-norske-krav-for-a-fa-ny-migrenemedisin-uholdbart/ 2023-07-05T08:20:15+00:00 https://www.lmi.no/2023/07/05/novo-nordisk-utvider-kjernevirksomheten-til-fire-sykdomsomrader/ 2023-07-05T08:21:52+00:00 https://www.lmi.no/2023/07/05/dag-morten-dalen-blareseptanbud-truer-ikke-velferdsstaten/ 2023-07-05T08:23:25+00:00 https://www.lmi.no/2023/07/05/jeg-hadde-nok-ikke-vaert-i-live-uten-legemiddel-studiene/ 2023-07-05T08:24:32+00:00 https://www.lmi.no/2023/07/05/heller-forebygging-enn-blalys/ 2023-07-05T08:35:58+00:00 https://www.lmi.no/2023/07/06/debatt-naeringslivsdelegasjonen-til-danmark-ma-folges-opp-med-avtaler/ 2023-07-06T08:35:01+00:00 https://www.lmi.no/2023/07/06/astrazeneca-vil-plante-skog-for-over-fire-milliarder-kroner/ 2023-07-06T08:36:40+00:00 https://www.lmi.no/2023/07/06/statssekretaer-om-migrene-kritikken-samfunnet-har-begrensede-ressurser/ 2023-07-06T08:37:24+00:00 https://www.lmi.no/2023/07/07/moderna-inngar-avtale-i-kina-som-lover-bedre-vilkar-for-internasjonale-legemiddelselskap/ 2023-07-07T08:20:14+00:00 https://www.lmi.no/2023/07/07/tolv-land-i-afrika-far-ny-malariavaksine/ 2023-07-07T08:21:09+00:00 https://www.lmi.no/2023/07/07/de-tre-ekspertgruppene-er-na-satt/ 2023-07-07T11:01:30+00:00 https://www.lmi.no/wp-content/uploads/2022/08/headway-5QgIuuBxKwM-unsplash-scaled.jpg https://www.lmi.no/2023/07/10/thermo-fisher-kjoper-dataanalyseselskap-for-975-milliarder-kroner/ 2023-07-10T08:57:04+00:00 https://www.lmi.no/2023/07/10/alzheimers-medisin-gir-hap-naermere-en-kur/ 2023-07-10T08:57:57+00:00 https://www.lmi.no/2023/07/10/norge-far-fem-millioner-til-samarbeid-om-sjeldne-diagnoser/ 2023-07-10T08:59:32+00:00 https://www.lmi.no/2023/07/10/pfizer-okonom-mener-staten-ikke-kun-bor-fokusere-pa-kortsiktige-migrene-kostnader/ 2023-07-10T09:01:07+00:00 https://www.lmi.no/2023/07/10/nykode-varsler-disse-milepaelene-det-neste-aret/ 2023-07-10T09:01:56+00:00 https://www.lmi.no/2023/07/12/samsung-biologics-inngar-milliardavtale-med-novartis/ 2023-07-12T09:29:03+00:00 https://www.lmi.no/2023/07/12/novartis-mister-patent-pa-blockbustermiddel-og-anker/ 2023-07-12T09:29:58+00:00 https://www.lmi.no/2023/07/12/novo-nordisk-skal-lansere-fedmemiddel-i-tyskland/ 2023-07-12T09:30:59+00:00 https://www.lmi.no/2023/07/13/photocure-onsker-a-selge-eget-blalys-cystoskop/ 2023-07-13T07:38:33+00:00 https://www.lmi.no/2023/07/13/rsv-vaksinen-til-gsk-far-britisk-godkjenning/ 2023-07-13T07:41:02+00:00 https://www.lmi.no/2023/07/14/legemiddelverket-varsler-mangel-pa-diabetesmedisinen-ozempic-en-god-stund-framover/ 2023-07-14T08:00:29+00:00 https://www.lmi.no/2023/07/14/pfizer-blareseptanbud-i-teori-og-praksis/ 2023-07-14T08:16:36+00:00 https://www.lmi.no/2023/07/17/nho-geneo-om-de-heloffentlige-ekspertgruppene-til-prioriteringsmeldingen-overraskende-og-skuffende/ 2023-07-17T10:12:55+00:00 https://www.lmi.no/2023/07/17/hostens-kurs-og-moter/ 2023-07-17T10:34:56+00:00 https://www.lmi.no/wp-content/uploads/2023/07/the-climate-reality-project-Hb6uWq0i4MI-unsplash-scaled.jpg https://www.lmi.no/2023/07/18/eli-lilly-kjoper-fedmeselskap-for-opptil-193-milliarder-kroner/ 2023-07-18T08:26:42+00:00 https://www.lmi.no/2023/07/18/norske-kortvokste-drommer-om-voksemedisin-svaret-fra-statens-legemiddelverk-fyll-ut-et-skjema/ 2023-07-18T08:27:55+00:00 https://www.lmi.no/2023/07/18/lovende-tester-av-nytt-legemiddel-som-bremser-alzheimer/ 2023-07-18T08:28:38+00:00 https://www.lmi.no/2023/07/19/pfizer-og-flagship-investerer-100-millioner-dollar-inn-i-legemiddelforskning/ 2023-07-19T09:28:06+00:00 https://www.lmi.no/2023/07/19/eu-skal-jobbe-med-antibiotikaprodusenter-for-a-unnga-mangelsituasjon-i-vinter/ 2023-07-19T09:29:45+00:00 https://www.lmi.no/2023/07/19/rsv-midlet-til-sanofi-og-astrazeneca-far-amerikansk-godkjennelse/ 2023-07-19T09:30:45+00:00 https://www.lmi.no/2023/07/19/curida-leverer-positivt-halvarsresultat-etter-a-ha-femdoblet-underskuddet-i-fjor/ 2023-07-19T10:14:58+00:00 https://www.lmi.no/2023/07/24/pfizer-og-flagship-gar-sammen-for-a-utvikle-10-nye-legemidler/ 2023-07-24T11:13:47+00:00 https://www.lmi.no/2023/07/24/johnson-johnson-overgikk-kvartalsforventninger/ 2023-07-24T11:16:03+00:00 https://www.lmi.no/2023/07/24/mangelsituasjon-ogsa-for-fedmemiddelet-saxenda/ 2023-07-24T11:18:43+00:00 https://www.lmi.no/2023/07/24/klarsignal-for-pfizers-rs-vaksine-for-sma-barn-og-eldre-voksne/ 2023-07-24T11:44:00+00:00 https://www.lmi.no/2023/07/05/oppsummering-2-kvartal-2023-faggruppen-for-regulatory-og-pharmacovigilance/ 2023-07-24T12:52:46+00:00 https://www.lmi.no/wp-content/uploads/2023/07/Pharmacovigilance_AdobeStock-1280x853-1.jpeg https://www.lmi.no/2023/07/25/palla-pharma-gikk-med-millionunderskudd-i-2022/ 2023-07-25T09:58:52+00:00 https://www.lmi.no/2023/07/25/godkjenner-14-nye-legemidler-overraskende-avslag-for-lungekreftbehandling/ 2023-07-25T10:00:44+00:00 https://www.lmi.no/2023/07/25/gilead-inn-i-oslo-cancer-cluster/ 2023-07-25T10:01:38+00:00 https://www.lmi.no/2023/07/27/innovasjon-norge-direktor-helsenaeringen-har-stort-potensial-som-nytt-eksportlokomotiv/ 2023-07-27T09:38:52+00:00 https://www.lmi.no/2023/07/27/nytt-legemiddel-mot-lymfekreft-pa-vei-mot-eu-godkjenning/ 2023-07-27T09:40:09+00:00 https://www.lmi.no/2023/07/27/moderna-og-msd-starter-fase-3-studie-pa-kreftvaksine/ 2023-07-27T09:44:14+00:00 https://www.lmi.no/2023/07/27/gsk-hever-forventningene-sine-for-2023-zantac-soksmal-i-vente/ 2023-07-27T09:48:15+00:00 https://www.lmi.no/2023/07/27/biogen-skal-kvitte-seg-med-1000-ansatte-vil-spare-en-milliard-dollar/ 2023-07-27T09:49:49+00:00 https://www.lmi.no/2023/07/27/anbefaler-immunterapi-i-tidlige-stadier-av-foflekkreft/ 2023-07-27T09:54:08+00:00 https://www.lmi.no/2023/07/27/adhd-medisineringen-har-doblet-seg-siden-2016-aduvanz-og-ritalin-blant-de-mest-omsatte-blareseptlegemidlene-i-2022/ 2023-07-27T09:55:12+00:00 https://www.lmi.no/2023/07/27/pfizer-tilbudet-for-noen-legemidler-i-fare-pa-grunn-av-tornado-odeleggelse/ 2023-07-27T10:44:30+00:00 https://www.lmi.no/2023/07/31/globale-legemiddelfirmaer-satser-tungt-i-kina/ 2023-07-31T11:03:39+00:00 https://www.lmi.no/2023/07/31/glp-1-midler-under-lupen-ogsa-i-storbritannia-etter-rapporter-om-selvskadings-og-selvmordstanker/ 2023-07-31T11:04:51+00:00 https://www.lmi.no/2023/07/31/gsk-far-gront-lys-for-sin-hiv-forebyggingsmedisin-i-europa/ 2023-07-31T11:05:51+00:00 https://www.lmi.no/2023/07/31/ge-healthcare-hever-sin-resultatprognose-drar-fordel-av-godkjenning-av-alzheimers-behandling/ 2023-07-31T11:08:02+00:00 https://www.lmi.no/2023/07/31/moderna-merck-starter-senfasestudie-av-mrna-kreftvaksine/ 2023-07-31T11:12:25+00:00 https://www.lmi.no/2023/07/31/astrazeneca-kjoper-pfizers-genterapi-portefolje-for-sjeldne-sykdommer/ 2023-07-31T11:14:19+00:00 https://www.lmi.no/2023/07/31/biogen-kjoper-sjelden-selskapet-reata-i-milliardavtale/ 2023-07-31T11:14:50+00:00 https://www.lmi.no/2023/07/31/wegovy-lansert-i-tyskland-dekkes-ikke-av-forsikringen/ 2023-07-31T11:16:52+00:00 https://www.lmi.no/2023/07/31/immunterapi-viser-gode-resultater-i-studie-for-behandling-av-brystkreft-for-kirurgi/ 2023-07-31T11:20:56+00:00 https://www.lmi.no/2023/07/31/thermo-fishers-inntekter-faller-peker-pa-vanskelige-tider-for-biotek-bransjen/ 2023-07-31T11:36:00+00:00 https://www.lmi.no/2023/07/31/lederbytte-i-gsk-norge/ 2023-07-31T11:38:15+00:00 https://www.lmi.no/2023/07/24/ous-vi-onsker-industristudier-pa-kvinnehelse-velkommen/ 2023-07-31T12:23:22+00:00 https://www.lmi.no/wp-content/uploads/2023/07/kvinneklinikken-ous-gruppebilde.png https://www.lmi.no/wp-content/uploads/2023/07/Kliniske-studier-teamet-Kvinneklinikken-OUS-scaled.jpg https://www.lmi.no/2023/08/01/nyhetsbrev-fra-aesgp-euro-otc-juli-2023/ 2023-08-01T07:44:33+00:00 https://www.lmi.no/wp-content/uploads/2023/08/aesgp-nyhetsbrev-2.png https://www.lmi.no/wp-content/uploads/2023/08/AESGP-nyhetsbrev.png https://www.lmi.no/2023/08/01/eli-lillys-fedmekandidat-leverer-i-nye-fase-3-studier/ 2023-08-01T10:23:28+00:00 https://www.lmi.no/2023/08/01/biontech-klar-med-oppkjop-gjor-sin-entre-pa-ki-markedet/ 2023-08-01T10:25:04+00:00 https://www.lmi.no/2023/08/01/britisk-milliardaer-tiltalt-for-innsidehandel-i-biotek-selskaper/ 2023-08-01T10:29:15+00:00 https://www.lmi.no/2023/08/01/kragero-tablettproduksjon-med-million-vekst-har-aldri-gatt-i-minus/ 2023-08-01T10:30:44+00:00 https://www.lmi.no/2023/08/01/salgstall-fra-farmastat-for-juli-2023/ 2023-08-01T10:49:54+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/08/01/lmi-i-healthtalk-om-arets-verdioverforinger-til-helsepersonell-helseforetak-og-pasient-og-brukerorganisasjoner/ 2023-08-01T10:58:22+00:00 https://www.lmi.no/wp-content/uploads/2023/08/ramona.jpg https://www.lmi.no/2023/08/03/sanofi-og-biontech-avbryter-kreftvaksine-program/ 2023-08-03T09:36:23+00:00 https://www.lmi.no/2023/08/03/pfizer-nedjusterer-forventninger-etter-inntektsfall/ 2023-08-03T09:37:31+00:00 https://www.lmi.no/2023/08/03/msd-norge-brukte-50-millioner-kroner-pa-forskning-sa-mye-brukte-de-andre-selskapene/ 2023-08-03T09:38:32+00:00 https://www.lmi.no/2023/08/03/kan-dette-vaere-arsaken-til-overraskende-eu-nei-til-ny-kreftmedisin/ 2023-08-03T09:39:45+00:00 https://www.lmi.no/2023/08/03/eli-lilly-26-prosent-vektreduksjon-i-to-studier-med-nytt-fedmelegemiddel/ 2023-08-03T09:40:47+00:00 https://www.lmi.no/2023/08/03/gsk-gar-rettens-vei-mener-pfizer-krenker-patenten-pa-rsv-vaksine/ 2023-08-03T09:42:34+00:00 https://www.lmi.no/2023/08/03/gsk-slar-msd-i-kapplopet-om-livmorkreft-behandling/ 2023-08-03T09:43:58+00:00 https://www.lmi.no/2023/08/03/salget-av-keytruda-overgar-forventningen-na-oppjusterer-msd/ 2023-08-03T09:45:53+00:00 https://www.lmi.no/2023/08/03/novo-nordisk-lanserer-sin-egen-utgave-av-chatgpt/ 2023-08-03T09:46:56+00:00 https://www.lmi.no/2023/08/04/pameldingsfrist-til-mote-under-esc-kongressen-norge-som-studieland/ 2023-08-04T07:43:44+00:00 https://www.lmi.no/wp-content/uploads/2023/06/Amsterdam_AdobeStock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/06/Amsterdam_AdobeStock-scaled.jpeg https://www.lmi.no/2023/08/04/vaksineforsker-vil-at-vaksinestudier-skal-inkludere-sporsmal-om-menstruasjon/ 2023-08-04T10:51:58+00:00 https://www.lmi.no/2023/08/04/biogen-kutter-1000-jobber-usikkert-om-konsekvensene-for-biogen-norge/ 2023-08-04T10:58:30+00:00 https://www.lmi.no/2023/08/04/amgen-med-sterke-resultater-oppjusterer-forventninger/ 2023-08-04T11:00:23+00:00 https://www.lmi.no/2023/08/04/astrazeneca-direktor-skal-lede-utredning-om-innovasjon-og-forskning-for-den-svenske-regjeringen/ 2023-08-04T11:01:42+00:00 https://www.lmi.no/2023/08/04/ultimovacs-i-mal-med-rekruttering-til-studie-pa-hode-og-halskreft/ 2023-08-04T11:08:24+00:00 https://www.lmi.no/2023/08/07/curida-satser-etter-okonomitrobbelet-er-i-heftig-vekst/ 2023-08-07T09:08:14+00:00 https://www.lmi.no/2023/08/07/nyoppdaget-bakterie-kan-bidra-til-a-utrydde-malaria/ 2023-08-07T09:09:19+00:00 https://www.lmi.no/2023/08/07/studiesuksess-for-medisin-til-pasienter-med-tarmkreft/ 2023-08-07T09:10:41+00:00 https://www.lmi.no/2023/08/07/ny-slankemedisin-aktuell-for-norge-viser-ekstreme-resultater/ 2023-08-07T09:11:42+00:00 https://www.lmi.no/2023/08/07/slankemidler-granskes-etter-meldinger-om-alvorlige-bivirkninger/ 2023-08-07T09:13:41+00:00 https://www.lmi.no/2023/08/07/presisjonsmedisin-skreddersys-til-behandling-av-kreftsvulstene/ 2023-08-07T09:15:54+00:00 https://www.lmi.no/2023/08/07/gullkantede-fiskevaksiner-pharmaq-fikk-en-driftsmargin-pa-536-prosent-ifjor/ 2023-08-07T09:20:06+00:00 https://www.lmi.no/2023/08/07/lmi-tilbyr-engelsk-oversettelse-av-arendalsukamotene-vare/ 2023-08-07T11:26:06+00:00 https://www.lmi.no/wp-content/uploads/2022/08/Arendalsuka-ute-1-1-scaled.jpg https://www.lmi.no/2023/08/09/usa-godkjenner-den-forste-pillen-for-behandling-av-fodselsdepresjon/ 2023-08-09T08:59:09+00:00 https://www.lmi.no/2023/08/09/pfizer-setter-medisiner-pa-nodbestillingsliste-etter-tornado/ 2023-08-09T09:00:31+00:00 https://www.lmi.no/2023/08/09/salgsboom-pa-legemidler-pilene-peker-oppover-pa-alle-omrader/ 2023-08-09T09:02:40+00:00 https://www.lmi.no/2023/08/09/wegovy-reduserer-alvorlige-hjertekomplikasjoner-med-20-prosent-dette-er-veldig-gode-nyheter/ 2023-08-09T09:04:54+00:00 https://www.lmi.no/2023/08/09/student-har-laget-ki-chatbot-for-ge-healthcare-i-lindesnes/ 2023-08-09T09:07:32+00:00 https://www.lmi.no/2023/08/09/hvordan-kan-vi-sammen-bidra-til-riktig-legemiddelbruk/ 2023-08-09T09:08:08+00:00 https://www.lmi.no/wp-content/uploads/2023/08/askeland-skjermbilde.png https://www.lmi.no/2023/08/09/meld-deg-pa-hostens-reklamekurs-2/ 2023-08-09T09:42:56+00:00 https://www.lmi.no/wp-content/uploads/2019/02/Reklamekurs_digforside2019_uten-tekst.jpg https://www.lmi.no/2023/08/09/lmi-samler-industrien-under-arendalsuka/ 2023-08-09T10:41:26+00:00 https://www.lmi.no/wp-content/uploads/2022/08/Arendalsuka-ute-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/08/Arendalsuka-ute-3-1-scaled.jpg https://www.lmi.no/2023/08/09/lmi-i-dagens-medisin-om-alternative-prisavtaler/ 2023-08-09T11:07:58+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Karoline-Knutsen.jpg https://www.lmi.no/wp-content/uploads/2023/08/Karoline-Knutsen.jpg https://www.lmi.no/2023/08/10/disse-14-medisinene-har-sykehusene-tatt-i-bruk-gjennom-alternative-avtaler/ 2023-08-10T07:41:07+00:00 https://www.lmi.no/2023/08/10/na-kan-det-bli-mangel-pa-denne-medisinen-i-et-helt-ar/ 2023-08-10T07:45:25+00:00 https://www.lmi.no/2023/08/10/markedsverdien-til-novo-nordisk-storre-enn-danmarks-bnp/ 2023-08-10T07:48:07+00:00 https://www.lmi.no/2023/08/10/curidas-produksjon-ikke-rammet-av-hans/ 2023-08-10T07:53:20+00:00 https://www.lmi.no/2023/08/10/fant-ingen-ulovlige-stoffer-i-oppdrettsfisken/ 2023-08-10T07:55:19+00:00 https://www.lmi.no/2023/08/10/photocures-inntekter-vokser-planlegger-blalys-tiltak/ 2023-08-10T08:04:37+00:00 https://www.lmi.no/2023/08/10/astrazeneca-har-inngatt-avtale-med-statkraft/ 2023-08-10T08:06:48+00:00 https://www.lmi.no/2023/08/11/slv-tror-pa-ny-diskusjon-med-novo-nordisk-om-blaresept-for-wegovy-ganske-snart/ 2023-08-11T08:58:19+00:00 https://www.lmi.no/2023/08/11/novo-nordisk-kjoper-biotekselskap-for-10-milliarder-kroner-og-legger-frem-rekordoverskudd/ 2023-08-11T08:59:56+00:00 https://www.lmi.no/2023/08/11/medisin-mot-genetisk-blodsykdom-trekkes-fra-markedet/ 2023-08-11T09:01:18+00:00 https://www.lmi.no/2023/08/11/astrazeneca-inngar-produksjonsavtale-med-kinesiske-cansino/ 2023-08-11T09:02:34+00:00 https://www.lmi.no/2023/08/11/elen-hoeg-blir-daglig-leder-i-health2b/ 2023-08-11T09:07:12+00:00 https://www.lmi.no/2023/08/11/den-opplyste-pasient/ 2023-08-11T11:47:28+00:00 https://www.lmi.no/2023/08/11/livsviktig-eksportsatsing/ 2023-08-11T11:48:32+00:00 https://www.lmi.no/2023/08/11/budskap-arendalsuka-2023/ 2023-08-11T13:02:39+00:00 https://www.lmi.no/2023/08/14/dansk-forsker-bak-sensasjonell-slankemedisin-ble-oppfattet-som-ikke-ekte-forskning/ 2023-08-14T13:22:30+00:00 https://www.lmi.no/2023/08/14/slik-skal-nye-metoder-videreutvikles-de-neste-fem-arene/ 2023-08-14T13:24:15+00:00 https://www.lmi.no/2023/08/14/navamedics-omsetning-vokser-etter-okt-ettersporsel-for-fedmemiddel/ 2023-08-14T13:27:27+00:00 https://www.lmi.no/2023/08/14/spesialistinvestor-norge-har-en-umoden-helseindustri-nar-det-gjelder-utvikling-av-nye-medisinske-produkter/ 2023-08-14T13:30:15+00:00 https://www.lmi.no/2023/08/14/ny-rapport-hjernehinnebetennelse-vaksine-i-vaksinasjonsprogrammet-kan-redde-liv/ 2023-08-14T13:31:19+00:00 https://www.lmi.no/2023/08/14/en-innholdsrik-uke-ligger-foran-oss/ 2023-08-14T13:52:41+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Leif-Rune-Arendal-1_skjermdump.png https://www.lmi.no/2023/08/14/arendalsuka-2023-dette-skjedde-mandag/ 2023-08-14T14:12:42+00:00 https://www.lmi.no/wp-content/uploads/2023/08/arendal-mandag-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/IMG_4558-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/IMG_1251-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-mandag-10-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-mandag-17-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-mandag-25-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-mandag-26-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-mandag-24-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-mandag-2023-6-scaled.jpg https://www.lmi.no/2023/08/15/norsk-forsker-med-sensasjonelt-kreft-gjennombrudd/ 2023-08-15T08:32:14+00:00 https://www.lmi.no/2023/08/15/eli-lilly-fullforer-kjop-av-diabetesselskap/ 2023-08-15T08:33:10+00:00 https://www.lmi.no/2023/08/15/novartis-gjennomforer-kjop-av-amerikansk-bioteknologiselskap-for-335-milliarder-kroner/ 2023-08-15T08:34:32+00:00 https://www.lmi.no/2023/08/15/midlertidig-tilgang-i-norge-fungerer-modellen-som-tiltenkt/ 2023-08-15T08:40:57+00:00 https://www.lmi.no/2023/08/15/norge-er-klare-for-eus-mission-on-cancer/ 2023-08-15T08:47:24+00:00 https://www.lmi.no/wp-content/uploads/2023/08/490AEA7C-4115-454E-B8D7-394184230601-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/490AEA7C-4115-454E-B8D7-394184230601-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/8A86739D-7C2E-4935-8754-08B6602EE76D-scaled.jpeg https://www.lmi.no/2023/08/15/opplever-et-betydelig-bedre-samarbeid-og-mindre-mistro/ 2023-08-15T11:43:38+00:00 https://www.lmi.no/2023/08/15/arendalsuka-2023-dette-skjedde-tirsdag/ 2023-08-15T14:38:47+00:00 https://www.lmi.no/wp-content/uploads/2023/08/35F98CD5-A95B-4677-89AD-B87B17C70032-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/ADC2B572-9D5C-4104-8E53-36969601051A-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/970E83BB-E896-4D41-AD60-12A8CB84579B-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/8A86739D-7C2E-4935-8754-08B6602EE76D-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/87724CE7-74EE-448A-81B0-F0FA88273C73-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/E47AE744-A108-4976-ADB3-DD541D982F6C-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/6257FEAE-6620-479A-9AC9-483DEDAFCCE4-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/28449E0A-3606-49FF-B223-D59F8C70BD66-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/E4C0EE77-1C51-402D-AEE4-028C34C5F745-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/6587319E-B306-45F2-9B4B-7FC6ACB5E2E7-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/DBDBA597-0668-4410-AEB5-1ACA13C4D9E5-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/14902E4C-F8B1-4C77-8B6D-A7458CE1218D-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/837D9414-C962-4FA7-8C04-5997BA7384D5-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/EF0D0C21-851C-4511-B09C-7FB23BDE3EB1-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/94672482-DFC8-4AC7-8BD9-E44F7F327AD7-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/5ACB99CB-C438-42A3-9625-D6984B72CA30-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/86797D2E-F30D-453C-B083-A39F273B236A-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/E81F9554-C581-421D-9C64-384021627918-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/35F98CD5-A95B-4677-89AD-B87B17C70032-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/C4DA7C9B-D608-49A6-BCE8-5DEABC28D892-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/7AD71374-B330-4197-9F6E-B12965D56B70-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/0DDAA3A8-F69F-45B0-ACB2-9C0CC3F6DE31-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/D158A5C8-D3CD-48E2-82D0-79BB554F94BC-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/94A45DCF-33C6-4D91-A4E9-F9A3E550FA63-scaled.jpeg https://www.lmi.no/2023/08/11/venterommet-hvorfor-ma-vi-vente-pa-livsviktig-behandling/ 2023-08-15T14:54:01+00:00 https://www.lmi.no/2023/08/16/ny-rapport-om-legemiddeltilgang-tar-stadig-lengre-tid/ 2023-08-16T08:37:36+00:00 https://www.lmi.no/wp-content/uploads/2023/08/rapport-aug-23-1.jpg https://www.lmi.no/wp-content/uploads/2023/08/rapport-aug-23-1.jpg https://www.lmi.no/wp-content/uploads/2023/08/rapport-aug-23-2.jpg https://www.lmi.no/wp-content/uploads/2023/08/rapport-aug-23-3.jpg https://www.lmi.no/2023/08/16/faerre-nye-industrifinansierte-kliniske-studier-i-2023/ 2023-08-16T14:05:23+00:00 https://www.lmi.no/2023/08/16/healthtalk-opplever-et-betydelig-bedre-samarbeid-og-mindre-mistro/ 2023-08-16T14:07:59+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Skjermbilde-2023-08-16-160406.png https://www.lmi.no/wp-content/uploads/2023/08/Skjermbilde-2023-08-16-160406.png https://www.lmi.no/2023/08/16/novo-nordisk-kjoper-canadisk-biotek-selskap/ 2023-08-16T14:15:07+00:00 https://www.lmi.no/2023/08/16/alternativet-var-a-flytte-fra-kone-og-ufodt-barn-og-ikke-vite-om-jeg-fikk-vaere-med-pa-fodsel/ 2023-08-16T14:20:08+00:00 https://www.lmi.no/wp-content/uploads/2023/08/0B6CF7F8-428B-43A7-8585-A82C771B77D0-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/0B6CF7F8-428B-43A7-8585-A82C771B77D0-scaled.jpeg https://www.lmi.no/2023/08/16/arendalsuka-2023-dette-skjedde-onsdag/ 2023-08-16T14:32:15+00:00 https://www.lmi.no/wp-content/uploads/2023/08/6EC86233-5929-4D5A-8182-9070485CB536-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/0109CA29-A58C-48E5-A15B-CCE309971BA0-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/537ACF73-F052-46CA-9245-688934765950-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/6EC86233-5929-4D5A-8182-9070485CB536-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/84B38382-AAAC-41B6-AFC6-8B666D4398D5-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/D3A373B0-1F4D-4788-B8D7-E9C0A1F965F9-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/AF1123EC-22AB-4070-BE74-0293E113B759-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/28805754-BDEF-43AB-BFA3-B82CA320BEA8-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/3AA92180-490E-4BA8-98DB-E750C4530DC2-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/432BE80C-2B92-41D1-8A81-64514D4D67C9-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/456E07EF-4632-48CB-9FA1-86EDD43FF8A5-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/A85B847D-3C85-4672-BDA6-CB6AABF47844-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/91EE43C6-0961-4B10-9965-201FF7B20F3E-scaled.jpeg https://www.lmi.no/2023/08/16/slik-kan-vi-bidra-til-at-faerre-pasienter-skades-og-dor-av-feil-legemiddelbruk/ 2023-08-16T17:44:06+00:00 https://www.lmi.no/wp-content/uploads/2023/08/35F98CD5-A95B-4677-89AD-B87B17C70032-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/C4DA7C9B-D608-49A6-BCE8-5DEABC28D892-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/D57CB45D-D64D-439D-9AF5-042AC35B03EA-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/35F98CD5-A95B-4677-89AD-B87B17C70032-scaled.jpeg https://www.lmi.no/2023/08/17/slik-forklarer-curida-styrelederen-det-store-underskuddet/ 2023-08-17T08:48:18+00:00 https://www.lmi.no/2023/08/17/medisin-mot-ryggsmerter-kan-ha-motsatt-effekt/ 2023-08-17T08:51:01+00:00 https://www.lmi.no/2023/08/17/fedme-og-diabetes-type-2-kan-paverka-kva-dose-legemiddel-pasienten-skal-ha/ 2023-08-17T08:55:28+00:00 https://www.lmi.no/2023/08/17/ema-anbefaler-tislelizumab-for-kreft-i-spiseroret/ 2023-08-17T08:56:53+00:00 https://www.lmi.no/2023/08/17/ms-koster-samfunnet-12-milliarder-at-pasientene-er-for-slitne-til-a-jobbe-koster-mest/ 2023-08-17T08:58:13+00:00 https://www.lmi.no/2023/08/17/arendalsuka-2023-dette-skjedde-torsdag/ 2023-08-17T13:14:20+00:00 https://www.lmi.no/wp-content/uploads/2023/08/CBB43ABF-5C4C-4A11-8CE4-379AC46A18BD-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/A85B847D-3C85-4672-BDA6-CB6AABF47844-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/29AAB3D5-9945-4F8E-96AC-FA638A893F4D-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/39C14690-4BC9-44C5-96E0-D40C3F513C33-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/Ina-i-debatt-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/5D67A86C-6D18-4F45-BDE1-1A92342B59EE-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/051DABF2-C8FE-491A-ABFA-3C22B4D7A6E1-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/E6A5E26C-5E42-4504-83E5-C7494B91F963-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/D73B80D8-25AB-4BB1-A020-01344A909D7B-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/7513F5C5-8701-477B-81DA-9ECFF5A715F5-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/236EB35C-D021-42A5-94E2-EEDEE21AD260-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/CD01C007-DB66-49DD-B04E-DD1F63F5FB93-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/CBB43ABF-5C4C-4A11-8CE4-379AC46A18BD-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/C578EE95-7BE8-4EC8-9633-C292AA37EF75-scaled.jpeg https://www.lmi.no/2023/08/17/ventetiden-for-pasientene-fortsetter-a-oke-enighet-om-at-alle-parter-ma-ta-grep/ 2023-08-17T13:29:04+00:00 https://www.lmi.no/wp-content/uploads/2023/08/84B38382-AAAC-41B6-AFC6-8B666D4398D5-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/84B38382-AAAC-41B6-AFC6-8B666D4398D5-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/6EC86233-5929-4D5A-8182-9070485CB536-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/537ACF73-F052-46CA-9245-688934765950-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/0B6CF7F8-428B-43A7-8585-A82C771B77D0-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/E4A8AB9F-FA05-4DDA-9CA4-FC67179B3EF6-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/FD74489B-55C7-4955-AB9E-1246A408688F-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/A037D6EE-67A4-4AA8-8673-16CEA7D4313B-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/4064CD54-D084-4379-B4C3-DBE5B905E48C-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/6E9A13BA-B767-43D7-B34B-C1BE6AFEABE5-scaled.jpeg https://www.lmi.no/2023/08/18/bilder-fra-bransjesamlingen-i-arendal/ 2023-08-18T09:55:45+00:00 https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-1002-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0832-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0830-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0836-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0840-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0842-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0854-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0855-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0860-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0869-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0863-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0906-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0921-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0928-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0939-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0963-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0977-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0994-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-1006-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-1007-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0891-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0895-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0952-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0877-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0873-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0871-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0899-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0934-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-1002-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0959-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0955-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0862-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/arendal-2023-fest-fengselet-1-0849-scaled.jpg https://www.lmi.no/2023/08/18/leif-rune-oppsummerer-arendalsuka-2023/ 2023-08-18T10:36:15+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Leif-Rune-oppsummerer_skjermdump.png https://www.lmi.no/2023/08/18/kan-persontilpasset-medisin-bidra-til-a-lose-ressurskrisen-i-helsevesenet/ 2023-08-18T10:38:28+00:00 https://www.lmi.no/2023/08/18/nykode-grunder-dette-ma-vi-laere-av-danmark-for-a-tiltrekke-oss-kompetanse/ 2023-08-18T10:43:00+00:00 https://www.lmi.no/2023/08/18/investinor-direktoren-kompetent-kapital-er-bare-en-av-ingrediensene/ 2023-08-18T10:44:06+00:00 https://www.lmi.no/2023/08/18/boehringer-ingelheim-planlegger-fase-3-studier-med-fedmekandidat/ 2023-08-18T10:44:56+00:00 https://www.lmi.no/2023/08/18/velkommen-til-regulatorisk-hostmote-2023/ 2023-08-18T13:49:57+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Regulatorisk-hostmote-2023-ill.jpg https://www.lmi.no/wp-content/uploads/2023/08/Regulatorisk-hostmote-2023.png https://www.lmi.no/2023/08/17/bred-enighet-om-satsing-pa-var-bransje/ 2023-08-21T06:36:15+00:00 https://www.lmi.no/wp-content/uploads/2023/08/peggy-og-OE-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/peggy-og-OE-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/02B7ACC3-6EDF-4AE4-8DDB-B3D1EEEB2D06-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/AE816065-A75E-4857-902D-BA7F7AB0A83E-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/4D14DF2E-717C-4223-8444-145C6ADB6188-scaled.jpeg https://www.lmi.no/2023/08/21/ja-til-ny-effektiv-migrentablett-men-far-den-bla-resept/ 2023-08-21T10:40:25+00:00 https://www.lmi.no/2023/08/21/navamedic-ledelsen-kjoper-aksjer-for-to-millioner/ 2023-08-21T10:41:39+00:00 https://www.lmi.no/2023/08/21/dine-egne-immunceller-blir-oppgradert-til-en-behandling/ 2023-08-21T10:43:00+00:00 https://www.lmi.no/2023/08/21/kunstig-intelligens-vil-revolusjonere-helsevesenet/ 2023-08-21T10:46:56+00:00 https://www.lmi.no/2023/08/16/ny-rapport-om-legemiddeltilgang-tar-stadig-lengre-tid-2/ 2023-08-21T11:50:16+00:00 https://www.lmi.no/wp-content/uploads/2023/08/forside-rapport-aug-23.jpg https://www.lmi.no/wp-content/uploads/2023/08/rapport-aug-23-1.jpg https://www.lmi.no/wp-content/uploads/2023/08/rapport-aug-23-3.jpg https://www.lmi.no/2023/08/22/biogen-har-startet-prosessen-med-a-sparke-ansatte/ 2023-08-22T08:24:07+00:00 https://www.lmi.no/2023/08/22/er-dette-enhertus-neste-store-utfordrer/ 2023-08-22T08:25:17+00:00 https://www.lmi.no/2023/08/22/resultater-fra-ultimovacs-studie-utsatt-ytterligere/ 2023-08-22T08:26:17+00:00 https://www.lmi.no/2023/08/22/usa-godkjenner-rsv-vaksine-til-gravide/ 2023-08-22T08:27:13+00:00 https://www.lmi.no/2023/08/22/veikart-for-helsenaeringen-lanseres-onsdag/ 2023-08-22T10:16:21+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Skjermbilde-2023-08-22-103340.jpg https://www.lmi.no/wp-content/uploads/2023/08/Skjermbilde-2023-08-22-103340.jpg https://www.lmi.no/2023/08/22/ectrims-kongressen-presenterer-norge-som-studieland/ 2023-08-22T11:28:59+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Milano-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/Milano-Adobe-Stock-scaled.jpeg https://www.lmi.no/2023/08/23/farmasoytisk-institutt-satsar-pa-radiofarmasi-men-er-avhengig-av-stotte-fra-industrien/ 2023-08-23T06:28:50+00:00 https://www.lmi.no/2023/08/23/advarer-om-falsk-slankemedisin/ 2023-08-23T06:31:44+00:00 https://www.lmi.no/2023/08/23/veikartet-for-helsenaeringen-kommer-i-dag-dette-vil-bransjetoppene-ha-lmi-kommenterer/ 2023-08-23T06:36:55+00:00 https://www.lmi.no/2023/08/23/penger-til-senter-for-beredskap-og-helseindustri/ 2023-08-23T06:39:54+00:00 https://www.lmi.no/2023/08/23/antipsykotika-har-effekt/ 2023-08-23T06:47:25+00:00 https://www.lmi.no/2023/08/23/ultimovacs-om-forsinket-studie-nye-endepunkter-kommer-sakte-til/ 2023-08-23T06:48:55+00:00 https://www.lmi.no/2023/08/23/nye-pasienter-med-blodkreft-far-ikke-bli-med-i-studier-med-medisin-fra-gilead/ 2023-08-23T06:49:55+00:00 https://www.lmi.no/2023/08/23/edvartsen-gar-til-msd-etter-16-ar-i-salmar/ 2023-08-23T06:51:04+00:00 https://www.lmi.no/2023/08/23/fa-med-deg-produksjonsdagen-2023/ 2023-08-23T08:05:11+00:00 https://www.lmi.no/wp-content/uploads/2015/08/P%C3%A5-Storo-jobber-det-370-ansatte-innen-blant-annet-forskning-utvikling-og-produksjon..jpg https://www.lmi.no/2023/08/23/et-taktskifte-for-helsenaeringen/ 2023-08-23T11:10:58+00:00 https://www.lmi.no/wp-content/uploads/2023/08/B4126595-404E-4AE4-BBCC-C876FB286E8A-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/4187582D-1ED6-4E2C-B8F1-C5624460BF49-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/53136165966_0a50d5c6c4_c.jpg https://www.lmi.no/2023/08/23/lmi-direktoren-besokte-eksportgiganten-ge-pa-lindesnes/ 2023-08-23T17:00:55+00:00 https://www.lmi.no/wp-content/uploads/2023/08/B96528EA-E9BC-4453-ACAD-C67E0969F107-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/C548C852-4DE8-4908-AA39-55DA22E4F26E-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/B96528EA-E9BC-4453-ACAD-C67E0969F107-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/7FD6D7F5-0246-4AAB-BD3C-36A4EEEE3CF4-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/E8EC3126-C01D-42CA-8E19-0171119DBD98-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/B7ED6A63-BE8D-40DE-B0D9-60AAF2B517BE-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/A7A320CE-D1FB-4947-9855-519B3A16EDC9-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/AADEEBBB-8811-4181-987B-672C0338C2E7-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/5BB5934C-EA2E-4FAB-BA24-0B3EE62366DC-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/927B2271-DE45-4066-A1B7-FB0BE7B8287D-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/2EFEFA20-5FAC-4E2C-AD67-F367468B2834-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/2E0F2D14-64CD-4282-8876-21623DAD1394-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/1A281FB7-15E9-4F3D-9761-6A6DA8602929-scaled.jpeg https://www.lmi.no/2023/08/28/ambassaden-samlet-naering-og-helsepersonell/ 2023-08-28T07:30:22+00:00 https://www.lmi.no/wp-content/uploads/2023/08/IMG_1398-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/IMG_1401-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/IMG_1415-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/IMG_1387-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/IMG_1398-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/IMG_1407-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/FullSizeRender-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/IMG_1429-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/IMG_1408-scaled.jpeg https://www.lmi.no/2023/07/10/lmi-inviterer-til-helseokonomisk-fagdag-20-september/ 2023-08-28T08:04:35+00:00 https://www.lmi.no/wp-content/uploads/2017/06/helse%C3%B8konomi_bilde-DIG-004.jpg https://www.lmi.no/2023/08/28/disse-nye-metodene-skal-beslutningsforum-ta-stilling-til/ 2023-08-28T09:15:05+00:00 https://www.lmi.no/2023/08/28/studie-hjertesviktpasienter-med-fedme-fikk-bedre-livskvalitet-med-slankemedisin-som-a-fa-et-nytt-liv/ 2023-08-28T09:15:38+00:00 https://www.lmi.no/2023/08/28/beslutningsforums-nye-strategi-helsenaeringen-er-helt-avhengig-av-eksperter-utenfra-og-beslutningsforum-trenger-nye-prioriteringskriterier/ 2023-08-28T09:16:10+00:00 https://www.lmi.no/2023/08/28/staten-brukte-15-ar-pa-a-vurdere-livsviktig-kreftmedisin-en-arroganse-som-mangler-sidestykke/ 2023-08-28T09:16:42+00:00 https://www.lmi.no/2023/08/28/dette-mener-helsenaeringen-om-regjeringens-veikart-vanskelig-a-komme-inn-pa-markedet/ 2023-08-28T09:17:16+00:00 https://www.lmi.no/2023/08/28/analyseselskap-disse-legemiddelselskapene-er-best-forberedt-pa-ki-revolusjonen/ 2023-08-28T09:17:48+00:00 https://www.lmi.no/2023/08/28/spetalen-investerer-flere-millioner-i-vistin-pharma-aksjer/ 2023-08-28T09:18:22+00:00 https://www.lmi.no/2023/08/28/beslutningsforum-sier-ja-til-utvidet-bruk-av-celleterapi-norge-forst-ut-i-skandinava/ 2023-08-28T09:19:09+00:00 https://www.lmi.no/2023/08/28/beslutningsforum-disse-metodene-fikk-ja-til-innforing/ 2023-08-28T09:56:04+00:00 https://www.lmi.no/2023/08/29/lymfekreftbehandling-innfores-vanskelig-a-vurdere-effekten-sammenlignet-med-standardbehandling/ 2023-08-29T09:19:49+00:00 https://www.lmi.no/2023/08/29/formue-ser-lyst-pa-kapitaltilgangen-for-biotek-mye-tort-krutt-som-skal-investeres-framover/ 2023-08-29T09:20:39+00:00 https://www.lmi.no/2023/08/29/horing-gjennomgang-av-allmennlegetjenesten/ 2023-08-29T13:23:48+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2017/06/GettyImages-537893375.jpg https://www.lmi.no/2023/08/29/sporreundersokelse-om-arsaker-til-sen-varsling-om-legemiddelmangel/ 2023-08-29T13:49:39+00:00 https://www.lmi.no/wp-content/uploads/2019/05/Legemiddelmangel-apotek.jpeg https://www.lmi.no/wp-content/uploads/2019/05/Legemiddelmangel-apotek.jpeg https://www.lmi.no/2023/08/30/den-nye-gsk-direktoren-om-voksenvaksinasjonsprogram-kan-vaere-en-kjapp-og-enkel-seier-for-norge/ 2023-08-30T10:53:13+00:00 https://www.lmi.no/2023/08/30/vi-onsker-a-fa-bidra-til-legemiddelberedskapen-i-norge/ 2023-08-31T07:46:53+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Skjermbilde-as2.png https://www.lmi.no/wp-content/uploads/2023/08/As-Produksjonslabb-Orjan-Leiknes-Apeland-9774-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/As-Produksjonslabb-Orjan-Leiknes-Apeland-9689-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/As-Produksjonslabb-Orjan-Leiknes-Apeland-9840-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/As-Produksjonslabb-Orjan-Leiknes-Apeland-9441-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/As-Produksjonslabb-Orjan-Leiknes-Apeland-9565-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/As-Produksjonslabb-Orjan-Leiknes-Apeland-9788-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/As-Produksjonslabb-Orjan-Leiknes-Apeland-9432-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/As-Produksjonslabb-Orjan-Leiknes-Apeland-9770-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/As-Produksjonslabb-Orjan-Leiknes-Apeland-9318-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/As-Produksjonslabb-Orjan-Leiknes-Apeland-9656-scaled.jpg https://www.lmi.no/2023/08/30/esmo-kongressen-presenterer-norge-som-studieland/ 2023-08-31T08:33:41+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Madrid-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/Madrid-Adobe-Stock-scaled.jpeg https://www.lmi.no/2023/08/31/gsk-skal-delta-i-impress-studien/ 2023-08-31T08:53:30+00:00 https://www.lmi.no/2023/08/31/pfizer-investerer-250-millioner-kroner-i-svensk-produksjonsanlegg/ 2023-08-31T08:54:27+00:00 https://www.lmi.no/2023/08/30/store-muligheter-med-kunstig-intelligens-innen-farmasien/ 2023-08-31T09:20:49+00:00 https://www.lmi.no/2023/09/01/kan-biologiske-legemidler-og-avanserte-terapier-produseres-i-norge/ 2023-09-01T09:05:24+00:00 https://www.lmi.no/wp-content/uploads/2023/08/PRODUKSJONSDAGEN-3003-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/PRODUKSJONSDAGEN-2993-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/PRODUKSJONSDAGEN-2912-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/PRODUKSJONSDAGEN-2925-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/PRODUKSJONSDAGEN-2959-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/PRODUKSJONSDAGEN-2983-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/PRODUKSJONSDAGEN-2991-scaled.jpg https://www.lmi.no/2023/09/01/hoyre-ber-om-regjeringens-vurdering-av-eus-legemiddelreform/ 2023-09-01T09:24:33+00:00 https://www.lmi.no/2023/09/01/endring-forenkler-behandling-med-langtidsvirkende-insulin/ 2023-09-01T09:27:31+00:00 https://www.lmi.no/2023/09/01/debatt-ingen-blir-frisk-av-forskning/ 2023-09-01T09:34:25+00:00 https://www.lmi.no/2023/09/01/pci-biotechs-bioprosess-program-har-produsert-nye-resultater/ 2023-09-01T09:37:49+00:00 https://www.lmi.no/2023/09/01/forskning-45-prosent-mindre-risiko-for-blodning-med-moderne-blodfortynnende/ 2023-09-01T09:39:08+00:00 https://www.lmi.no/2023/09/01/ema-anbefaler-godkjennelse-av-oppdatert-koronavaksine/ 2023-09-01T09:46:24+00:00 https://www.lmi.no/2023/09/01/salgstall-fra-farmastat-for-august-2023/ 2023-09-01T12:51:56+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/09/04/lmi-pa-helsedagen-2023/ 2023-09-04T07:53:04+00:00 https://www.lmi.no/wp-content/uploads/2023/09/Skymoen-panel1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/IMG_1486-scaled.jpg https://www.lmi.no/2023/09/04/migreneekspert-er-du-borte-fire-dager-i-maneden-koster-det-mer-enn-medisinene/ 2023-09-04T09:18:29+00:00 https://www.lmi.no/2023/09/04/novartis-direktor-norge-har-et-godt-utgangspunkt-for-a-satse-pa-nukleaermedisin/ 2023-09-04T09:34:30+00:00 https://www.lmi.no/2023/09/04/et-veldig-stort-fremskritt-for-pasienter-med-lymfekreft-og-brystkreft/ 2023-09-04T09:36:25+00:00 https://www.lmi.no/2023/09/04/helland-om-nyhet-for-pasienter-med-tidlig-lungekreft-lovende/ 2023-09-04T09:38:12+00:00 https://www.lmi.no/2023/09/04/nykode-gar-videre-med-satsing-pa-autoimmune-sykdommer-og-etablerer-ny-forskningsgruppe/ 2023-09-04T09:39:23+00:00 https://www.lmi.no/2023/09/05/tribune-therapeutics-har-inngatt-utviklings-og-produksjonsavtale-med-bayer/ 2023-09-05T09:09:35+00:00 https://www.lmi.no/2023/09/05/fresenius-kabi-jakter-fortsatt-nye-eiere/ 2023-09-05T09:10:41+00:00 https://www.lmi.no/2023/09/05/nykode-far-gront-lys-fra-fda-for-livmorhalskreft-studie/ 2023-09-05T09:11:58+00:00 https://www.lmi.no/2023/09/05/amerikansk-bank-tror-nykode-kan-fa-en-arlig-inntektstopp-pa-70-milliarder-norske-kroner/ 2023-09-05T10:41:14+00:00 https://www.lmi.no/2023/09/05/lmis-horingssvar-forslag-til-endringer-i-helselovgivingen/ 2023-09-05T11:29:53+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/09/06/legemidler-en-del-av-verktoykassa-for-lusebehandling/ 2023-09-06T07:58:01+00:00 https://www.lmi.no/wp-content/uploads/2023/09/66A2566-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/66A2566-scaled.jpg https://www.lmi.no/2023/09/07/lanserer-fedmemiddel-i-storbritannia-til-en-brokdel-av-prisen-i-usa/ 2023-09-07T08:40:08+00:00 https://www.lmi.no/2023/09/07/analyseselskap-dette-er-de-ti-mest-lovende-biotekmidlene/ 2023-09-07T08:42:21+00:00 https://www.lmi.no/2023/09/07/ultimovacs-sikre-pa-finanser-til-tross-for-forsinkelser-i-kreftstudie/ 2023-09-07T08:44:49+00:00 https://www.lmi.no/2023/09/07/hun-er-ny-novo-nordisk-direktor-for-alvorlig-fedme-og-overvekt/ 2023-09-07T08:49:31+00:00 https://www.lmi.no/2023/09/07/legemiddelgigant-berger-danmarks-okonomi/ 2023-09-07T08:50:39+00:00 https://www.lmi.no/2023/09/07/rort-forsamling-hedret-algeta-historien/ 2023-09-07T10:41:23+00:00 https://www.lmi.no/wp-content/uploads/2023/09/Bayer-Xofigo-Skymoen-og-Ramdahl-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/Bayer-Xofigo-Skymoen-og-Ramdahl-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/BayerXofigo_Bruland-og-Larsen-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/Bayer-Xofigo-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/Bayer-Xofigo-Jakobsen-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/Bayer-Xofigo_Einarsson-og-Widerberg-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/Bayer-Xofigo_Jubileum-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/Bayer-Xofigo-2-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/Bayer-Xofigo-3-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/Bayer-Xofigo-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/Bayer-Xofigo-Andersen-og-Nakkim-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/Bayer-Xofigo-salen-scaled.jpeg https://www.lmi.no/2023/09/08/algeta-historien-pa-to-minutter/ 2023-09-08T08:11:49+00:00 https://www.lmi.no/wp-content/uploads/2023/09/Skjermbilde-Jan-Borge.png https://www.lmi.no/2023/09/08/pci-biotech-har-fatt-europeisk-patent/ 2023-09-08T10:25:22+00:00 https://www.lmi.no/2023/09/08/nye-metoder-kan-gi-bedre-stralebehandling-av-kreft/ 2023-09-08T10:26:29+00:00 https://www.lmi.no/2023/09/08/jubeltall-for-pharmaq-i-2022/ 2023-09-08T10:27:50+00:00 https://www.lmi.no/2023/09/08/regjeringen-med-milliard-satsing-pa-kunstig-intelligens/ 2023-09-08T10:29:10+00:00 https://www.lmi.no/2023/09/08/meld-deg-pa-science-impact-konferansen/ 2023-09-08T10:31:53+00:00 https://www.lmi.no/wp-content/uploads/2023/09/banner_science_impact_june-e1694168378306.png https://www.lmi.no/2023/09/12/status-for-lmis-arbeid-med-nasjonal-implementering-av-hta-regulation/ 2023-09-12T10:02:58+00:00 https://www.lmi.no/wp-content/uploads/2019/07/christian-wiediger-735834-unsplash-2.jpg https://www.lmi.no/2023/09/12/eksplosjon-av-barn-som-bruker-avforingsmidler-%e2%88%92-tyder-pa-uheldig-kosthold/ 2023-09-12T10:45:39+00:00 https://www.lmi.no/2023/09/12/har-utviklet-antibiotikum-med-ny-virkningsmekanisme/ 2023-09-12T10:47:35+00:00 https://www.lmi.no/2023/09/12/legemiddelverket-inngar-gmo-avtale-med-vitenskapskomite/ 2023-09-12T10:50:13+00:00 https://www.lmi.no/2023/09/12/carl-erik-blir-jim-roger-sin-etterfolger-i-milliardbedriften-stim/ 2023-09-12T11:08:59+00:00 https://www.lmi.no/2023/09/12/vaksine-mot-lungebetennelse-det-du-trenger-a-vite/ 2023-09-12T11:11:09+00:00 https://www.lmi.no/2023/09/12/helseforsikringen-gir-kreftpasient-tina-schau-mer-tid-dette-handler-ikke-om-a-snike-i-koen-dette-handler-om-a-overleve/ 2023-09-12T11:12:45+00:00 https://www.lmi.no/2023/09/06/helseindustrien-er-blant-fremtidens-store-eksportnaeringer/ 2023-09-12T13:02:56+00:00 https://www.lmi.no/wp-content/uploads/2023/09/NHO-LMI-LO-kopi.jpg https://www.lmi.no/wp-content/uploads/2023/09/LeifRune-LMI-4.jpg https://www.lmi.no/wp-content/uploads/2023/09/OleErik-NHO-4.jpg https://www.lmi.no/wp-content/uploads/2023/09/Are-LO-3.jpg https://www.lmi.no/2023/09/12/myndighetene-oker-prisen-pa-antibiotika/ 2023-09-12T13:25:57+00:00 https://www.lmi.no/wp-content/uploads/2017/04/legemidler-til-barn.jpg https://www.lmi.no/wp-content/uploads/2023/09/Anne-Margrethe-crop.jpg https://www.lmi.no/wp-content/uploads/2017/04/legemidler-til-barn.jpg https://www.lmi.no/2023/09/13/visste-du-at-as-har-et-legemiddelselskap-orjan-33-er-daglig-leder-omsatte-for-39-millioner-i-fjor/ 2023-09-13T07:18:34+00:00 https://www.lmi.no/2023/09/13/immunterapi-og-cellegift-sikret-flere-overlevende-lungekreftpasienter-etter-fem-ar-oppmuntrende/ 2023-09-13T07:19:27+00:00 https://www.lmi.no/2023/09/13/prisen-oker-pa-antibiotika/ 2023-09-13T07:20:06+00:00 https://www.lmi.no/2023/09/13/legemiddelverket-oker-prisen-pa-eldre-antibiotika-skal-komme-produsentene-til-gode/ 2023-09-13T07:20:45+00:00 https://www.lmi.no/2023/09/14/slv-direktoren-regelverk-burde-hatt-et-best-for-stempel/ 2023-09-14T06:55:37+00:00 https://www.lmi.no/2023/09/14/moderna-melder-om-vellykket-mrna-vaksine-mot-influensa/ 2023-09-14T06:56:16+00:00 https://www.lmi.no/2023/09/14/lmi-samlet-industrien-under-arendalsuka/ 2023-09-14T12:02:37+00:00 https://www.lmi.no/wp-content/uploads/2023/08/A85B847D-3C85-4672-BDA6-CB6AABF47844-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/08/peggy-og-OE-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/IMG_5713-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/08/E6A5E26C-5E42-4504-83E5-C7494B91F963-scaled.jpeg https://www.lmi.no/2023/09/15/kristin-krogsrud-blir-ny-sjef-for-myndighetskontakt-og-kommunikasjon-i-roche/ 2023-09-15T10:24:21+00:00 https://www.lmi.no/2023/09/15/legemiddelverket-etablerer-internasjonalt-sekretariat/ 2023-09-15T10:25:52+00:00 https://www.lmi.no/2023/09/15/to-nye-stoffer-pa-narkotikalisten/ 2023-09-15T10:27:14+00:00 https://www.lmi.no/2023/09/15/forsker-tror-at-flere-tiltak-er-nodvendig-for-a-sikre-tilgang-pa-eldre-antibiotika/ 2023-09-15T10:30:16+00:00 https://www.lmi.no/2023/09/15/pharmagellan-partnerens-rad-til-nye-biotekselskaper-overinvester-i-fase-1/ 2023-09-15T10:38:24+00:00 https://www.lmi.no/2023/09/15/world-patient-safety-day-bli-med-og-marker-dagen-og-spre-budskapet/ 2023-09-15T11:13:09+00:00 https://www.lmi.no/wp-content/uploads/2023/09/social-media-tiile-2.png https://www.lmi.no/wp-content/uploads/2023/09/social-media-tiile-2.png https://www.lmi.no/2023/09/18/komite-skal-gjore-risikovurderinger-for-genmodifiserte-legemidler/ 2023-09-18T10:34:25+00:00 https://www.lmi.no/2023/09/18/pfizers-bestselgende-migrenemedisin-anbefales-ogsa-som-akuttmedisin-i-storbritannia/ 2023-09-18T10:36:25+00:00 https://www.lmi.no/2023/09/18/hadde-jeg-ikke-hatt-sparepenger-ville-jeg-vaert-dod-na/ 2023-09-18T10:45:38+00:00 https://www.lmi.no/2023/09/18/jj-endrer-design-janssen-far-nytt-navn/ 2023-09-18T10:46:51+00:00 https://www.lmi.no/2023/09/18/spesialistkurs-i-regler-for-markedsforing-av-legemidler/ 2023-09-18T10:59:47+00:00 https://www.lmi.no/wp-content/uploads/2017/01/M%C3%B8terom-enkelt.jpg https://www.lmi.no/2023/09/18/meld-deg-pa-lmis-strategisamling-2023/ 2023-09-18T13:29:45+00:00 https://www.lmi.no/wp-content/uploads/2022/11/Strategisamling-LR-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/11/Strategisamling-LR-scaled.jpg https://www.lmi.no/2023/09/19/magnetar-trekkjer-kreftmedisinen-fram-til-svulsten/ 2023-09-19T08:14:25+00:00 https://www.lmi.no/2023/09/19/norm-vet-rapporten-2022-laveste-registrerte-antibiotikaforbruk-til-landdyr/ 2023-09-19T08:16:30+00:00 https://www.lmi.no/2023/09/19/fortsatt-flest-legemiddelrelaterte-pasientskader-ok-farmasoytkompetansen/ 2023-09-19T08:18:12+00:00 https://www.lmi.no/2023/09/19/eus-konkurransetilsyn-skal-vurdere-pfizers-gigantoppkjop/ 2023-09-19T08:19:54+00:00 https://www.lmi.no/2023/09/19/positiv-anbefaling-for-ny-enhertu-indikasjon/ 2023-09-19T08:22:06+00:00 https://www.lmi.no/2023/09/19/ge-healthcare-far-477-millioner-kroner-for-a-utvikle-ny-ultralyd-teknologi/ 2023-09-19T08:23:36+00:00 https://www.lmi.no/2023/09/19/ifjor-ble-det-solgt-425-kg-antibiotika-til-oppdrettsfisk-en-brokdel-av-salget-til-landdyr/ 2023-09-19T08:26:37+00:00 https://www.lmi.no/2023/09/18/debatt-pasientens-helsetjeneste/ 2023-09-19T09:09:43+00:00 https://www.lmi.no/wp-content/uploads/2020/06/ErlingUlltveit_portrett-scaled-e1605100056652.jpg https://www.lmi.no/wp-content/uploads/2016/10/ErlingUlltveit_portrett.jpg https://www.lmi.no/2023/08/28/program-for-helseokonomisk-fagdag-2023/ 2023-09-19T11:42:38+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Collage-Helsok-fagdag-DIG.png https://www.lmi.no/wp-content/uploads/2023/08/Collage-Helsok-fagdag-DIG.png https://www.lmi.no/2023/09/20/ny-rapport-viser-at-for-lav-betalingsvillighet-kan-fore-til-tap-av-liv-og-helse/ 2023-09-20T05:41:11+00:00 https://www.lmi.no/wp-content/uploads/2023/05/rapport_adobe-stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/rapporten.jpg https://www.lmi.no/2023/09/20/vi-trenger-en-prioriteringsmelding-for-hele-helsetjenesten-ikke-bare-for-legemiddelomradet/ 2023-09-20T07:22:27+00:00 https://www.lmi.no/wp-content/uploads/2023/09/Skymoen.jpg https://www.lmi.no/wp-content/uploads/2023/09/Skymoen.jpg https://www.lmi.no/2023/09/20/nukleaermedisin-fra-nord-norge-sprenger-kreftcellene-i-fillebiter/ 2023-09-20T09:15:32+00:00 https://www.lmi.no/2023/09/20/verdens-forste-vaksine-mot-rs-virus-tilgjengelig-i-norge/ 2023-09-20T09:27:35+00:00 https://www.lmi.no/2023/09/20/rapport-helsetjenestens-betalingsvillighet-for-et-godt-levear-kan-vaere-tre-ganger-hoyere-enn-tidligere-antatt/ 2023-09-20T10:24:17+00:00 https://www.lmi.no/2023/09/20/rapport-terskelverdien-for-et-godt-levear-bor-oppjusteres/ 2023-09-20T10:25:55+00:00 https://www.lmi.no/2023/09/21/rapport-hva-konkret-kan-vi-spare-pa-a-innfore-et-voksenvaksinasjonsprogram/ 2023-09-21T09:08:15+00:00 https://www.lmi.no/wp-content/uploads/2023/09/AdobeStock_vaksine-til-glad-mann-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/AdobeStock_mange-som-har-fatt-vaksine-scaled.jpeg https://www.lmi.no/2023/09/21/navamedic-far-mdr-sertifisering-for-dispenserapparat/ 2023-09-21T11:22:46+00:00 https://www.lmi.no/2023/09/21/nytt-forretningsbein-pa-vei-for-nykode/ 2023-09-21T11:23:34+00:00 https://www.lmi.no/2023/09/21/norsk-helsesektor-kan-na-vurdere-bruk-av-amerikanske-skylosninger-pa-lik-linje-med-europeiske/ 2023-09-21T11:24:46+00:00 https://www.lmi.no/2023/09/21/etterlyser-analyser-med-norske-tall-for-a-kunne-fastsette-terskelverdi-for-et-godt-levear/ 2023-09-21T11:26:53+00:00 https://www.lmi.no/2023/09/21/helseokonom-lanserte-nytt-sykdomsbegrep-tror-det-kan-provosere-noen/ 2023-09-21T11:28:48+00:00 https://www.lmi.no/2023/09/21/rapport-terskelverdien-for-et-godt-levear-bor-opp-til-minst-400-000-kroner/ 2023-09-21T11:29:30+00:00 https://www.lmi.no/2023/09/21/prioriteringsmeldingens-far-tallet-fra-rapporten-er-basert-pa-gjetting/ 2023-09-21T11:30:09+00:00 https://www.lmi.no/2023/09/21/medisaker-om-helseokonomisk-fagdag-og-ny-rapport-om-terskelverdi-fra-menon/ 2023-09-21T12:53:43+00:00 https://www.lmi.no/wp-content/uploads/2023/09/59492411-B8F3-41DC-9F22-E624230582C8-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/59492411-B8F3-41DC-9F22-E624230582C8-scaled.jpeg https://www.lmi.no/2023/09/21/gode-diskusjoner-og-innspill-til-de-tre-ekspertgruppenes-arbeid-opp-mot-ny-prioriteringsmelding-pa-helseokonomisk-fagdag/ 2023-09-21T12:54:11+00:00 https://www.lmi.no/wp-content/uploads/2023/09/45F63846-2D4D-4D6B-A221-23333B0CF3C6-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/45F63846-2D4D-4D6B-A221-23333B0CF3C6-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/4B49D489-2077-48A6-8161-2E2DDCB7EFB6-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/5B485CEA-5A9E-4B56-B565-128C678DC476-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/03C5F231-AC56-4ACE-AA57-C7E2434F0BD1-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/67256D27-0305-43CC-B797-10DE121EBFB7-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/87A7C090-A542-47E7-AB0F-03A525FD578E-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/59492411-B8F3-41DC-9F22-E624230582C8-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/B2316418-AB73-428D-BAE0-F71D0A413249-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/18AEDAB2-E98C-4423-9C95-49F1F8535C0D-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/9A878C1A-AFFC-4C2D-BE75-E09501FACD6A-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/17AE3E53-652F-45E2-B4C8-1ACD347A1519-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/A1837698-825D-4455-8C5F-31225E7361B9-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/58C91CC9-5B76-458B-9F3F-DB14F91626B0-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/6FFAFCAB-64D7-4871-AB7D-A71EBCBB36C1-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/D8D583F8-0A36-4BDE-B52E-C4B0139783CC-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/8EA92E2D-F7E3-4257-9F9C-B6EF97A5C2E7-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/3FF59379-6867-467F-BCF7-CD1D96C0B76D-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/F6A5FC99-0FF9-428D-A432-15F557D0AB68-scaled.jpeg https://www.lmi.no/2023/09/21/hvordan-kan-vi-bidra-til-mer-fou-i-norsk-naeringsliv/ 2023-09-21T14:05:33+00:00 https://www.lmi.no/wp-content/uploads/2023/09/Panel-med-GE-NHO-lansering-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/Panel-med-GE-NHO-lansering-scaled.jpg https://www.lmi.no/2023/09/22/pa-mandag-kan-denne-medisinen-bli-en-av-norges-dyreste-eller-skape-politisk-hodepine/ 2023-09-22T07:20:40+00:00 https://www.lmi.no/2023/09/22/hpv-vaksinen-ma-bli-invitert-til-voksenfesten/ 2023-09-22T07:21:18+00:00 https://www.lmi.no/2023/09/22/lmis-horingssvar-om-rapporten-gjennomgang-av-allmennlegetjenesten/ 2023-09-22T07:58:11+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2017/11/inge-f%C3%A5r-vaksine.jpg https://www.lmi.no/2023/09/22/fra-stoltenberg-til-skymoen-ase-solberg-blir-kommunikasjonsradgiver-i-lmi/ 2023-09-22T08:21:28+00:00 https://www.lmi.no/wp-content/uploads/2023/09/Ase-Solberg-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/Ase-Solberg-scaled.jpg https://www.lmi.no/2023/09/22/skymoen-i-innopodden/ 2023-09-22T10:45:48+00:00 https://www.lmi.no/wp-content/uploads/2023/09/Leif-Rune-Skymoen-HH-og-KSB-4-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/Leif-Rune-Skymoen-og-HH-i-studio-scaled.jpg https://www.lmi.no/2023/09/25/fra-stoltenberg-til-skymoen-ase-solberg-blir-kommunikasjonsradgiver-i-lmi-2/ 2023-09-25T06:25:20+00:00 https://www.lmi.no/wp-content/uploads/2023/09/Ase-Solberg-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/09/Ase-Solberg-scaled.jpg https://www.lmi.no/2023/09/25/roche-pafallende-at-en-slik-sak-ble-satt-i-ko-sa-lenge/ 2023-09-25T09:26:59+00:00 https://www.lmi.no/2023/09/25/novartis-sender-kreftkandidat-i-retur/ 2023-09-25T09:27:50+00:00 https://www.lmi.no/2023/09/25/skal-ta-stilling-til-alzheimer-legemiddel-kan-bli-tilgjengelig-i-europa-neste-ar/ 2023-09-25T09:28:49+00:00 https://www.lmi.no/2023/09/25/kreftmiddel-opp-i-beslutningsforum-etter-halvannet-ar-i-ko/ 2023-09-25T09:29:41+00:00 https://www.lmi.no/2023/09/25/oyner-nytt-hap-om-livsviktig-medisin/ 2023-09-25T09:33:23+00:00 https://www.lmi.no/2023/09/25/novo-nordisk-og-unicef-forlenger-globalt-partnerskap-mot-overvekt-hos-barn/ 2023-09-25T09:34:20+00:00 https://www.lmi.no/2023/09/25/ny-behandling-for-benmargskreft-kan-tilbys-i-norge/ 2023-09-25T09:35:18+00:00 https://www.lmi.no/2023/06/30/legemiddelindustrien-brukte-159-millioner-pa-legemiddelforskning-i-norge/ 2023-09-25T09:49:39+00:00 https://www.lmi.no/wp-content/uploads/2020/06/offentliggj%C3%B8ring-2020.jpg https://www.lmi.no/wp-content/uploads/2016/06/Offentliggj%C3%B8ring-av-verdioverf%C3%B8ringer.gif https://www.lmi.no/wp-content/uploads/2023/06/DSC_2493-854x1280-1.jpg https://www.lmi.no/2023/09/21/presentasjonene-fra-helseokonomisk-fagdag-20-september-2023/ 2023-09-25T13:08:36+00:00 https://www.lmi.no/2023/09/26/regulatorisk-hostmote-naermer-seg/ 2023-09-26T06:06:30+00:00 https://www.lmi.no/wp-content/uploads/2023/08/Regulatorisk-hostmote-2023-ill.jpg https://www.lmi.no/wp-content/uploads/2023/08/Regulatorisk-hostmote-2023.png https://www.lmi.no/2023/09/26/ja-til-medisin-mot-lungekreft-kan-forhindre-tilbakefall-for-pasientene/ 2023-09-26T08:58:24+00:00 https://www.lmi.no/2023/09/26/gsk-betalte-90-millioner-dollar-for-legemiddelet-na-trekkes-det-fra-markedet/ 2023-09-26T08:59:37+00:00 https://www.lmi.no/2023/09/26/norge-tidlig-ute-med-godkjenning-av-enhertu-mot-her2-lav-brystkreft-jeg-er-overrasket/ 2023-09-26T09:00:42+00:00 https://www.lmi.no/2023/09/28/pfizer-gjenopptar-produksjonen-pa-tornadorammet-anlegg/ 2023-09-28T10:25:38+00:00 https://www.lmi.no/2023/09/28/salget-av-nye-diabetes-og-fedmelegemidler-har-nadd-samme-volum-som-metformin/ 2023-09-28T10:26:52+00:00 https://www.lmi.no/2023/09/28/biden-bevilger-en-milliard-kroner-til-forskning-pa-antibiotikaresistente-bakterier/ 2023-09-28T10:27:58+00:00 https://www.lmi.no/2023/09/28/exact-henter-prosjektdirektor-fra-nykode/ 2023-09-28T10:29:14+00:00 https://www.lmi.no/2023/09/28/astrazeneca-vokser-i-norge-har-rundet-100-ansatte/ 2023-09-28T10:30:20+00:00 https://www.lmi.no/2023/09/28/nykodes-utviklingssjef-ingen-tvil-om-at-vi-har-bevist-en-vaksine-effekt/ 2023-09-28T10:32:46+00:00 https://www.lmi.no/2023/09/28/novo-nordisk-trar-pa-bremsen-ved-nye-lanseringer-av-fedmebehandling/ 2023-09-28T10:33:59+00:00 https://www.lmi.no/2023/09/28/ultimovacs-kraftig-opp-pa-borsen-etter-nyhet-om-kreftstudie/ 2023-09-28T11:02:07+00:00 https://www.lmi.no/2023/09/29/nykode-melder-oppstart-av-kreftvaksine-studie/ 2023-09-29T07:54:48+00:00 https://www.lmi.no/2023/09/29/verdens-hjertedag-30-000-nordmenn-har-sikret-seg-denne-norskutviklede-medisinen-mot-akutt-hjerteinfarkt/ 2023-09-29T07:55:43+00:00 https://www.lmi.no/2023/09/29/pfizer-inngar-potensielt-milliardsamarbeid-med-rna-selskap/ 2023-09-29T07:56:35+00:00 https://www.lmi.no/2023/09/29/legger-frem-ultimovacs-studie-pa-esmo/ 2023-09-29T07:59:15+00:00 https://www.lmi.no/2023/09/28/upresise-formuleringer-i-sak-om-legemiddelutgifter-i-norge/ 2023-09-29T08:25:09+00:00 https://www.lmi.no/wp-content/uploads/2017/02/tomme-apotekhyller.gif https://www.lmi.no/2023/10/02/novo-nordisk-saksoker-amerikanske-helsemyndigheter-for-prisforhandlinger/ 2023-10-02T07:45:13+00:00 https://www.lmi.no/2023/10/02/olav-ljosne-i-blodkreftforeningen-de-siste-13-arene-har-vaert-som-en-langsiktig-sorgprosess/ 2023-10-02T07:49:24+00:00 https://www.lmi.no/2023/10/02/ny-lymfekreft-medisin-fra-abbvie-har-fatt-eu-godkjenning/ 2023-10-02T07:55:38+00:00 https://www.lmi.no/2023/10/02/lege-kalte-medisin-magisk-hadde-fatt-fire-millioner-fra-produsenten/ 2023-10-02T08:33:06+00:00 https://www.lmi.no/2023/10/02/hostens-nyhetsbrev-fra-aesgp-euro-otc/ 2023-10-02T09:39:50+00:00 https://www.lmi.no/wp-content/uploads/2023/10/Aesgp-logo.png https://www.lmi.no/wp-content/uploads/2023/10/AESGP-nyhetsbrev-hosten-23.png https://www.lmi.no/2023/10/02/salgstall-fra-farmastat-for-september-2023/ 2023-10-02T10:04:20+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/09/28/cra-kurs-i-oktober-er-apent-for-pamelding/ 2023-10-02T12:36:30+00:00 https://www.lmi.no/wp-content/uploads/2023/01/CRA-kurs-2023.jpg https://www.lmi.no/2023/10/02/katalin-kariko-og-drew-weissman-far-nobelprisen-i-medisin-for-covid-19-vaksine/ 2023-10-02T14:18:08+00:00 https://www.lmi.no/wp-content/uploads/2023/10/Kariko_Katalin.jpg https://www.lmi.no/wp-content/uploads/2023/10/Kariko_Katalin.jpg https://www.lmi.no/2023/10/03/merck-siri-boro-er-ny-medisinsk-direktor-i-norge/ 2023-10-03T09:04:44+00:00 https://www.lmi.no/2023/10/03/fda-setter-advarsel-pa-novo-nordisk-sitt-diabetesmiddel/ 2023-10-03T09:13:59+00:00 https://www.lmi.no/2023/10/03/johnson-johnson-med-positive-resultater-i-lungekreftstudie/ 2023-10-03T09:18:52+00:00 https://www.lmi.no/2023/10/03/alzheimer-legemiddel-tas-videre-til-vurdering-hos-legemiddelverket-og-finose/ 2023-10-03T09:21:55+00:00 https://www.lmi.no/2023/10/04/lmi-til-tv2-hovedmalet-er-a-bygge-forstaelse-og-tillit-rundt-det-nodvendige-samarbeidet-mellom-industrien-og-helsepersonell/ 2023-10-04T08:52:16+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-alvorlig-5967-scaled.jpg https://www.lmi.no/2023/10/04/sanofi-og-johnson-johnson-gar-i-samarbeid-om-eksperimentell-vaksine/ 2023-10-04T09:03:45+00:00 https://www.lmi.no/2023/10/04/alzheimer-legemiddel-tas-videre-til-vurdering-hos-legemiddelverket-og-finose-2/ 2023-10-04T09:04:53+00:00 https://www.lmi.no/2023/10/04/mulighet-for-firma-a-delta-i-internship-ordning/ 2023-10-04T12:07:55+00:00 https://www.lmi.no/wp-content/uploads/2023/10/brooke-cagle-g1Kr4Ozfoac-unsplash-scaled.jpg https://www.lmi.no/2023/10/05/lmi-for-statsbudsjettet-legges-frem-ma-oke-kapasiteten-hos-legemiddelverket-slik-at-saksbehandlingstiden-gar-ned/ 2023-10-05T09:30:08+00:00 https://www.lmi.no/wp-content/uploads/2023/08/051E4FB3-5E6F-4126-984B-B9CCD632FA61-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-blid-5977-scaled.jpg https://www.lmi.no/2023/10/05/brystkreft-nye-sterke-data-kan-gi-ja-i-beslutningsforum/ 2023-10-05T09:31:54+00:00 https://www.lmi.no/2023/10/05/eu-kommisjonen-har-godkjent-legemiddel-for-nyresvikt/ 2023-10-05T09:33:11+00:00 https://www.lmi.no/2023/10/05/direktorene-i-slv-og-fhi-er-spente-pa-de-okonomiske-rammene-knyttet-til-endrede-oppdrag/ 2023-10-05T09:39:48+00:00 https://www.lmi.no/2023/10/05/na-er-novartis-og-sandoz-skilt/ 2023-10-05T09:40:46+00:00 https://www.lmi.no/2023/10/05/msd-norge-styrker-satsingen-pa-forskning-og-utvikling/ 2023-10-05T09:41:41+00:00 https://www.lmi.no/2023/10/06/na-er-den-forste-effektive-behandlingen-for-alzheimer-her-vil-norske-pasienter-fa-den/ 2023-10-06T08:27:54+00:00 https://www.lmi.no/2023/10/06/undersoker-om-medisiner-for-andre-diagnoser-kan-ha-effekt-hos-parkinsonpasienter/ 2023-10-06T08:29:18+00:00 https://www.lmi.no/2023/10/06/hvor-fort-vi-eliminerer-livmorhalskreft-i-norge-er-et-valg/ 2023-10-06T08:38:14+00:00 https://www.lmi.no/2023/10/06/pfizer-norge-om-anbud-pa-blareseptlegemidler-rett-og-slett-en-veldig-darlig-ide/ 2023-10-06T08:43:08+00:00 https://www.lmi.no/2023/10/06/boehringer-ingelheim-om-budsjettnyheten-vi-er-veldig-glade/ 2023-10-06T08:44:51+00:00 https://www.lmi.no/2023/10/06/helsenaeringen-kan-fa-150-millioner-kroner-i-statsbudsjettet/ 2023-10-06T08:53:44+00:00 https://www.lmi.no/2023/10/06/331-millioner-kroner-flyttes-nar-slv-blir-direktorat-bevilgningen-foreslas-okt-med-ti-millioner/ 2023-10-06T08:59:26+00:00 https://www.lmi.no/2023/10/06/astma-og-allergiforbundet-om-blareseptanbud-regjeringen-bryter-lofter/ 2023-10-06T09:47:49+00:00 https://www.lmi.no/2023/10/06/statsbudsjettet-voksenvaksinasjonsprogrammet-pa-stedet-hvil/ 2023-10-06T09:49:03+00:00 https://www.lmi.no/2023/10/06/statsbudsjettet-2024-her-er-regjeringens-forslag-pa-helsefeltet/ 2023-10-06T09:50:58+00:00 https://www.lmi.no/2023/10/06/lmi-regjeringen-legger-ikke-til-rette-for-en-baerekraftig-helsetjeneste-med-dette-budsjettet/ 2023-10-06T10:00:27+00:00 https://www.lmi.no/2023/10/06/skuffet-over-at-regjeringen-videreforer-anbud-pa-blareseptomradet/ 2023-10-06T10:59:19+00:00 https://www.lmi.no/wp-content/uploads/2023/10/LRbredde.jpg https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-alvorlig-5967-scaled.jpg https://www.lmi.no/2023/10/09/meld-deg-pa-hostens-lov-og-bransjekurs-3/ 2023-10-09T09:16:22+00:00 https://www.lmi.no/wp-content/uploads/2020/02/Lovkurs-2020-DIGFORSIDE-uten-tekst.jpg https://www.lmi.no/2023/10/09/ultimovacs-far-orphan-drug-status-i-usa/ 2023-10-09T09:24:11+00:00 https://www.lmi.no/2023/10/09/dette-er-vinnerne-og-taperne-i-statsbudsjettet/ 2023-10-09T09:25:41+00:00 https://www.lmi.no/2023/10/09/20-millioner-til-blaresept-refusjon-av-to-legemidler-mot-hjertesvikt/ 2023-10-09T10:14:16+00:00 https://www.lmi.no/2023/10/09/frokostmote-hva-konkret-kan-vi-spare-pa-a-innfore-et-voksenvaksinasjonsprogram/ 2023-10-09T10:35:31+00:00 https://www.lmi.no/wp-content/uploads/2023/09/AdobeStock_vaksine-til-glad-mann-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/AdobeStock_vaksine-til-glad-mann-scaled.jpeg https://www.lmi.no/2023/10/10/ny-forskning-pa-klasehodepine-%e2%88%92-en-hinsides-smerte/ 2023-10-10T07:38:31+00:00 https://www.lmi.no/2023/10/10/norge-har-flere-mennesker-med-ms-enn-andre-land-kan-kyssesyken-vaere-en-del-av-arsaken/ 2023-10-10T07:42:07+00:00 https://www.lmi.no/2023/10/10/roche-kan-skilte-med-ny-sma-studie-pa-spedbarn/ 2023-10-10T07:45:28+00:00 https://www.lmi.no/2023/10/10/modernas-2-i-1-vaksine-bestar-sikkerhetstest-og-viser-effekt/ 2023-10-10T07:53:27+00:00 https://www.lmi.no/2023/10/10/bristol-myers-squibb-kjoper-kreftselskap-for-milliardbelop/ 2023-10-10T07:55:18+00:00 https://www.lmi.no/2023/09/19/medietrening-i-host/ 2023-10-10T08:05:27+00:00 https://www.lmi.no/wp-content/uploads/2023/09/erik-vold-1.jpg https://www.lmi.no/wp-content/uploads/2023/09/erik-vold-1.jpg https://www.lmi.no/2023/10/10/janssen-norge-far-ny-daglig-leder-pa-nyaret/ 2023-10-10T08:33:50+00:00 https://www.lmi.no/2023/10/11/har-du-innspill-til-nasjonal-kreftstrategi-2024-2028/ 2023-10-11T12:49:54+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/10/12/fedmemidler-forbindes-med-okt-forekomst-av-mageproblemer-i-ny-studie/ 2023-10-12T09:16:29+00:00 https://www.lmi.no/2023/10/12/ms-og-ocrevus-sproyte-under-huden-er-ikke-darligere-enn-intravenos-infusjon/ 2023-10-12T09:18:25+00:00 https://www.lmi.no/2023/10/12/ema-endrer-reglene-for-publisering-av-info-om-kliniske-studier/ 2023-10-12T09:21:39+00:00 https://www.lmi.no/2023/10/12/langtidsstudie-viser-vedvarende-effekt-og-sikkerhet-med-rinvoq-i-behandling-av-atopisk-eksem/ 2023-10-12T09:50:09+00:00 https://www.lmi.no/2023/10/13/enklere-a-skanne-frem-pakningsvedlegg-pa-mobilen/ 2023-10-13T08:42:08+00:00 https://www.lmi.no/wp-content/uploads/2023/10/scanne-pakningsvedlegg-3.png https://www.lmi.no/wp-content/uploads/2023/10/scanne-pakningsvedlegg-3.png https://www.lmi.no/2023/10/13/jon-magnussen-i-altinget-kan-vi-sette-en-pris-pa-et-godt-levear/ 2023-10-13T08:44:31+00:00 https://www.lmi.no/wp-content/uploads/2023/09/4B49D489-2077-48A6-8161-2E2DDCB7EFB6-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/4B49D489-2077-48A6-8161-2E2DDCB7EFB6-scaled.jpeg https://www.lmi.no/2023/10/13/biotek-nestor-mener-det-er-penger-tilgjengelig-for-gode-biotekselskaper-markedet-er-ikke-helt-paralysert/ 2023-10-13T08:59:58+00:00 https://www.lmi.no/2023/10/13/ultimovacs-deler-overlevelsesdata/ 2023-10-13T09:03:17+00:00 https://www.lmi.no/2023/10/13/msd-med-immunterapi-milepael-for-fda-beslutning/ 2023-10-13T09:07:30+00:00 https://www.lmi.no/2023/10/13/mulighetene-ligger-i-innovative-anskaffelser/ 2023-10-13T09:15:09+00:00 https://www.lmi.no/2023/10/13/north-of-the-ordinary-norsk-aften-i-milano/ 2023-10-13T12:23:11+00:00 https://www.lmi.no/wp-content/uploads/2023/10/ECTRIMS-fornoyde-arrangorerNY-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/ECTRIMS-fornoyde-arrangorerNY-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/ECTRIMS-innledereNY-scaled.jpg https://www.lmi.no/2023/10/16/medisinmangel-rammer-norge-hannah-27-er-nodt-til-a-rasjonere/ 2023-10-16T10:01:13+00:00 https://www.lmi.no/2023/10/16/bare-tre-halstabletter-har-dokumentert-effekt-de-andre-er-sukkertoy/ 2023-10-16T10:01:57+00:00 https://www.lmi.no/2023/10/16/novo-nordisk-oppjusterer-forventningene-markant/ 2023-10-16T10:02:37+00:00 https://www.lmi.no/2023/10/16/ema-anbefaler-disse-nye-legemidlene/ 2023-10-16T10:03:33+00:00 https://www.lmi.no/2023/10/16/sarsia-partner-hadde-ikke-vi-satset-pa-vaccibody-hadde-det-ikke-vaert-noe-nykode-i-dag/ 2023-10-16T10:30:29+00:00 https://www.lmi.no/2023/10/16/lmis-horingssvar-totalberedskapskommisjonen/ 2023-10-16T10:53:31+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/10/16/mote-med-forvaltningen-om-fiskevelferd/ 2023-10-16T11:08:20+00:00 https://www.lmi.no/wp-content/uploads/2023/10/Pharmaq-LMI-front-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/Pharmaq-LMI-scaled.jpg https://www.lmi.no/2023/10/16/lmi-har-sendt-innspill-til-statens-legemiddelverks-retningslinjer/ 2023-10-16T11:50:47+00:00 https://www.lmi.no/wp-content/uploads/2017/08/SLV.png https://www.lmi.no/2023/10/16/ledige-plasser-pa-medietrening/ 2023-10-16T13:48:00+00:00 https://www.lmi.no/wp-content/uploads/2023/09/erik-vold-1.jpg https://www.lmi.no/wp-content/uploads/2023/09/erik-vold-1.jpg https://www.lmi.no/2023/10/17/lmi-pa-apen-horing-i-stortingets-helse-og-omsorgskomite/ 2023-10-17T07:51:40+00:00 https://www.lmi.no/wp-content/uploads/2023/07/Leif-Rune-Skymoen1-scaled.jpg https://www.lmi.no/2023/10/17/kliniske-studier-i-norge-nortrials-skal-fungere-som-en-vei-inn-og-vaere-nasjonalt-kontaktpunkt/ 2023-10-17T08:13:16+00:00 https://www.lmi.no/2023/10/17/norske-sykehus-med-i-industristudie-pa-ny-ms-medisin-ved-full-klaff-er-effekten-lik-stamcellebehandling/ 2023-10-17T08:16:43+00:00 https://www.lmi.no/2023/10/17/eu-utsetter-godkjenningen-av-novavax-sin-covid-vaksine/ 2023-10-17T08:18:23+00:00 https://www.lmi.no/2023/10/17/pfizer-nedjusterer-forventningene-med-ni-milliarder-dollar/ 2023-10-17T08:20:34+00:00 https://www.lmi.no/2023/10/17/medwatch-lmi-med-12-krav-til-statsbudsjettet-for-2024/ 2023-10-17T08:20:51+00:00 https://www.lmi.no/wp-content/uploads/2023/10/MedWatch-front.png https://www.lmi.no/wp-content/uploads/2023/10/MedWatch-inns.png https://www.lmi.no/2023/10/17/gir-gront-lys-for-ny-behandling-mot-benmargskreft/ 2023-10-17T08:23:35+00:00 https://www.lmi.no/2023/10/17/novo-nordisk-kjoper-fase-3-legemiddel-for-potensielt-milliardbelop/ 2023-10-17T08:24:36+00:00 https://www.lmi.no/2023/10/17/medwatch-lmi-med-12-krav-til-statsbudsjettet-for-2024-2/ 2023-10-17T08:24:41+00:00 https://www.lmi.no/wp-content/uploads/2023/10/MedWatch-front.png https://www.lmi.no/wp-content/uploads/2023/10/MedWatch-front.png https://www.lmi.no/2023/10/17/langtidsdata-pa-utprovende-ms-medisin-knyttet-stor-spenning-til-btk-hemmere/ 2023-10-17T08:39:32+00:00 https://www.lmi.no/2023/10/18/qa-mediehandtering-verdioverforinger/ 2023-10-18T08:31:56+00:00 https://www.lmi.no/2023/09/29/science-impact-2023-vi-ma-gjore-i-dag-det-pasienter-trenger-i-fremtiden/ 2023-10-18T08:51:35+00:00 https://www.lmi.no/wp-content/uploads/2023/09/IMG_6470-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6474-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6478-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/Thorbjorn-Lund-Halvorsen-Roche-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6482-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6470-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6494-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6501-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6495-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6493-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6485-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6504-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6503-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6496-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6505-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/IMG_6515-scaled.jpeg https://www.lmi.no/2023/10/18/slv-ilegger-novo-nordisk-milliongebyrfor-brudd-pa-reklamereglene/ 2023-10-18T10:01:29+00:00 https://www.lmi.no/2023/10/18/rapport-diabetesmiddel-sprenger-budsjett-estimat-etter-off-label-forskrivning/ 2023-10-18T10:04:28+00:00 https://www.lmi.no/2023/10/18/resultater-fra-ultimovacs-kreftvaksine-sluppet-dette-er-helt-ratt/ 2023-10-18T10:05:39+00:00 https://www.lmi.no/2023/10/18/ema-anbefaler-utvidelse-av-indikasjonen-for-jemperli/ 2023-10-18T10:06:41+00:00 https://www.lmi.no/2023/10/18/lytix-bioharma-sikret-143-millioner-kroner-fra-skattefunn/ 2023-10-18T10:07:47+00:00 https://www.lmi.no/2023/10/18/johnson-johnson-oppjusterer/ 2023-10-18T10:09:29+00:00 https://www.lmi.no/2023/10/17/lmi-pa-horing-i-naeringskomiteen/ 2023-10-18T11:13:16+00:00 https://www.lmi.no/wp-content/uploads/2023/10/LR-og-Monica6.png https://www.lmi.no/wp-content/uploads/2023/10/stortinget-Leif-Rune-Skymoen-Monica-Larsen-2964-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/LR-og-Monica6.png https://www.lmi.no/wp-content/uploads/2023/10/LR-og-Monica4.png https://www.lmi.no/2023/10/19/gynekologisk-kreft-tror-forskningsfremskritt-vil-endre-behandlingspraksis/ 2023-10-19T08:58:18+00:00 https://www.lmi.no/2023/10/19/goldman-sachs-tror-fedmemidler-vil-selge-for-100-milliarder-dollar-i-2030/ 2023-10-19T08:59:25+00:00 https://www.lmi.no/2023/10/19/thermo-fisher-kjoper-svenske-olink-for-34-milliarder-kroner/ 2023-10-19T09:00:35+00:00 https://www.lmi.no/2023/10/19/ultimovacs-direktoren-om-kreftvaksine-gjennombruddet-har-ingen-planer-om-a-vente-med-neste-skritt/ 2023-10-19T09:01:28+00:00 https://www.lmi.no/2023/10/19/seniorradgiver-i-lmi-katrine-bryne-til-dagens-medisin-vi-trenger-en-prioriteringsmelding-for-hele-helsetjenesten-inkludert-legemidler/ 2023-10-19T10:09:19+00:00 https://www.lmi.no/wp-content/uploads/2023/10/592832.jpg https://www.lmi.no/wp-content/uploads/2023/10/592832.jpg https://www.lmi.no/2023/10/19/tv2-oppsiktsvekkende-hpv-tall-far-kreftregisteret-til-a-juble/ 2023-10-19T10:44:39+00:00 https://www.lmi.no/wp-content/uploads/2023/10/livmorhalskreft-1.jpg https://www.lmi.no/wp-content/uploads/2023/10/livmorhalskreft-1.jpg https://www.lmi.no/2023/10/23/msd-inngar-milliardavtale-med-daiichi-sankyo-for-tre-kreftlegemidler/ 2023-10-23T08:32:36+00:00 https://www.lmi.no/2023/10/23/ultimovacs-sjefen-om-vaksinenyhet-svaert-viktig/ 2023-10-23T08:34:12+00:00 https://www.lmi.no/2023/10/23/mer-enn-60-prosent-av-blaresept-soknadene-ble-ikke-behandlet-innen-180-dagers-fristen/ 2023-10-23T08:35:24+00:00 https://www.lmi.no/2023/10/23/eksterne-gjester-pa-arets-strategisamling/ 2023-10-23T10:57:19+00:00 https://www.lmi.no/wp-content/uploads/2023/10/Bergstrom-and-hayes-kopi.jpg https://www.lmi.no/wp-content/uploads/2019/10/St%C3%B8tvig.jpeg https://www.lmi.no/wp-content/uploads/2023/10/Richard.jpeg https://www.lmi.no/wp-content/uploads/2023/10/BenteHayes-550x541-1.jpg https://www.lmi.no/2023/10/24/esmo-fullsatt-nortrials-mote-om-kreftstudier-i-madrid/ 2023-10-24T07:43:03+00:00 https://www.lmi.no/wp-content/uploads/2023/10/NorTrials-ESMO-2023_arrangorene2-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/NorTrials-ESMO-2023_arrangorene2-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/Ambassador-Haugstveit_NorTrials-ESMO-2023-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/NorTrials-ESMO-2023_deltakere-scaled.jpg https://www.lmi.no/2023/10/24/blaerekreft-doblet-overlevelsen-med-ny-kombinasjon-ny-standardbehandling/ 2023-10-24T07:45:22+00:00 https://www.lmi.no/2023/10/24/enhertu-godkjent-til-lungekreftbehandling-i-europa/ 2023-10-24T08:30:31+00:00 https://www.lmi.no/2023/10/24/ultimovacs-sjefen-bekrefter-big-pharma-moter-pa-esmo-men-er-stille-om-studie-kritikk/ 2023-10-24T08:34:06+00:00 https://www.lmi.no/2023/10/24/roche-kjoper-telavant-holdings-for-803-milliarder-kroner/ 2023-10-24T08:35:43+00:00 https://www.lmi.no/2023/10/24/mange-viktige-lungekreftnyheter-vi-trenger-nye-behandlinger/ 2023-10-24T08:49:56+00:00 https://www.lmi.no/2023/10/24/beslutningsforum-sier-ja-til-tre-av-seks-metoder-og-terje-rootwelt-fortsetter/ 2023-10-24T08:54:07+00:00 https://www.lmi.no/2023/10/24/velkommen-til-drug-safety-forum-6-november/ 2023-10-24T09:07:52+00:00 https://www.lmi.no/wp-content/uploads/2021/08/Pakningsvedlegg-2-Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2021/08/Pakningsvedlegg-2-Adobe-Stock-scaled.jpeg https://www.lmi.no/2023/10/24/dagens-medisin-usikkert-om-anbud-pa-blaresept-blir-permanent/ 2023-10-24T09:50:30+00:00 https://www.lmi.no/wp-content/uploads/2023/10/blaresept.jpg https://www.lmi.no/wp-content/uploads/2023/10/blaresept.jpg https://www.lmi.no/2023/10/24/nytt-elektronisk-skjema-for-tilbakemeldinger/ 2023-10-25T07:36:21+00:00 https://www.lmi.no/wp-content/uploads/2023/10/Frustrert-lege-pc-problemer-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/Frustrert-lege-pc-problemer-scaled.jpeg https://www.lmi.no/2023/10/25/bruk-av-falske-ozempic-penner-skal-ha-fort-til-sykehusinnleggelser-i-osterrike/ 2023-10-25T09:00:07+00:00 https://www.lmi.no/2023/10/25/brystkreftstudie-bekrefter-data-haper-at-det-skal-bli-tilgjengelig-ogsa-for-vare-pasienter/ 2023-10-25T09:01:30+00:00 https://www.lmi.no/2023/10/25/livmorkreft-studie-gir-astrazeneca-hap-om-ny-behandlingstilnaerming/ 2023-10-25T09:04:14+00:00 https://www.lmi.no/2023/10/25/katrine-bryne-holdt-innlegg-pa-blodkreftforeningens-fagsamling-om-myelomatose/ 2023-10-25T10:21:08+00:00 https://www.lmi.no/wp-content/uploads/2023/10/IMG_5169-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/IMG_5169-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/IMG_5184-scaled.jpg https://www.lmi.no/2023/10/25/lmi-arrangerer-fagdag-om-klinikernes-rolle-ved-innforing-av-nye-behandlinger/ 2023-10-25T13:23:54+00:00 https://www.lmi.no/wp-content/uploads/2023/09/E6D51E6E-67D4-46F3-8CBD-AFCD3613DC33-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/09/E6D51E6E-67D4-46F3-8CBD-AFCD3613DC33-scaled.jpeg https://www.lmi.no/2023/10/26/faren-er-stor/ 2023-10-26T08:23:22+00:00 https://www.lmi.no/2023/10/26/norsk-kreftlege-presenterte-norsk-medisin-pa-europas-storste-kreftkongress/ 2023-10-26T08:32:10+00:00 https://www.lmi.no/2023/10/26/eu-klare-til-a-lempe-pa-kravene-til-kritiske-legemidler/ 2023-10-26T08:33:12+00:00 https://www.lmi.no/2023/10/26/vil-ha-et-nasjonalt-mangelutvalg-for-legemidler/ 2023-10-26T08:34:23+00:00 https://www.lmi.no/2023/10/27/brystkreft-ny-malrettet-cellegift-gir-bedre-effekt-enn-vanlig-cellegift/ 2023-10-27T08:40:49+00:00 https://www.lmi.no/2023/10/27/blareseptordningen-stortinget-ma-sette-pasientsikkerhet-forst/ 2023-10-27T08:41:36+00:00 https://www.lmi.no/2023/10/24/presentasjoner-cra-kurs-hosten-2023/ 2023-10-27T09:27:02+00:00 https://www.lmi.no/2023/10/24/faggruppen-for-pasientkontakt-i-lmi-arrangerer-seminar-for-pasientforeninger/ 2023-10-27T11:49:07+00:00 https://www.lmi.no/wp-content/uploads/2020/10/pasientforeninger-og-legemiddelindustrien-Arr_bilde-1280x960-2.jpg https://www.lmi.no/2023/10/30/populaer-medisin-er-blitt-mangelvare/ 2023-10-30T12:41:25+00:00 https://www.lmi.no/2023/10/30/urologisk-kreft-dette-var-de-viktigste-nyhetene-pa-esmo/ 2023-10-30T12:42:33+00:00 https://www.lmi.no/2023/10/30/leo-pharma-har-laget-sin-egen-utgave-av-populaer-kunstig-intelligens/ 2023-10-30T12:45:19+00:00 https://www.lmi.no/2023/10/30/bard-hoksrud-skuffet-over-at-regjeringen-droppet-debatt-om-anbud-pa-blaresept/ 2023-10-30T12:46:37+00:00 https://www.lmi.no/2023/10/06/statsbudsjettet-for-2024-budsjettet-understotter-ikke-utviklingen-av-en-baerekraftig-helsetjeneste/ 2023-10-31T10:12:52+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-alvorlig-5967-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/LR.jpg https://www.lmi.no/2023/10/18/a-vaksinere-befolkningen-er-like-smart-som-a-stro-fortauene-om-vinteren/ 2023-10-31T10:28:26+00:00 https://www.lmi.no/wp-content/uploads/2023/10/Rapport-Hva-konkret-kan-vi-spare-pa-a-innfore-et-voksenvaksinasjonsprogram-6419-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/Rapport-Hva-konkret-kan-vi-spare-pa-a-innfore-et-voksenvaksinasjonsprogram-6419-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/Forside-OE-rapport-om-gevinster-ved-voksenvaksinasjonsprogram.png https://www.lmi.no/wp-content/uploads/2023/10/Rapport-Hva-konkret-kan-vi-spare-pa-a-innfore-et-voksenvaksinasjonsprogram-6458-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/Anne-karin-Rime-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/Rapport-Hva-konkret-kan-vi-spare-pa-a-innfore-et-voksenvaksinasjonsprogram-6477-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/Rapport-Hva-konkret-kan-vi-spare-pa-a-innfore-et-voksenvaksinasjonsprogram-6449-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/Rapport-Hva-konkret-kan-vi-spare-pa-a-innfore-et-voksenvaksinasjonsprogram-6452-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/Rapport-Hva-konkret-kan-vi-spare-pa-a-innfore-et-voksenvaksinasjonsprogram-6425-scaled.jpg https://www.lmi.no/2023/10/31/muligheter-for-kliniske-studier-ved-nevroklinikken-ous/ 2023-10-31T12:49:08+00:00 https://www.lmi.no/wp-content/uploads/2023/10/AdobeStock_hjerne-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/AdobeStock_hjerne-scaled.jpeg https://www.lmi.no/2023/11/02/falske-slankemedisiner-slik-forhindrer-eu-landene-at-de-blir-solgt-i-apotekene/ 2023-11-02T09:03:40+00:00 https://www.lmi.no/2023/11/02/ber-helsepolitikerne-trekke-i-nodbremsen/ 2023-11-02T09:06:33+00:00 https://www.lmi.no/2023/11/02/slv-direktoren-mener-eus-legemiddelreform-kan-vaere-positiv-for-sma-innkjopere/ 2023-11-02T09:12:58+00:00 https://www.lmi.no/2023/11/02/astrazeneca-gjor-ny-milliardsatsing-innen-celle-og-genterapi/ 2023-11-02T09:16:27+00:00 https://www.lmi.no/2023/11/02/novo-nordisk-starter-forste-studie-pa-mennesker-med-oppkjopt-kreftkandidat/ 2023-11-02T09:17:34+00:00 https://www.lmi.no/2023/11/02/astma-og-allergiforbundet-om-blaresept-anbud-piloten-er-darlig-evaluert/ 2023-11-02T09:18:45+00:00 https://www.lmi.no/2023/11/02/inntektshopp-for-navamedic/ 2023-11-02T09:20:25+00:00 https://www.lmi.no/2023/11/02/gsk-norge-om-blaresept-anbud-dagens-ordning-fungerer/ 2023-11-02T09:25:18+00:00 https://www.lmi.no/2023/11/02/ultimovacs-studie-far-alternativ-avlesing/ 2023-11-02T09:29:34+00:00 https://www.lmi.no/2023/11/02/salgstall-fra-farmastat-for-oktober-2023/ 2023-11-02T09:34:42+00:00 https://www.lmi.no/wp-content/uploads/2020/04/hero.jpg https://www.lmi.no/2023/11/01/efpia-revisjonen-av-eu-pharma-legislation-er-et-maraton/ 2023-11-02T10:28:05+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Per-Tellner-2023-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/88805F63-4647-4E0D-8644-52754CE2DF29-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/Vekt-efpia.png https://www.lmi.no/wp-content/uploads/2023/10/38609045-ACBB-4FEB-B88E-B78E89004B1B-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/10/CB98860A-0902-4F12-B811-C1A37217040B-scaled.jpeg https://www.lmi.no/2023/11/02/verifikasjonssystemet-omtalt-i-medwatch-og-healthtalk-systemet-virker-slik-det-skal/ 2023-11-02T10:29:46+00:00 https://www.lmi.no/wp-content/uploads/2019/02/Kai-Mjaanes.jpg https://www.lmi.no/wp-content/uploads/2019/02/Kai-Mjaanes.jpg https://www.lmi.no/2023/11/02/dra-forum-inviterer-til-digitalt-medlemsmote/ 2023-11-02T18:47:54+00:00 https://www.lmi.no/wp-content/uploads/2022/06/chris-montgomery-smgTvepind4-unsplash-2-scaled.jpg https://www.lmi.no/wp-content/uploads/2022/06/chris-montgomery-smgTvepind4-unsplash-2-scaled.jpg https://www.lmi.no/2023/11/02/lmis-horingssvar-til-nasjonal-kreftstrategi-2024-2028/ 2023-11-02T19:42:07+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/11/03/karoline-knutsen-i-lmi-holdt-innlegg-pa-den-nasjonale-prostatakreftdagen/ 2023-11-03T09:15:50+00:00 https://www.lmi.no/wp-content/uploads/2023/11/IMG_5936-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_5936-scaled.jpeg https://www.lmi.no/2023/11/03/ny-podcast-sterk-motstand-mot-blareseptanbud-og-vinn-eller-forsvinn-for-ultimovacs/ 2023-11-03T12:36:00+00:00 https://www.lmi.no/2023/11/03/sv-er-mot-anbud-pa-blaresept-men-holder-kortene-tett-til-brystet/ 2023-11-03T12:36:47+00:00 https://www.lmi.no/2023/11/03/legemiddelselskap-utfordrer-brenna-djerve-tanker-ma-folges-av-nye-losninger/ 2023-11-03T12:37:16+00:00 https://www.lmi.no/2023/11/06/medisiner-pa-anbud-helseministeren-far-kritikk-for-hemmelighold-og-hastverk/ 2023-11-06T12:06:57+00:00 https://www.lmi.no/2023/11/06/samfunnsperspektiv-i-prioriteringer-bor-det-heller-kalles-verdsetting-av-produktivitet/ 2023-11-06T12:09:18+00:00 https://www.lmi.no/2023/11/06/ultimovacs-tilleggsstudie-pa-foflekkreft-er-fullrekruttert/ 2023-11-06T12:27:01+00:00 https://www.lmi.no/2023/11/06/novo-nordisk-toppsjefen-advarer-om-eus-legemiddelreform/ 2023-11-06T12:27:52+00:00 https://www.lmi.no/2023/11/06/han-er-ny-sjef-i-takeda-norge-og-norden/ 2023-11-06T12:30:38+00:00 https://www.lmi.no/2023/11/06/rundebordskonferanse-om-prioriteringsmeldingen/ 2023-11-06T15:02:42+00:00 https://www.lmi.no/wp-content/uploads/2023/11/IMG_2863-front-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/IMG_2863-scaled.jpg https://www.lmi.no/2023/11/07/kommunene-kan-fa-palegg-om-a-fjerne-medisinrester-fra-avlopsvann/ 2023-11-07T08:59:24+00:00 https://www.lmi.no/2023/11/07/pfizer-innforer-omfattende-sparetiltak-200-far-sparken-i-usa/ 2023-11-07T09:00:59+00:00 https://www.lmi.no/2023/11/07/ny-utstilling-stiller-sporsmal-om-legemiddelberedskap/ 2023-11-07T09:05:07+00:00 https://www.lmi.no/2023/11/07/sv-uklokt-med-blareseptanbud/ 2023-11-07T09:13:45+00:00 https://www.lmi.no/2023/11/07/heinrich-etter-esmo-kongressen-innforing-av-ny-behandling-tar-unodvendig-lang-tid/ 2023-11-07T10:07:25+00:00 https://www.lmi.no/2023/11/08/sv-om-blaresept-pa-anbud-uheldig-at-regjeringen-tar-et-slikt-grep/ 2023-11-08T08:13:33+00:00 https://www.lmi.no/2023/11/03/innovasjoner-fra-industrien-pa-times-liste-over-the-best-inventions-2023/ 2023-11-08T08:16:07+00:00 https://www.lmi.no/wp-content/uploads/2023/11/AdobeStock_medisinske-innovasjoner_crop-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/AdobeStock_medisinske-innovasjoner-scaled.jpeg https://www.lmi.no/2023/11/08/ms-syke-anne-matte-til-mexico-for-behandling-hun-ble-nektet-i-norge/ 2023-11-08T08:37:41+00:00 https://www.lmi.no/2023/11/08/novartis-vil-flytte-radioaktivt-legemiddel-fremover-i-linjene-fda-ber-om-overlevelsesdata/ 2023-11-08T10:24:02+00:00 https://www.lmi.no/2023/11/08/starter-viktig-prioriteringsdebatt/ 2023-11-08T10:26:39+00:00 https://www.lmi.no/2023/11/09/fda-godkjenner-ny-slankemedisin-som-vil-konkurrere-med-wegovy/ 2023-11-09T08:27:59+00:00 https://www.lmi.no/2023/11/09/kraftige-reaksjoner-pa-solbergs-lobby-uttalelse/ 2023-11-09T08:31:31+00:00 https://www.lmi.no/2023/11/09/apocillin-mangel-seks-maneders-forbruk-pa-beredskapslager/ 2023-11-09T08:37:30+00:00 https://www.lmi.no/2023/10/27/nho-sjefen-kommer-pa-strategisamlingen/ 2023-11-09T10:10:26+00:00 https://www.lmi.no/wp-content/uploads/2023/10/OleErikAlmlid-113.jpg https://www.lmi.no/wp-content/uploads/2023/10/Richard.jpeg https://www.lmi.no/wp-content/uploads/2023/10/OleErikAlmlid-113-port.jpg https://www.lmi.no/wp-content/uploads/2023/10/BenteHayes-550x541-1.jpg https://www.lmi.no/2023/11/09/pa-stand-under-farmasidagene/ 2023-11-09T10:51:37+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Standen-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Standen-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Stand-uten-folk-scaled.jpg https://www.lmi.no/2023/11/09/se-lmis-seminar-for-pasientforeninger-her/ 2023-11-09T12:16:41+00:00 https://www.lmi.no/wp-content/uploads/2023/11/IMG_5989-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_5989-scaled.jpeg https://www.lmi.no/2023/11/10/artbio-henter-pfizer-veteran-til-toppstilling/ 2023-11-10T08:17:25+00:00 https://www.lmi.no/2023/11/10/biogen-oppjusterer-salgsprognose/ 2023-11-10T08:18:13+00:00 https://www.lmi.no/2023/11/10/novo-nordisk-blar-opp-67-milliarder-til-okt-produksjon/ 2023-11-10T08:19:00+00:00 https://www.lmi.no/2023/11/10/katrine-bryne-holdt-innlegg-og-deltok-i-panelsamtale-pa-fagmote-i-humangenetikk/ 2023-11-10T11:54:00+00:00 https://www.lmi.no/wp-content/uploads/2023/11/IMG_6017-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6017-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6031-scaled.jpeg https://www.lmi.no/2023/11/13/novo-nordisk-fedmemiddel-reduserer-risikoen-for-blodpropp-og-alvorlige-kardiovaskulaere-hendelser/ 2023-11-13T09:43:51+00:00 https://www.lmi.no/2023/11/13/anbefaler-at-diabetesmedisinen-mounjaro-godkjennes-som-slankemiddel-i-europa/ 2023-11-13T09:45:19+00:00 https://www.lmi.no/2023/11/13/mener-ny-medisin-kan-redde-tusenvis-av-kvinner/ 2023-11-13T09:46:21+00:00 https://www.lmi.no/2023/11/13/6-legemiddelselskaper-helsemyndighetene-gambler-med-folketrygdens-grunnmur/ 2023-11-13T09:47:10+00:00 https://www.lmi.no/2023/11/13/eu-pharma-legislation-revision-hva-mener-lmi/ 2023-11-13T09:51:29+00:00 https://www.lmi.no/wp-content/uploads/2023/11/EU-pharma-strategy_legislation_Adobe-Stock-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/EU-pharma-strategy_legislation_Adobe-Stock_bredde-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Par-Tellner-pa-Regulatorisk-hostmote-2023-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/10/38609045-ACBB-4FEB-B88E-B78E89004B1B-scaled.jpeg https://www.lmi.no/2023/11/14/novo-nordisk-i-moter-med-legemiddelverket-om-wegovy-etter-slipp-av-studiedata/ 2023-11-14T08:59:29+00:00 https://www.lmi.no/2023/11/14/medisinmangel-over-hele-landet-alvorlig-situasjon/ 2023-11-14T09:01:49+00:00 https://www.lmi.no/2023/11/14/venstre-vil-oke-satsingen-pa-helsekatapult/ 2023-11-14T11:07:09+00:00 https://www.lmi.no/wp-content/uploads/2023/11/51234147691_b18117ac91_c.jpg https://www.lmi.no/wp-content/uploads/2023/11/51234147691_b18117ac91_c.jpg https://www.lmi.no/wp-content/uploads/2019/04/Monica2.jpg https://www.lmi.no/2023/11/14/skymoen-i-medwatch-for-lav-betalingsvillighet-kan-fore-til-tap-av-liv-og-helse/ 2023-11-14T13:45:15+00:00 https://www.lmi.no/wp-content/uploads/2023/01/Leif-Rune-Skymoen-alvorlig-5967-scaled.jpg https://www.lmi.no/2023/11/14/fresenius-kabi-fabrikken-viderefores/ 2023-11-14T14:24:15+00:00 https://www.lmi.no/wp-content/uploads/2023/11/fk-h.jpg https://www.lmi.no/wp-content/uploads/2023/11/fk-h.jpg https://www.lmi.no/2023/11/14/fresenius-kabi-fabrikken-viderefores-2/ 2023-11-14T14:31:31+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Thon-fresenius-2048x1035-1.jpg https://www.lmi.no/wp-content/uploads/2023/11/Thon-fresenius-2048x1035-1.jpg https://www.lmi.no/2023/11/14/samarbeidsmote-mellom-de-nordiske-legemiddelindustriforeningene-og-nordisk-legemiddelforum/ 2023-11-14T19:18:10+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Nordisk-mote1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Nordisk-mote1-scaled.jpg https://www.lmi.no/2023/11/15/far-livstruande-anfall-eg-er-langt-forbi-a-vere-lei/ 2023-11-15T10:13:06+00:00 https://www.lmi.no/2023/11/15/koki-sato-ny-sjef-for-takeda-i-norge-og-norden/ 2023-11-15T10:22:25+00:00 https://www.lmi.no/wp-content/uploads/2023/11/IMG_0074-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/IMG_0074-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/0ep0vuiu.png https://www.lmi.no/2023/11/15/ny-takeda-sjef-apnet-nye-lokaler-i-asker-vil-sikre-innovative-medisiner-til-norske-pasienter/ 2023-11-15T10:33:30+00:00 https://www.lmi.no/2023/11/15/legemiddelfabrikk-i-halden-blir-solgt/ 2023-11-15T10:34:47+00:00 https://www.lmi.no/2023/11/15/blareseptanbudet-diabetesbehandling-pa-vei-baklengs-inn-i-fremtiden/ 2023-11-15T10:38:12+00:00 https://www.lmi.no/2023/11/15/astrazenecas-lungekreft-studie-mislyktes/ 2023-11-15T10:41:42+00:00 https://www.lmi.no/2023/11/15/lmi-i-mote-med-sykehusinnkjop-hvor-tiltak-for-a-sikre-konfidensialitet-ble-diskutert/ 2023-11-15T15:29:07+00:00 https://www.lmi.no/wp-content/uploads/2023/11/IMG_2177-1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/IMG_2177-1-scaled.jpg https://www.lmi.no/2023/11/16/hvordan-kan-norge-fa-mer-ut-av-helsedata/ 2023-11-16T12:10:16+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Banner-Livsvitenskapskonferansen_crlp.png https://www.lmi.no/wp-content/uploads/2023/11/Banner-Livsvitenskapskonferansen.png https://www.lmi.no/2023/11/17/legemiddelverket-snur-dette-er-legemidlene-de-vil-ha-pa-anbud/ 2023-11-17T07:45:09+00:00 https://www.lmi.no/wp-content/uploads/2023/11/erling-healthtalk-blaresept.png https://www.lmi.no/wp-content/uploads/2023/11/erling-healthtalk-blaresept.png https://www.lmi.no/wp-content/uploads/2023/11/erling-i-medwatch-blaresept.png https://www.lmi.no/2023/11/17/slv-mener-diabetesmidlene-til-novo-nordisk-kan-egne-seg-for-anbud/ 2023-11-17T07:48:02+00:00 https://www.lmi.no/2023/11/17/bard-hoksrud-mener-begrunnelse-for-hemmelighold-er-syltynn/ 2023-11-17T07:49:05+00:00 https://www.lmi.no/2023/11/17/derfor-offentliggjor-legemiddelverket-hele-anbudsevalueringen-na/ 2023-11-17T07:50:01+00:00 https://www.lmi.no/2023/11/17/antibiotikabruken-oker-raskt-igjen/ 2023-11-17T07:51:25+00:00 https://www.lmi.no/2023/11/17/corona-og-influensa-bekymret-fa-barn-og-unge-vaksinert/ 2023-11-17T07:54:17+00:00 https://www.lmi.no/2023/11/17/pasient-dode-etter-feilmedisinering/ 2023-11-17T07:56:11+00:00 https://www.lmi.no/2023/11/17/jorgen-vik-blir-organisasjonsdirektor-ved-ife/ 2023-11-17T07:57:52+00:00 https://www.lmi.no/2023/11/17/helland-om-utviklingen-av-lungekreft-behandling-flere-pasienter-vi-na-kan-gjore-mye-for/ 2023-11-17T07:59:30+00:00 https://www.lmi.no/2023/11/17/eli-lilly-skal-bygge-fabrikk-til-to-milliarder-euro-i-tyskland/ 2023-11-17T08:00:23+00:00 https://www.lmi.no/2023/11/17/hivnorge-vil-ha-prep-med-i-blaresept-anbud/ 2023-11-17T08:03:26+00:00 https://www.lmi.no/2023/11/20/professor-hyller-ny-kronisk-bihulebetennelse-medisin/ 2023-11-20T10:31:14+00:00 https://www.lmi.no/2023/11/20/mener-anbudspiloten-ikke-har-gitt-bedre-medisintilgang-til-pasienter-med-alvorlig-sykdom/ 2023-11-20T10:34:33+00:00 https://www.lmi.no/2023/11/20/far-inn-ekstreme-mengder-sexmidler-hver-uke-noen-bestiller-opp-til-1000-stykker/ 2023-11-20T10:42:18+00:00 https://www.lmi.no/2023/11/20/advarer-om-antibiotikatabbe-skal-destrueres/ 2023-11-20T11:12:36+00:00 https://www.lmi.no/2023/11/20/takeda-i-nytt-hus-alle-bor-ha-en-ordentlig-god-kaffemaskin-den-binder-oss-sammen/ 2023-11-20T11:15:55+00:00 https://www.lmi.no/2023/11/20/lmi-arrangerer-informasjonsmote-om-innforing-av-eu-htar/ 2023-11-20T11:18:07+00:00 https://www.lmi.no/wp-content/uploads/2019/07/christian-wiediger-735834-unsplash-2.jpg https://www.lmi.no/2023/11/20/okt-antibiotikabruk-krever-en-ny-handlingsplan/ 2023-11-20T11:18:49+00:00 https://www.lmi.no/2023/11/20/kronikk-revisjonen-av-eus-legemiddellover-slar-feil-vei/ 2023-11-20T11:31:45+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Leif-Rune-kronikk-medwatch-nov-23.png https://www.lmi.no/wp-content/uploads/2023/11/Leif-Rune-kronikk-medwatch-nov-23.png https://www.lmi.no/2023/11/21/ecdc-det-gar-sakte-fremover-i-kampen-mot-antibiotikaresistens/ 2023-11-21T08:30:35+00:00 https://www.lmi.no/2023/11/21/fresenius-kabi-bytter-navn-til-halden-pharma/ 2023-11-21T08:40:40+00:00 https://www.lmi.no/2023/11/21/tyskland-vurderer-eksportforbud-av-ozempic/ 2023-11-21T08:42:56+00:00 https://www.lmi.no/2023/11/21/bayer-avbryter-delvis-norsk-fase-3-studie-med-blodfortynnende-legemiddelkandidat/ 2023-11-21T08:47:44+00:00 https://www.lmi.no/2023/11/21/beslutningsforum-disse-fikk-ja-og-disse-fikk-nei-i-dag/ 2023-11-21T08:51:17+00:00 https://www.lmi.no/2023/11/21/verdens-forste-crispr-medisin-godkjent-for-sigdcelleanemi-og-beta-talassemi/ 2023-11-21T08:52:36+00:00 https://www.lmi.no/2023/11/21/slik-vil-halden-pharmas-nye-eiere-oke-lonnsomheten/ 2023-11-21T08:53:28+00:00 https://www.lmi.no/2023/11/21/ge-ansatt-blir-varaordforer-i-lindesnes/ 2023-11-21T08:54:31+00:00 https://www.lmi.no/2023/11/21/nye-endringer-i-lmis-utvalgsstruktur/ 2023-11-21T09:56:08+00:00 https://www.lmi.no/wp-content/uploads/2023/03/LMIs-styre-2023-25_crop1-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/03/LMIs-styre-2023-25_crop1-scaled.jpg https://www.lmi.no/2023/11/02/program-for-motet-klinikernes-rolle-ved-innforing-av-nye-behandlinger-hva-bringer-fremtiden/ 2023-11-21T10:22:53+00:00 https://www.lmi.no/wp-content/uploads/2023/10/Collage-Dig.png https://www.lmi.no/wp-content/uploads/2023/10/Collage-Dig.png https://www.lmi.no/2023/11/23/medlemsmote-om-arbeidet-med-implementeringen-av-eus-hta-forordning-pa-metodevurderinger/ 2023-11-23T08:34:45+00:00 https://www.lmi.no/wp-content/uploads/2021/11/EU2-scaled.jpg https://www.lmi.no/wp-content/uploads/2017/12/Audun-Ohna_roche.jpg https://www.lmi.no/2023/11/23/lmi-disse-tiltakene-vil-styrke-legemiddelberedskapen-dagens-medisin/ 2023-11-23T12:36:59+00:00 https://www.lmi.no/wp-content/uploads/2023/11/front-DM-kopi.jpg https://www.lmi.no/wp-content/uploads/2023/11/front-DM-kopi.jpg https://www.lmi.no/wp-content/uploads/2023/03/Leif-Rune-Skymoen_portrett-nytt-scaled.jpg https://www.lmi.no/2023/11/23/rekordar-for-slankesproyter-utviklingen-bekymrer/ 2023-11-23T12:49:47+00:00 https://www.lmi.no/2023/11/23/pa-helseministerens-eksamen-er-alle-hjelpemidler-tillatt/ 2023-11-23T12:50:33+00:00 https://www.lmi.no/2023/11/23/baerekraftig-bruk-av-lusemidler-lovende-med-flytefor/ 2023-11-23T13:03:55+00:00 https://www.lmi.no/2023/11/24/ny-podcast-hvorfor-blir-immunterapi-mot-kreft-kanskje-snart-hurtiginnfort/ 2023-11-24T08:28:21+00:00 https://www.lmi.no/2023/11/24/ekstremt-engstelig-for-unge-som-tar-smertestillende-for-a-skade-seg-selv/ 2023-11-24T08:38:40+00:00 https://www.lmi.no/2023/11/24/sjomat-norge-tar-til-orde-for-tiltakspakke-for-a-styrke-fiskevelferd/ 2023-11-24T08:39:42+00:00 https://www.lmi.no/2023/11/24/barn-med-sterke-smerter-far-for-lite-hjelp-viser-forsking/ 2023-11-24T08:54:10+00:00 https://www.lmi.no/2023/11/24/msd-kjoper-parkinsons-selskap-i-milliardavtale/ 2023-11-24T09:24:48+00:00 https://www.lmi.no/2023/11/24/horing-endringer-i-trinnprissystemet-2/ 2023-11-24T09:28:02+00:00 https://www.lmi.no/wp-content/uploads/2022/12/Horing_illustrasjon.png https://www.lmi.no/2023/11/24/helseberedskapsmeldingen-for-svak-pa-nasjonale-tiltak/ 2023-11-24T14:16:21+00:00 https://www.lmi.no/wp-content/uploads/2023/11/Leif-Rune-og-Kjerkol_Helseberedskapsmeldingen-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Leif-Rune-og-Kjerkol_Helseberedskapsmeldingen-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Leif-Rune-intervjues-av-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/Leif-Rune-intervjues-av-Dagens-Medisin-scaled.jpg https://www.lmi.no/2023/11/27/lmi-bidro-pa-motet-promotional-compliance-in-the-nordics-i-danmark/ 2023-11-27T09:11:12+00:00 https://www.lmi.no/wp-content/uploads/2023/11/20231116_114142-scaled.jpg https://www.lmi.no/wp-content/uploads/2023/11/20231116_114142-scaled.jpg https://www.lmi.no/2023/11/27/novo-nordisk-pressesjefen-om-eksplosjon-i-medieomtale-fenomenalt-sprott-og-utrolig/ 2023-11-27T10:25:15+00:00 https://www.lmi.no/2023/11/27/deltakerne-raste-ned-i-vekt-ny-slankepille-kan-naerme-seg-lansering/ 2023-11-27T10:25:36+00:00 https://www.lmi.no/2023/11/27/slik-kan-kunstig-intelligens-hindre-dodsfall-av-livstruende-sykdom/ 2023-11-27T10:32:36+00:00 https://www.lmi.no/2023/11/27/helseberedskapsmeldingen-%e2%88%92-loser-ikke-oppdraget-og-tar-ikke-vare-pa-folka/ 2023-11-27T10:40:59+00:00 https://www.lmi.no/2023/11/27/helseberedskapsmeldingen-savner-at-penger-legemiddelmangel-og-bemanning-adresseres/ 2023-11-27T10:47:47+00:00 https://www.lmi.no/2023/11/27/enighet-om-at-klinikerne-bor-involveres-mer-i-fremtidens-prioriteringer-i-helsevesenet/ 2023-11-27T14:29:28+00:00 https://www.lmi.no/wp-content/uploads/2023/11/IMG_6244-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6244-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_0159-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6202-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6218-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6220-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6144-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6152-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6153-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6189-scaled.jpeg https://www.lmi.no/wp-content/uploads/2023/11/IMG_6206-scaled.jpeg https://www.lmi.no/2023/11/28/apotek-sjef-reagerer-pa-oppblast-statistikk/ 2023-11-28T07:14:55+00:00 https://www.lmi.no/2023/11/28/mener-legemiddelverket-ma-tillate-mer-usikkerhet-i-metodevurderinger-for-sjeldne-tilstander/ 2023-11-28T07:20:14+00:00 https://www.lmi.no/2023/11/28/biontech-forventer-kreftvaksine-godkjenning-innen-2030/ 2023-11-28T07:38:59+00:00 https://www.lmi.no/2023/11/28/hod-har-brukt-fh-pasienter-i-et-kynisk-spill-for-a-skape-en-suksesshistorie-om-anbud-pa-blaresept/ 2023-11-28T07:48:25+00:00